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I. CURRICULUM VITAE 
 
Née le 28 avril 1971 à Libourne (33), France, nationalité française. 
 
Adresse professionnelle:  
Institut de Biologie du Développement de Marseille (IBDM), 
UMR CNRS 7288 - Aix Marseille Université,  
Parc scientifique de Luminy, Case 907, 13288 Marseille cedex 9. 
Tél: +33(0)4 91 26 92 50; Fax: +33(0)4 91 26 92 44  
e-mail: corinne.beurrier@univ-amu.fr 
 
Situation actuelle:  
Chargé de Recherche de 1ère classe CNRS à l’IBDM dirigé par le Dr. A Le Bivic, commission 25 : 
"Neurobiologie moléculaire et cellulaire, neurophysiologie". 
 
 
GRADES UNIVERSITAIRES ET PARCOURS SCIENTIFIQUE  
 
• 1993 : Maîtrise de Psychologie Expérimentale, Université de Bordeaux II.  
Ces quatre années d’étude en psychologie ont été très enrichissantes d’un point de vue personnel. 
Cependant, ne me projetant pas dans une carrière professionnelle en tant que psychologue, j’ai décidé 
de changer d’orientation. L’université de Bordeaux offrant l’opportunité aux étudiants en psychologie 
de s’inscrire dans un cursus neuroscientifique, j’ai saisi cette occasion.  
 • 1994 : Diplôme d’Etudes Approfondies de Neurosciences et Pharmacologie, Universités de 
Bordeaux I et II.  
• 1994-1998 : Doctorat Sciences biologiques et médicales, Université de Bordeaux II.  
J’ai effectué ma thèse dans le laboratoire de Neurophysiologie dirigé par le Dr. B. Bioulac, UMR CNRS 
5543. Après mon stage de DEA effectué dans le même laboratoire où j’ai travaillé sur l’effet de la 
stimulation à haute fréquence du noyau subthalamique chez le singe, j’ai décidé, pour une raison qui 
m’échappe encore, de faire de l’électrophysiologie in vitro sur des tranches de cerveau. Le noyau 
subthalamique est resté mon centre d’intérêt et j’ai décortiqué au cours de ma thèse les propriétés 
intrinsèques de ces neurones par des enregistrements intracellulaires et en patch-clamp. 
L’électrophysiologie in vitro sur tranches étant une approche nouvelle dans le laboratoire, je dois 
remercier ici  plusieurs personnes sans lesquelles mon parcours scientifique aurait pu s’arrêter là … 
Particulièrement : Jean-Marc Israel, chercheur travaillant sur les neurones de l’hypothalamus  dans le 
laboratoire de D. Poulain, qui m’a appris l’électrophysiologie ; Jacques Audin, électronicien dans le 
laboratoire, qui m’a apporté une aide technique (et amicale) inestimable et enfin Constance Hammond 
qui a co-encadré ma thèse avec Bernard Bioulac. J’ai soutenu mon travail de thèse en novembre 1998. 
• 1999-2002 : Post-doctorat, Stanford University dans le Nancy Pritzker laboratory dirigé par le Dr. 
Robert.C. Malenka, Department of Psychiatry and Behavioral Sciences, School of Medicine.  
J’ai décidé d’explorer le monde de la synapse que je n’avais pas du tout abordé au cours de ma thèse 
chez Robert C. Malenka qui venait de s’installer à l’université de Stanford après avoir travaillé de 
nombreuses années dans le laboratoire de Roger Nicoll. J’ai travaillé principalement sur l’effet de la 
cocaïne sur la transmission glutamatergique dans le noyau accumbens. Nous avons montré que la 
dépression à long terme entre les synapses du cortex pré-frontal et les neurones de projection du 
noyau acccumbens pouvait être un des substrats neuronaux de la sensibilisation à la cocaïne.    
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• 2002-2003 : Post-doctorat, Institut de Neurobiologie de la Méditerranée (INMED) dirigé par le Dr. 
Y. Ben-Ari, INMED - INSERM U29, Marseille. Après mon post-doc, j’ai décidé d’intégrer l’équipe de 
Constance Hammond avec qui j’avais travaillé pendant ma thèse. J’ai ainsi rejoint l’INMED qui venait 
tout juste de s’installer à Marseille. J’ai développé au cours de ces années une préparation permettant 
de conserver le réseau des ganglions de la base in vitro.  
• 2003 : Recrutée au CNRS en tant que chargé de recherche de 2ième classe par la commission 24 
"Interactions cellulaires". Affectée à l’Institut de Neurosciences de la Méditerranée (INMED) dirigé par 
le Dr. Y. Ben-Ari, INSERM U29, Marseille. 
• 2003-2006 : J’ai poursuivi le travail entamé pendant mon post-doc toujours dans l’équipe de 
Constance Hammond à l’INMED.  
• 2006 - présent : en 2006, Lydia Kerkerian m’a accueillie dans son équipe "Interactions Cellulaires, 
Neurodégénérescence et Neuroplasticité" installée depuis peu à l’Institut de Biologie du 
Développement de Marseille (IBDM, UMR CNRS 6216 - Aix Marseille Université) dirigé à l’époque par 
le Dr. Geneviève Rougon et actuellement par le Dr. André Le Bivic. En 2007, j’ai été promue au grade 
de chargé de recherche de 1ère classe. La thématique de l’équipe se focalise sur la fonction des 
ganglions de la base dans un contexte normal et pathologique, particulièrement la maladie de 
Parkinson. A mon arrivée, j’ai travaillé en étroite collaboration avec Paolo Gubellini sur des projets en 
cours dans le laboratoire s’attachant à décrire le rôle des transporteurs et des récepteurs 
métabotropiques du glutamate dans un contexte parkinsonien. Depuis quelques années, je développe 
ma propre thématique au sein du laboratoire que j’exposerai plus en détail dans ce manuscrit.    
 
 
ENCADREMENT 
• Delphine Révy : Master 2 Biologie des Eucaryotes, Aix-Marseille Université, 2007-2008. Delphine a 
caractérisé les effets d’un nouvel agoniste orthostérique des récepteurs mGlu4 au niveau de la synapse 
striato-pallidale. Ce travail s’inscrivait dans une collaboration plus large impliquant J-P Pin, F. Acher et 
M. Amalric sur le potentiel thérapeutique de nouvelles molécules agissant sur les récepteurs mGlu 
dans la maladie de Parkinson.  
• Delphine Révy : Thèse de doctorat Aix-Marseille Université, Spécialité : Neurosciences, 2008-2012. 
Delphine a décidé de rester faire sa thèse dans le laboratoire après avoir obtenu une bourse du 
ministère de l’Enseignement Supérieur et de la Recherche et a été ma première étudiante en thèse. 
Elle a caractérisé d’un point de vue cellulaire et comportemental un modèle de souris transgénique 
que j’ai créé en collaboration avec le Dr. Hélène Marie permettant l’ablation spécifique des neurones 
striato-nigraux. 
• Latéfa Yekhlef : Master 2 Neurosciences Aix-Marseille Université, Spécialité : cellulaire et 
moléculaire, 2011-2012. Latéfa est arrivée au laboratoire au moment où je développais 
l’optogénétique. Elle a testé les effets de deux types d’opsines, la channelrhodopsine (activation) et 
l’halorhodopsine (inhibition), sur l’activité électrique de la population que nous voulions cibler : les 
interneurones cholinergiques du striatum.  
• Florence Jaouen : Ingénieur de recherche en CDD de 2011 à 2016. Nous avons recruté Florence grâce 
à l’ANR que nous avions obtenu en 2011. Florence a énormément contribué à la mise en place de la 
technique d’optogénétique grâce à ses compétences en biologie moléculaire et cellulaire. 
• Marion Deroche : Etudiante en Licence 3 Sciences de la vie, Aix-Marseille Université, 2012-2013. 
Marion a été co-encadrée par Florence et moi-même et a participé à la caractérisation du modèle 
optogénétique.  
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• Dorian Chabbert : Master 2 Neurosciences Aix-Marseille Université, Spécialité : Neurobiologie, 
Neurophysiologie, Neuropathologie, 2012-2013.  Dorian a repris la suite du travail de thèse de 
Delphine et a approfondi les relations entre les neurones striato-nigraux et les interneurones 
cholinergiques. Il a obtenu une bourse du ministère de l’Enseignement Supérieur et de la Recherche à 
l’issue de son master 2 et a poursuivi sa thèse dans le laboratoire sous la direction de P. Gubellini.  
• Gwenaëlle Laverne : Master 2 Biologie Santé, Sciences du médicament de l’Université de Poitiers, 
Spécialité : Recherche et Ingénierie et Bio-santé, 2015-2016.  Gwenaëlle effectuait son Master à 
Poitiers et a voulu faire son stage dans le laboratoire pour se former aux techniques 
d’électrophysiologie et d’optogénétique. Elle a caractérisé le patron induit par l’activation de la 
channelrhodopsine sur l’activité électrique des interneurones cholinergiques. 
• Gwenaëlle Laverne : Thèse de doctorat Aix-Marseille Université, Spécialité : Neurosciences, 2016 -
présent. Bien qu’ayant obtenu une bourse à l’université de Poitiers, Gwenaëlle a décidé de faire sa 
thèse avec moi sur les effets de la manipulation optogénétique des interneurones cholinergiques sur 
la plasticité cortico-striée à long terme. Elle est financée par un contrat que j’ai obtenu à la Fondation 
de France. 
 
BOURSES DE RECHERCHE ET PRIX 
• 1994-1997 : Bourse de thèse du ministère de la recherche et de l’éducation nationale, Université de 
Bordeaux II. 
• 1998 : Bourse de thèse de l’Institut Lilly, Université de Bordeaux II. 
• 1999-2000 : Bourse de post-doctorat attribuée par la Fondation pour la Recherche Médicale, 
Université de Stanford, USA. 
• 2000 : Prix du jeune post-doctorant attribué par la Société Française des Neurosciences. 
• 2000-2002 : CDD de 2 ans comme post-doctorante à l’Université de Stanford, USA. 
• 2002 : Bourse candidat INSERM/CNRS attribuée par la Fondation pour la Recherche Médicale, 
INSERM U29, Marseille. 
• 2003 : CDD du CNRS  comme post-doctorante, CNRS UMR 5543, Bordeaux. 
• 2005 : Financement de la Ville de Marseille pour l'aide à l'installation de chercheurs extérieurs. 
 
 
TRAVAUX D’EXPERTISE 
• Evaluation de demande de financement pour : 
- Fondation de France, comité Parkinson (depuis 2015) 
- Dystonia Foundation 
- Fonds de la Recherche Scientifique, Belgique 
- Fédération pour la Recherche sur le Cerveau.  
• Revues scientifiques : Journal of Neurophysiology, Neurobiology of Disease, PlosOne, The Journal of 
Neuroscience, Cell Reports. 
• Jurys de thèse   
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FINANCEMENTS POUR LA RECHERCHE 
Financements demandés et obtenus : 
• 2007 : Fondation de France, programme "Physiopathologie de la maladie de Parkinson", PI.  
- Titre: "Contrôle de l’équilibre GABA/glutamate dans le réseau des ganglions de la base par les voies 
directe et indirecte en situation normale et pathologique". 
- Partenaire : Dr. H. Marie, European Brain Research Institute, Rome, Italie. 
- Montant : 2 ans, 70 000 €.  
• 2007 : Fédération pour la Recherche sur le Cerveau, PI.  
- Titre : "Characterization of the GABAergic and glutamatergic drives in the basal ganglia network in 
physiological and pathological conditions". 
- Partenaire : Dr. H. Marie, European Brain Research Institute, Rome, Italie. 
- Montant : 2 ans, 30 000 €. 
• 2010 : Association France Parkinson, PI.  
- Titre: "Plasticity and role of cholinergic-driven striatal microcircuits in basal ganglia 
pathophysiological functioning". 
- Durée et montant : 2 ans, 25 000 €. 
• 2010 : ANR, programme blanc (comité d’évaluation : SVSE 4 Neurosciences), partenaire. 
- Titre : "Plasticity and role of cholinergic-driven striatal microcircuits in basal ganglia 
pathophysiological functioning". 
- Acronyme : OptoChAT-Park. 
- Partenaires : Equipe du Dr. Marianne Amalric, Laboratoire de Neurobiologie de la Cognition 
(UMR6155 CNRS/Aix-Marseille Université), France. 
- Durée et montant : 3 ans, 455 918  €. 
• 2016 : Fondation de France (comité d’évaluation : Parkinson), PI. 
- Titre : “Modulation de la plasticité corticostriatale par les interneurones cholinergiques du striatum 
en situation normale et parkinsonienne“. 
- Durée et montant : 2 ans, 102 600 €. 
• 2017 : Association France Parkinson, co-PI. 
- Titre : “Investigating the expression of miR-124, miR-128 and miR-132 in specific striatal neuronal 
subsets and their changes in a mouse model of Parkinson disease”. 
- Partenaire et co-PI : Dr. Eduardo Gascon, Institut de Neurosciences de la Timone, Marseille. 
- Durée et montant : 2 ans, 35 000 € (20 000 € et 15 000 € après évaluation de l’avancement du projet 
au bout d’un an). 
 
Financements demandés et non-obtenus : 
• 2006 : Association France Parkinson, PI. 
- Titre: "Contrôle de l’équilibre GABA/glutamate dans le réseau des ganglions de la base par les voies 
directe et indirecte en situation normale et pathologique". 
- Partenaire : Dr. H. Marie, European Brain Research Institute, Rome, Italie. 
- Montant : 2 ans, 35 000 €.  
• 2008 : Appel PEPS CNRS/INSB, Projets exploratoires / Premier soutien, PI.  
- Titre : “Plasticité du réseau cholinergique dans la maldie de Parkinson : une approche anatomo-
fonctionnelle par la méthode d’optogénétique”. 
- Acronyme : OptoPark. 
- Montant : 15 000 €. 
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• 2015-2016 : Projet de Recherche Collaborative soumis à l’ANR (Défi sociétal 4 : Vie, santé et bien-
être), partenaire. Ce projet a été pré-sélectionné et n’a pas été retenu en phase finale.  
- Titre: “Function of the coxsackievirus & adenovirus receptor (CAR) in adult neurogenesis”. 
- Acronyme : CAR-LOF. 
- PI : Eric Kremer, Institut de Génétique Moléculaire de Montpellier. Autre partenaire : H Cremer, 
Institut de Biologie du Développement de Marseille. 
- Durée et montant : 4 ans, 640 920 €. 
• 2015-2016 : Projet de Recherche Collaborative soumis à l’ANR (Défi sociétal 4 : Vie, santé et bien-
être), PI. Ce projet a été pré-sélectionné et n’a pas été retenu en phase finale.  
- Titre : “Gating of long-term corticostriatal plasticity by cholinergic interneurons in normal and 
parkinsonian conditions”. 
- Acronyme : CholGATE. 
- Partenaires : Nicolas Mallet, Institute of Neurodegenerative Diseases (UMR5293 CNRS/University of 
Bordeaux), France. 
- Durée et montant : 3 ans, 650 522 €. 
• 2016-2017 : Projet de Recherche Collaborative soumis à l’ANR (Défi sociétal : Vie, santé et bien-
être), PI. Ce projet a été pré-sélectionné et n’a pas été retenu en phase finale.  
- Titre : “Gating of long-term corticostriatal plasticity by cholinergic interneurons in normal and 
parkinsonian conditions”. 
- Acronyme : CholGATE. 
- Partenaires : Nicolas Mallet, Institute of Neurodegenerative Diseases (UMR5293 CNRS/University of 
Bordeaux), France. 
- Durée et montant : 3 ans, 689 741 €. 
• 2016-2017 : A*MIDEX, Initiative d’excellence Aix-Marseille, appel à projets Interdisciplinarité, PI. 
En cours d’évaluation.  
- Titre : “Cholinergic interneurons: key players in striatal plasticity and reward-based learning”. 
- Acronyme : ChoPPY. 
- Partenaires : Emmanuel Daucé, Institut de Neurosciences des Systèmes (UMR Aix-Marseille 
University/Inserm 1106), France. 
- Durée et montant : 3 ans, 300 448 €. 
 
 
PUBLICATIONS  
Liste des publications durant ma thèse : 
• Beurrier C, Bézard E, Bioulac B, Gross C. 
Subthalamic stimulation elicits hemiballismus in normal monkey. NeuroReport, 1997, 8:1625-1629. 
• Beurrier C, Congar P, Bioulac B, Hammond C. 
Subthalamic nucleus neurons switch from single spike activity to burst firing mode. Journal of 
Neuroscience, 1999, 19:599-609. 
• Beurrier C, Bioulac B, Hammond C. 
The slowly inactivating sodium current (INaP) underlies single-spike activity in rat subthalamic neurons. 
Journal of Neurophysiology, 2000, 83:1951-1957. 
• Beurrier C, Bioulac B, Audin J, Hammond C.  
High frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic 
neurons. Journal of Neurophysiology, 2001, 85:1351-1356. 
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Liste des publications durant mes stages post-doctoraux : 
• Thomas MJ, Beurrier C, Bonci A, Malenka RC.  
Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to 
cocaine. Nature Neuroscience, 2001, 4:1217-1223. 
• Beurrier C, Malenka RC.  
Enhanced inhibition of synaptic transmission by dopamine in the nucleus accumbens during behavioral 
sensitization to cocaine. Journal of Neuroscience, 2002, 22:5817-5822. 
• Beurrier C, Garcia L, Bioulac B, Hammond C. 
Subthalamic nucleus: a clock inside basal ganglia? Thalamus & Related Systems, 2002, 1:1-8. (Article 
de revue) 
 
Liste des publications depuis mon recrutement au CNRS : 
• Beurrier C, Ben-Ari Y, Hammond C.  
Preservation of the direct and indirect pathways in an in vitro preparation of the mouse basal ganglia. 
Neuroscience, 2006, 140:77-86.  
• Beurrier C, Bonvento G, Kerkerian-Le Goff L, Gubellini P.  
Role of glutamate transporters in corticostriatal synaptic transmission. Neuroscience, 2009, 158:1608-
1615.   
• Cuomo D, Martella G, Barabino E, Platania P, Vita D, Madeo G, Selvam C, Goudet C, Oueslati N, Pin J-
P, Acher F, Pisani A, Beurrier C, Melon C, Kerkerian-Le Goff L, Gubellini P.  
Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA 
transmission in the striatum: implications for Parkinson's disease treatment. Journal of 
Neurochemistry, 2009, 109:1096-1105.  
• Beurrier C, Lopez S, Revy D, Selvam C, Goudet C, Lherondel M, Gubellini P, Kerkerian-LeGoff L, Acher 
F, Pin J-P, Amalric M. 
Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 
with a new agonist reverses experimental parkinsonism. The FASEB Journal, 2009, 23(10):3619-3628. 
• Beurrier C, Faideau M, Bennouar KE, Escartin C, Kerkerian-Le Goff L, Bonvento G, Gubellini P. 
Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate 
uptake, PLoS ONE, 2010, 5(1): e8550.  
• Révy D*, Jaouen F*, Salin P, Melon C, Chabbert D, Tafi E, Concetta L, Langa F, Amalric M, Kerkerian-
Le Goff L, Marie H, Beurrier C. 
Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal 
functions, Neuropsychopharmacology, 2014, 39(11): 2662-2672. 
• Reynders A, Mantilleri A, Malapert P, Rialle S, Nidelet S, Laffray S, Beurrier C, Bourinet E, Moqrich A. 
Transcriptional Profiling of Cutaneous MRGPRD Free Nerve Endings and C-LTMRs, Cell Rep., 2015, 
10(6):1007-1019. 
• Maurice N, Liberge M, Jaouen F, Ztaou S, Hanini M, Camon J, Deisseroth K, Amalric M, Kerkerian-Le 
Goff L, Beurrier C.  
Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental 
Parkinsonism, Cell Rep., 2015, 13(4):657-666. 
• Martin HG, Bernabeu A, Lassalle O, Bouille C, Beurrier C, Pelissier-Alicot AL, Manzoni OJ. 
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in 
the Adult Medial Prefrontal Cortex, Front Cell Neurosci., 2015, 1(9):457. 
• Wei ZB, Yuan YF, Jaouen F, Ma MS, Hao CJ, Zhang Z, Chen Q, Yuan Z, Yu L, Beurrier C, Li W. 
SLC35D3 increases autophagic activity in midbrain dopaminergic neurons by enhancing BECN1-ATG14-
PIK3C3 complex formation, Autophagy, 2016, 12(7):1168-79. 
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• Tiveron MC, Beurrier C, Céni C, Andriambao N, Combes A, Koehl M, Maurice N, Gatti E, Abrous DN, 
Kerkerian-Le Goff L, Pierre P, Cremer H.  
LAMP5 fine-tunes GABAergic synaptic transmission in defined circuits of the mouse brain, PLoS One, 
2016, 11(6): e0157052. 
• Ztaou S, Maurice N, Camon J, Guiraudie-Capraz G, Kerkerian-Le Goff L, Beurrier C, Liberge M, Amalric 
M. 
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor 
Symptoms of Parkinson's Disease, The Journal of Neuroscience, 2016, 36(35):9161-9172. 
 
Chapitres de livre  
• Charpier S, Beurrier  C, Paz J.  
The Subthalamic Nucleus: From In Vitro to In Vivo Mechanisms,  in Handbook of basal ganglia structure 
and function, 2010, ed. H. Steiner and K. Tseng, 259-273, Elsevier.  
 
 
COMMUNICATIONS ORALES (SEMINAIRES - CONGRES) 
• 2012 : Laboratoire de Neurosciences Cognitives, Marseille, France. Optogenetics: principles and 
applications. 
• 2014 : European winter conference on brain research, Brides-les-bains, France. Striatal cholinergic 
interneurons control motor function and basal ganglia outflow in the parkinsonian condition. 
• 2015 : 9th Japanese-French Frontiers of Science (JFFoS) Symposium, Kyoto, Japan. Understanding the 
role of specific neuronal populations with light: the optogenetics contribution to neuroscience. 
• 2017 : 2nd Basal Ganglia and Parkinson’s disease Day organized by Centre of excellence on 
Neurodegenerative diseases (DHUNE), Marseille. Striatal cholinergic interneurons control motor 
behavior and basal ganglia function in experimental parkinsonism. 
• 2017 : NeuroFrance 2017, Annual meeting of the French Neuroscience Society, Bordeaux, France. 
Striatal cholinergic interneurons control motor behavior and basal ganglia function in experimental 
parkinsonism 
• 2017 : Co-organization of the symposium “Cholinergic signal dynamics in physiopathological 
conditions” for the annual meeting of the French Neuroscience Society, Bordeaux, France. 
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II. TRAVAUX ANTERIEURS 
 
Etant donné ma décision tardive à soutenir mon HDR, je ne vais pas développer dans ce manuscrit 
l’ensemble des travaux que j’ai menés au cours de ma carrière scientifique. Cela serait un exercice 
pénible, tant pour la rédactrice que pour les lecteurs ! J’ai donc décidé de développer 4 parties qui, je 
pense, illustrent particulièrement mes intérêts scientifiques. Ces travaux ont été réalisés à différentes 
étapes de mon parcours : durant ma thèse (II.1), mon post-doc (II.2) et depuis mon intégration dans 
l’équipe du Dr. Lydia Kerkerian (II.3 et 4), qui m’a laissée la liberté de développer des thématiques qui 
me tiennent particulièrement à cœur. Les articles se référant aux travaux que j’ai choisi d’exposer sont 
insérés à la fin du manuscrit et s’accompagnent, pour chaque article, d’un résumé.  
 
Mon travail s’est toujours focalisé sur le réseau des ganglions de la base en condition normale ou en 
condition de dysfonctionnement dopaminergique (hypo-dopaminergie : maladie de Parkinson ou 
hyper-dopaminergie : addiction à la cocaïne).  J’ai disséqué les propriétés  intrinsèques ou synaptiques 
dans plusieurs structures du réseau en utilisant une approche d’électrophysiologie in vitro sur tranches 
de cerveau. Le fil conducteur est de comprendre le normal pour mieux comprendre la pathologie et 
de relier, dans la mesure du possible, fonctions cellulaires et comportements. Des outils tels que les 
souris transgéniques, l’optogénétique et la chémogénétique, issus des avancées de la biologie 
moléculaire et de la génétique, ont rendu possible pour les neurosciences l’élucidation du rôle 
fonctionnel de circuits neuronaux spécifiques. Ainsi, pour pouvoir utiliser ces outils j’ai décidé quand 
je suis arrivée dans l’équipe de L. Kerkerian d’introduire la souris comme modèle. J’ai pu bénéficier de 
la nouvelle animalerie de l’IBDM et je remercie à cet égard Aziz Moqrich qui s’est investi dans la 
construction et la gestion du personnel de l’animalerie, indispensables pour gérer les différentes 
lignées transgéniques nécessaires à mes projets. Avant de rentrer dans le vif du sujet, voici un bref 
rappel sur l’organisation anatomo-fonctionnelle du réseau des ganglions de la base.  
 
Les ganglions de la base sont constitués d’un ensemble de structures sous-corticales impliquées dans 
le contrôle de la motricité extrapyramidale ainsi que dans la régulation de processus cognitifs et 
limbiques. Le principe de fonctionnement du réseau, décrit il y a plus de vingt ans, repose sur un 
équilibre fonctionnel entre des influences inhibitrices et excitatrices (Albin et al., 1989; DeLong, 1990). 
Selon ce modèle, le striatum, considéré comme la structure d’entrée du réseau recevant des 
informations de l’ensemble des aires corticales, contrôle les structures de sortie [la substance noire 
pars reticulata (SNr) et le globus pallidus interne (GPi)] via deux voies : une voie directe inhibitrice 
monosynaptique et une voie indirecte excitatrice polysynaptique qui contacte d’abord le globus 
pallidus externe (GPe) puis le noyau subthalamique (NST) avant d’atteindre les structures de sortie (fig. 
1). Les neurones de projection du striatum (95% de la population striatale, aussi appelés Medium Spiny 
Neurons, MSNs) exprimant le récepteur dopaminergique D2 sont à l’origine de la voie indirecte (MSNs 
D2) alors que les MSNs exprimant le récepteur dopaminergique D1 (MSNs D1) constituent la voie 
directe. Dans la maladie de Parkinson, l’absence de dopamine due à la dégénérescence des neurones 
de la substance noire pars compacta (SNc), entraîne une perturbation de l’activité de l’ensemble du 
réseau et notamment un déséquilibre entre les voies directe et indirecte en faveur de l’excitation. On 
constate une hyperactivité des MSNs D2 à l’origine de la voie indirecte et une hypoactivité des MSNs 
D1 à l’origine de la voie directe. Un des grands défis dans le domaine des mouvements anormaux est 
de comprendre les mécanismes à l’origine de ce déséquilibre. Il faut cependant souligner que des 
données récentes suggèrent que les voies directe et indirecte fonctionneraient plus en synergie qu’en 
opposition pour contrôler les différentes fonctions associées aux ganglions de la base. Il n’est pas 
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impossible que les deux modes de fonctionnement, opposition et synergie, cohabitent selon la tâche 
engagée (Calabresi et al., 2014; Cui et al., 2013).  
 
Figure 1. Schéma simplifié du réseau des ganglions de la base. Les flèches représentent les connexions 
synaptiques entre les différentes structures. 
 GPe: globus pallidus externe; STN : noyau subthalamique; SNc/SNr : substance noire pars compacta/reticulata; 
Thal : thalamus, DA : dopamine ; CIN : interneurones cholinergiques. D1 et D2 : récepteurs dopaminergiques de 
type 1 et 2.  
 
II.1 LES PROPRIETES INTRINSEQUES DES NEURONES DU NOYAU SUBTHALAMIQUE ET L’EFFET DE LA 
STIMULATION A HAUTE FREQUENCE  
 
Le noyau subthalamique (NST) occupe une position particulière au sein des ganglions de la base. Ce 
noyau est la seule structure glutamatergique et joue un rôle fondamental dans le maintien d'une 
activité tonique excitatrice au niveau des structures de sortie du réseau, la SNr et le GPi (Robledo and 
Féger, 1990). Les projections du NST sont loin d'être limitées au GPi et à la SNr et il reçoit également 
de nombreuses afférences des autres structures du réseau, ainsi que du cortex, du thalamus et de la 
SNc. Ces entrées et sorties multiples placent le STN comme une véritable «structure clef» intervenant 
en différents points du réseau pour réguler le flot d'informations qui y circule (Parent and Hazrati, 
1995). 
Le modèle physiopathologique de la maladie de Parkinson met en avant I'hyperactivité des neurones 
du NST qui retentit de façon drastique sur les structures de sortie (figure 9A). Chez le rat présentant 
une déplétion du système monoaminergique ou une lésion du système dopaminergique nigro-strié par 
la 6-hydroxydopamine (6-OHDA), les neurones du NST augmentent leur fréquence de décharge, mais 
ils ont surtout tendance à décharger en bouffées de potentiels d'action (Hassani et al., 1996; Hollerman 
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and Grace, 1992; Kreiss et al., 1997; Robledo and Féger, 1990) de façon synchrone (Ryan et al., 1992). 
Cette activité en bouffées a également été rapportée chez le singe traité au 1-méthyl-4-phényl-1,2,3,6-
tétrahydropyridine (MPTP)  (Bergman et al., 1994) et chez les malades parkinsoniens (Benazzouz et al., 
2002; Rodriguez-Oroz et al., 2001). Ce patron de décharge en bouffées des neurones du STN est donc 
une caractéristique des états parkinsoniens. Ces modifications qualitatives de l'activité électrique des 
neurones jouent sans doute un rôle essentiel dans la genèse des symptômes. La mise en évidence, 
dans les années 90, d'une amélioration des symptômes parkinsoniens suite à la lésion ou à la 
stimulation à haute fréquence de ce noyau conforte définitivement cette idée. La stimulation à haute 
fréquence du NST reste actuellement une option thérapeutique pour les malades parkinsoniens. Si les 
effets cliniques de la stimulation à haute fréquence sont incontestables, son mode d'action au niveau 
neuronal était (et est encore en partie) totalement inconnu au moment où je commençais ma thèse. 
Ceci nous a amené à développer un modèle adapté permettant d'aborder les mécanismes cellulaires 
de la stimulation à haute fréquence : l'électrophysiologie sur tranches de cerveau de rat. Il était en 
effet indispensable, dès lors qu'on applique cette technique en pathologie humaine, de préciser 
comment elle pouvait interagir sur l'activité même des neurones du NST. Mais là encore, il survenait 
une autre question fondamentale : les caractéristiques électrophysiologiques des neurones du NST 
étaient en effet fort mal connues. Les mécanismes ioniques sous-tendant l’activité électrique de ces 
neurones n'avaient jamais été abordés de manière approfondie. Il semblait pourtant essentiel de bien 
comprendre ces propriétés vu l’importance des neurones du STN dans la régulation de la motricité 
normale et dans un contexte parkinsonien. J’ai donc réalisé au cours de ma thèse (i) une étude 
approfondie des propriétés intrinsèques des neurones du NST et, (ii) une analyse des effets de la 
stimulation à haute fréquence sur ces propriétés intrinsèques. L’ensemble de ce travail peut être 
résumé en trois points principaux.  
 
II.1.1 Les neurones du STN présentent deux modes de décharge : une activité tonique et en 
bouffées  
Tous les neurones du NST que nous avons enregistré présentent une activité tonique (potentiels 
d'action émis à intervalle régulier). Parmi eux, 48% ont aussi la capacité de générer des bouffées de 
potentiels d'action rythmiques en réponse à une hyperpolarisation de la membrane (activité en 
bouffées). Les neurones qui présentent les deux patrons de décharge passent de l'un à l'autre selon la 
valeur de leur potentiel membranaire : une légère hyperpolarisation déclenche une décharge en 
bouffées alors qu'une dépolarisation favorise plutôt l'activité tonique. Le neurone illustré dans la figure 
2 présente d'abord une activité tonique lorsque aucun courant n'est injecté puis une activité en 
bouffées lorsque la membrane est hyperpolarisée. L'augmentation de l'intensité du courant négatif 
supprime tout type d'activité. L’application d’un agoniste des récepteurs glutamatergiques 
métabotropiques du groupe I et II, l’ACPD, favorise l’activité en bouffées.  
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Figure 2. Changement d’activité en fonction du potentiel membranaire. 
Les neurones du NST peuvent passer d’une activité tonique à une activité en bouffées sous l’effet d’une légère 
hyperpolarisation membranaire par injection d’un courant négatif continu. Les potentiels d’action constituant 
l’activité tonique sont tronqués.  
 
 
II.1.2 L’activité tonique et en bouffées résulte d’une cascade de courants sensibles au voltage  
Les résultats de nos expériences pharmacologiques et les caractéristiques de sensibilité au voltage de 
l’activité en bouffées nous ont permis d’établir que l’activité en bouffées est une propriété 
membranaire intrinsèque due à l’activation d’une cascade de courants sensibles au voltage. Nous 
pouvons distinguer plusieurs étapes dans cette activité, chacune étant caractérisée par la présence de 
courants sous-liminaires particuliers. Les oscillations du potentiel de membrane sous-jacentes aux 
bouffées de potentiels d’action peuvent être décomposées en trois phases (fig. 3) : dépolarisation (b-
c), plateau (c-d) et repolarisation (d-a) qui dépendent toutes des ions Ca2+. Ces oscillations sont 
séparées par des dépolarisations lentes de la membrane (dépolarisations inter-bouffées a-b). La phase 
de dépolarisation (b-c) résulte de l’activation d'un courant Ca2+ de type T (IT) qui dépolarise la 
membrane jusqu’au seuil d’activation d'un courant Ca2+ de type L (IL). Ce courant serait, avec le courant 
cationique non spécifique (ICAN), responsable de la phase plateau des oscillations sur lesquelles se 
greffent les potentiels d’action sodiques (c-d). L’augmentation de la concentration intracellulaire en 
ions Ca2+ qui en résulte active des courants K+ dépendants des ions Ca2+ (IK,Ca) responsables de la phase 
de repolarisation des bouffées (d-a). Cette hyperpolarisation permet la dé-inactivation de IT et, peut-
être, l’activation d’un courant cationique activé par l’hyperpolarisation (Ih). La membrane se dépolarise 
ensuite spontanément jusqu'au seuil d’activation de IT sous l’effet d’une inactivation des IK,Ca due à des 
mécanismes de clairance des ions Ca2+ libres intracellulaires (a-b) et un nouveau cycle est initié. 
L'activité en bouffées des neurones du NST résulte donc d'un équilibre entre des influences 
dépolarisantes (IT, I , ICAN) et hyperpolarisante (I K,Ca), équilibre est atteint dans une fourchette étroite 
de potentiel de membrane. 
 
 
 
 
 
20 mV 
4 s 
-48 mV 
-55 mV -60 mV I 
Activitée tonique Activitée en bouffées Silence 
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Figure 3. Hypothèse sur la cascade hypothétique des courants ioniques intervenant dans les différentes phases 
de l’activité en bouffées. 
En ce qui concerne l’activité tonique, nos résultats ont montré qu’il s’agit d’une activité intrinsèque 
indépendante des entrées synaptiques. Contrairement à l’activité en bouffées, elle ne repose pas sur 
des courants Ca2+ ou Ca2+-dépendants mais dépend essentiellement d’un courant Na+ persistant (INap). 
Dans certains neurones, Ih peut également participer à l’activité tonique en exerçant une influence 
dépolarisante qui amène le potentiel membranaire vers des valeurs proches du seuil d’activation de 
INap, favorisant ainsi l’activité tonique.    
 
II.1.3 La stimulation à haute fréquence du STN entraîne un blocage transitoire de 
conductances voltage-dépendantes essentielles à l’activité spontanée de ces neurones  
 
Nous avons ensuite analysé les effets de la stimulation à haute fréquence du STN sur les propriétés 
intrinsèques de ces neurones que nous avions mises en évidence. Nous avons particulièrement prêté 
attention aux paramètres de stimulation appliqués afin de mimer au plus près la situation clinique. 
Cette étude a constitué à l’époque la première tentative pour expliquer les effets cellulaires de la 
stimulation à haute fréquence. En raison des artéfacts électriques générés par la stimulation, nous 
n’avons pas été en mesure d’étudier les phénomènes à l’œuvre pendant la stimulation mais nous 
avons montré qu’une stimulation appliquée au niveau du STN pendant 1 minute entraine, juste après 
l’arrêt de la stimulation, un blocage transitoire de l’activité spontanée de ces neurones, qu’ils 
déchargent de façon tonique ou en bouffées (durée et intensité des stimuli : 100 µs, 5-8V) (fig. 4).  
Cet effet suppressif est dépendant de la fréquence de la stimulation. Parmi les fréquences que nous 
avons testées, nous avons observé que l’activité n’était pratiquement pas modifiée à 100 Hz, 
fortement diminuée à 125 Hz et totalement supprimée à des fréquences ≥ à 160 Hz. Une série 
d’expérience de pharmacologie et de voltage imposé nous a permis de déterminer que la stimulation 
à haute fréquence entrainait un blocage réversible de certaines conductances voltage-dépendantes 
impliquées dans la genèse de l’activité tonique et en bouffées (notamment les courants sodiques 
persistants et Ca2+ de type L et T).  
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Les résultats obtenus au cours de ma thèse ont comblé un manque significatif quant aux données 
relatives aux propriétés intrinsèques des neurones du STN et au mécanisme d’action de la stimulation 
à haute fréquence, approche largement utilisée pour traiter un certain nombre de patients 
parkinsoniens. C’est en effet la première fois que la capacité de ces neurones à décharger selon deux 
modes est mise en évidence et qu’une analyse extensive des mécanismes ioniques qui sous-tendent 
leur patron de décharge est faite. En outre, au-delà de son intérêt fondamental, ce travail a mis en 
évidence les cibles pharmacologiques à viser qui permettraient de diminuer l’activité en bouffées des 
neurones du STN dans les états parkinsoniens et révélé un mécanisme possible de la stimulation à 
haute fréquence.  
 
Articles  
• Beurrier C, Congar P, Bioulac B and Hammond C (1999). Subthalamic nucleus neurons switch from 
single-spike activity to burst-firing mode. Journal of Neuroscience, 19(2): 599-609. 
• Beurrier C, Bioulac B, Hammond C. The slowly inactivating sodium current (INaP) underlies single-
spike activity in rat subthalamic neurons (2000). Journal of Neurophysiology, 83(4): 1951-1957. 
• Beurrier C, Bioulac B, Audin J and Hammond C (2001). High-frequency stimulation produces a 
transient blockade of voltage-gated currents in subthalamic neurons. Journal of Neurophysiology, 
85(4): 1351-6. 
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Figure 4. La stimulation à haute 
fréquence du STN bloque 
transitoirement l’activité tonique et en 
bouffées de ces neurones. HFS : high 
frequency stimulation (250 Hz en haut et 
500 Hz en bas).  
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II.2 LA PLASTICITE A LONG TERME DANS LE NOYAU ACCUMBENS EST UN SUPPORT NEURONAL DE LA 
SENSIBILISATION A L A COCAÏNE   
A la fin de ma thèse, j’ai décidé de partir aux Etats-Unis et j’ai choisi d’explorer le monde de la synapse 
que je n’avais pas abordé au cours de ma thèse en faisant mon stage post-doctoral chez Robert C. 
Malenka, expert dans le domaine de la transmission et de la plasticité synaptique. Ce choix m’a permis 
de rester dans le domaine des ganglions de la base en abordant le fonctionnement de ce réseau en 
condition d’hyperdopaminergie (addiction). Je me suis notamment intéressée au dysfonctionnement  
des synapses entre le cortex et le noyau accumbens (NAc) suite à un traitement chronique à la cocaïne.   
L’administration répétée de psychostimulants tels la cocaïne entraîne une sensibilisation 
comportementale qui peut se définir comme une augmentation progressive des effets d’une drogue 
lors de son usage répété, cette augmentation pouvant se maintenir après de longues périodes 
d’abstinence. Le modèle de sensibilisation comportementale à long terme est censé refléter l’envie 
incontrôlable ("craving") de prise de drogue et les nombreuses rechutes ("relapse") que l’on observe 
chez l’humain, même après de nombreuses années d’abstinence (Robinson and Berridge, 1993). 
L’identification des substrats neurobiologiques impliqués dans ces comportements a été un des buts 
principaux de la recherche fondamentale dans le domaine de la toxicomanie. En d’autres termes, 
quelles sont les modifications physiologiques entraînées par la prise chronique de drogue qui sont à 
l’origine de la sensibilisation ? Chez l’animal, l’hyperactivité locomotrice induite par les 
psychostimulants subit une sensibilisation importante et constitue un modèle expérimental 
couramment utilisé en laboratoire (Kalivas and Stewart, 1991). Ce phénomène se manifeste par une 
augmentation progressive de l’activité locomotrice suite à l’injection répétée de la même dose de 
drogue. Un aspect particulièrement intéressant est que cette sensibilisation peut persister même 
après une longue période d’abstinence. Chez les rongeurs, l’augmentation de l’activité locomotrice 
suite à une « injection challenge » de psychostimulants peut se manifester plusieurs mois après l’arrêt 
du traitement chronique. Dans le protocole que j’aie utilisé au cours de mon post-doctorat dans le 
laboratoire du Dr. Robert C. Malenka (fig. 5), l’activité locomotrice des souris est mesurée pendant 5 
jours juste après une injection quotidienne de cocaïne (15 mg/kg). Après une interruption de 10 à 14 
jours, les animaux reçoivent une dernière injection de cocaïne à la même dose (test). Ce protocole 
produit bien une sensibilisation des réponses locomotrices : l’activité locomotrice augmente 
progressivement suite à l’injection quotidienne de la même dose de cocaïne (jours 3 à 7) et cette 
augmentation persiste dans le temps puisque la réponse locomotrice est toujours augmentée après 
l’interruption du traitement (injection test).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Sensibilisation comportementale 
induite par une administration répétée de 
cocaïne. L’activité locomotrice est mesurée 
pendant 15 min immédiatement après les 
injections de solution saline ou de cocaïne (15 
mg/kg).  
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Les adaptations neuronales qui ont lieu après administration de cocaïne impliquent des structures 
appartenant au système mésolimbique, dont l’aire tegmentale ventrale, le cortex pré-frontal et le 
noyau accumbens  (NAc) (Robinson and Berridge, 1993). A l’époque où j’ai rejoint le laboratoire de 
Robert C. Malenka, les données de la littérature suggéraient que les psychostimulants, au-delà de leurs 
effets directs sur la transmission dopaminergique, pouvaient également modifier la transmission 
synaptique glutamatergique dans le NAc ainsi que la modulation de cette transmission par la dopamine 
(Vanderschuren and Kalivas, 2000; Wolf, 1998). Pour tester ces hypothèses, nous avons enregistré les 
courants synaptiques glutamatergiques dans les MSNs du NAc sur des tranches de cerveau issues 
d’animaux préalablement traités à la cocaïne selon le protocole décrit ci-dessus (fig.5). Les tranches 
sont réalisées après la dernière injection de cocaïne ou saline (test). Trois questions ont guidé notre 
travail :  
• Les propriétés basiques de la transmission glutamatergique des synapses cortex préfrontal/NAc sont-
elles modifiées par un traitement chronique aux psychostimulants ?  
• La plasticité de la transmission glutamatergique entre cortex préfrontal et NAc est-elle modifiée par 
un traitement chronique aux psychostimulants ?  
• La modulation de la transmission glutamatergique par la dopamine est-elle modifiée par un 
traitement chronique aux psychostimulants ?  
 
 
II.2.1 Un traitement chronique à la cocaïne diminue l’amplitude des courants synaptiques de 
type AMPA  
La libération de glutamate ne semble pas être affectée par le traitement à la cocaïne puisque la 
"paired-pulse facilitation" (PPF) ainsi que la fréquence des courants post-synatiques excitateurs 
miniatures (mEPSC) AMPA ne diffèrent pas dans le groupe « saline »  et « cocaïne ». En revanche, un 
changement dans le nombre et/ou les propriétés des récepteurs glutamatergiques de la membrane 
postsynaptique peut avoir lieu. Pour vérifier cette hypothèse, nous avons calculé, pour chaque cellule, 
le rapport entre l'amplitude maximale des réponses AMPA et NMDA (AMPA/NMDA) afin d’évaluer la 
participation relative de ces deux courants dans la réponse synaptique globale. Nous enregistrons les 
EPSCs à +40 mV en absence puis en présence de D-APV (50 µM), un bloquant des récepteurs NMDA. 
La réponse moyenne obtenue en présence de D-APV (EPSC AMPA) est ensuite soustraite à celle 
obtenue en son absence, permettant d’obtenir un EPSC NMDA moyen (fig. 6A). Nous avons observé 
une diminution du ratio chez les animaux « cocaïne » suggérant que le traitement à la cocaïne peut 
diminuer les courants AMPA et/ou augmenter les courants NMDA (fig. 6A). 
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Figure 6. Diminution du ratio AMPA/NMDA (A) et de l’amplitude des mEPSCs enregistrés en présence de 
strontium (2.5 mM) des synapses corticales sur les neurones du NAc (B) après administration chronique de 
cocaïne. Echelles : A, 40 ms et 20 pA - B, 50 ms et 10 pA. 
Pour déterminer la nature du changement des réponses NMDA et AMPA chez les animaux traités à la 
cocaïne, nous avons entrepris une série d’expériences dont les principaux résultats sont résumés ci-
après. L’amplitude des mEPSCs AMPA et NMDA ne diffère pas chez les animaux « saline » et « cocaïne 
». Cependant, si l’on considère que le traitement à la cocaïne ne modifie qu’un nombre limité de 
synapses, il est vraisemblable qu’il ne soit pas possible de détecter ces modifications avec la technique 
ci-dessus, les mEPSCs que nous enregistrons étant générés par l’ensemble des synapses 
glutamatergiques contactant le neurone postsynaptique. Grâce à l’utilisation du strontium (Sr2+) qui 
a la propriété d’entrer dans les terminaisons stimulées à travers les canaux Ca2+ sensibles au voltage 
et de provoquer la libération asynchrone des vésicules (Goda and Stevens, 1994), nous avons pu 
spécifiquement  étudier les mEPSCs issus de la stimulation des fibres pré-limbiques corticales qui 
projettent vers le NAc. Nous avons dans ce cas observé une diminution significative de l’amplitude 
moyenne des mEPSCs chez les animaux « cocaïne », suggérant  que la diminution du rapport des 
courants AMPA/NMDA observée dans le groupe cocaïne est due à une diminution des réponses AMPA 
(fig. 6B). Nous n’avons en revanche pas mis en évidence de modification des réponses NMDA. 
 
II.2.2 Un traitement chronique à la cocaïne entraîne une dépression à long terme de la 
transmission synaptique glutamatergique 
Les données obtenues montrent que le traitement à la cocaïne entraîne une diminution des réponses 
AMPA due à une modification des récepteurs au niveau de la membrane postsynaptique. Cependant, 
les expériences ci-dessus ne nous permettaient pas de préciser les mécanismes à l’origine de cette 
diminution. Une des hypothèses serait que la cocaïne agit par un mécanisme similaire à celui de la 
dépression à long terme (LTD) de la transmission glutamatergique observée dans le NAc d’animaux 
contrôles (Thomas et al., 2000). Si tel est le cas, nous ne devrions plus être en mesure de déclencher 
une LTD des réponses glutamate de type AMPA dans le groupe cocaïne (phénomène d’occlusion). Nous 
avons en effet observé que  l’amplitude de la LTD est significativement plus faible chez les souris « 
cocaïne » (fig. 7). 
 
 
 
 
 
 
 
 
Figure 7. Le traitement chronique à la cocaïne diminue l’amplitude de la LTD dans le NAc. Le graphe montre la 
LTD moyenne obtenue chez les animaux saline et cocaïne. Le protocole d’induction de la LTD consiste en 1 train 
de stimulation synaptique à 5 Hz pendant 3 min répété 3 fois (flèches) couplé à une dépolarisation de la cellule à 
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-50 mV. Les traces montrent les EPSCs moyennés de deux cellules pendant la ligne de base (1) et 20 min après le 
dernier train de stimulation (2). Echelles : 20 ms et 50 pA. 
 
II.2.3 La sensibilisation à la cocaïne augmente le contrôle inhibiteur de la dopamine sur la 
transmission synaptique glutamatergique 
En situation contrôle, la dopamine inhibe de manière réversible la transmission glutamatergique dans 
le NAc en activant les récepteurs présynaptiques de type D1 (Harvey and Lacey, 1996; Nicola et al., 
1996). Nous nous sommes demandé si cet effet inhibiteur était retrouvé chez les animaux « cocaïne » 
sachant que l’administration chronique de cocaïne entraîne une adaptation du système 
dopaminergique mésolimbique, dont une augmentation de la libération de dopamine dans le NAc. 
Pour répondre à cette question, nous avons testé l’effet de la dopamine sur les EPSCs AMPA 
enregistrés en configuration cellule entière sur des tranches de NAc provenant d’animaux « saline » et 
« cocaïne ». L’application de dopamine (20 µM) pendant 10 min inhibe de façon significative les EPSCs 
dans le groupe cocaïne alors qu’elle n’a pratiquement aucun effet dans le groupe saline (fig. 8A). Dans 
le groupe cocaïne, l’inhibition entraînée par la dopamine (20 µM) est fortement réduite par un 
antagoniste des récepteurs D1 (10 µM SCH-23390) (fig. 8B). Le traitement à la cocaïne entraîne donc 
une augmentation de la modulation inhibitrice de la dopamine sur la transmission glutamatergique 
dans le NAc via l’activation de récepteurs D1. Le transporteur de la dopamine ne semble pas être 
impliqué dans cet effet puisque l’inhibition des EPSCs par la dopamine n’est pas modifiée en présence 
d’un inhibiteur spécifique du transporteur de la dopamine.  
 
 
 
 
 
 
 
 
 
Si l’effet inhibiteur présynaptique de la dopamine sur la libération de glutamate a été largement décrit, 
certains auteurs ont aussi rapporté une potentialisation des courants NMDA via l’activation de 
récepteurs D1 postsynaptiques (Harvey and Lacey, 1997). Ce dernier point est cependant controversé 
puisque d’autres laboratoires, dont celui de Robert C. Malenka, n’ont jamais été en mesure de 
reproduire ce résultat (Nicola and Malenka, 1998). Le traitement à la cocaïne peut néanmoins révéler 
un effet de la dopamine qui n’est pas détectable dans des conditions contrôles. Il est difficile de tester 
une potentialisation des courants NMDA par la dopamine en raison de l’effet présynaptique inhibiteur 
de la dopamine sur la libération de glutamate comme nous l’avons montré ci-dessus. Un moyen de 
contourner ce problème est de tester l’effet de la dopamine simultanément sur les courants AMPA et 
NMDA. Si la dopamine potentialise les courants NMDA en plus de l’inhibition présynaptique de la 
libération de glutamate, les courants NMDA devraient être moins inhibés que les courants AMPA. Pour 
réaliser cette expérience, nous avons testé l’effet de la dopamine sur les EPSCs enregistrés à +40 mV. 
Figure 8. L’administration répétée de cocaïne 
augmente les effets inhibiteurs de la dopamine 
sur les courants AMPA. Le graphe à gauche 
illustre les effets de la dopamine (20 µM) sur les 
souris contrôle (n=9 cellules, 7 souris) et cocaïne 
(n=10 cellules, n=5 souris). Les traces montrent 
les EPSCs moyennés de deux cellules à 10 (1) et 
20 min (2). A droite, le graphe montre 
l’amplitude de l’inhibition des EPSCs AMPA 
après application de dopamine (20 µM) 
(*p<0.05).  Echelles : saline, 50 ms et 100 pA - 
cocaïne, 50 ms et 200 pA.  
50 ms
200 pA
1, 2 1, 2 
saline cocaine
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L’application de dopamine (75 µM) entraîne une inhibition comparable des EPSCs AMPA et NMDA dans 
le groupe saline. Le traitement à la cocaïne ne permet pas de révéler une potentialisation des courants 
NMDA puisque, dans ce groupe aussi, l’application de dopamine (75 µM) entraîne une inhibition 
comparable des courants AMPA et NMDA. Pour s’assurer que la dialyse du milieu intracellulaire ne 
nous a pas empêchés de détecter un effet postsynaptique de la dopamine, nous avons répété la même 
expérience sur des souris contrôles en utilisant la technique du patch perforé. Cependant, une fois 
encore, l’amplitude de l’inhibition entraînée par la dopamine (100 µM) est similaire pour les courants 
AMPA et NMDA (données non montrées). 
L’ensemble du travail que j’ai réalisé en post-doctorat chez Robert C. Malenka  a mis en évidence qu’un 
traitement chronique à la cocaïne modifie de façon durable la transmission glutamatergique au niveau 
des synapses cortico-accumbens. Une diminution des réponses de type AMPA chez les animaux « 
cocaïne » par un mécanisme s’apparentant à celui de la LTD semble être à l’origine de ce phénomène. 
Si la libération de glutamate ne semble pas être modifiée chez les animaux « cocaïne », sa modulation 
par la dopamine l’est. Nous avons en effet montré une inhibition accrue des EPSCs glutamate de type 
AMPA par la dopamine chez les animaux « cocaïne » mettant en jeu l’activation des récepteurs D1. 
L'ensemble de ces modifications pourrait donc entraîner une diminution considérable de l'efficacité 
de la transmission synaptique glutamatergique cortico-accumbens. Ces mécanismes pourraient 
contribuer à la diminution d’excitabilité des neurones de projection du NAc observée après traitement 
aux psychostimulants.  
 
Articles  
• Thomas MJ, Beurrier C, Bonci A and Malenka RC (2001). Long-term depression in the nucleus 
accumbens: a neural correlate of behavioral sensitization to cocaine. Nature Neuroscience, 4(12): 
1217-23. 
• Beurrier C and Malenka RC (2002). Enhanced inhibition of synaptic transmission by dopamine in 
the nucleus accumbens during behavioral sensitization to cocaine. Journal of Neuroscience, 22(14): 
5817-5822. 
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II.3 L’ABLATION GENETIQUEMENT CIBLEE DES NEURONES STRIATO-NIGRAUX REVELE DES 
FONCTIONS TRES DIVERSES DE CES NEURONES   
Après mon recrutement au CNRS en 2003 et un certain nombre de cellules enregistrées sur tranches, 
j’ai ressenti le besoin d’élargir mes compétences techniques. Mon arrivée dans l’équipe de Lydia 
Kerkerian en 2006 m’a donné cette possibilité : l’équipe de Lydia est en effet spécialisée dans la 
neuroanatomie des ganglions de la base et maîtrise parfaitement des techniques telles que hybridation 
in situ, immunohistochimie … A la même époque, les premières souris transgéniques permettant 
d’identifier les deux sous-population de MSNs ont fait leur apparition (Gong et al., 2003). Un reporteur 
fluorescent est exprimé sous le contrôle du promoteur du récepteur dopaminerqique D1 ou D2 et 
permet ainsi d’identifier en direct les MSNs enregistrés. Cet outil a constitué une mini-révolution dans 
le domaine des ganglions de la base et a permis, entre autre, d’établir le profil électrophysiologique 
des deux populations de MSNs. Peut-on relier des profils électrophysiologiques à des rôles 
fonctionnels particuliers ?  Le modèle théorique des ganglions de la base attribue aux MSNs un rôle 
opposé dans le contrôle du mouvement : les MSNs D1 faciliteraient le mouvement (ou permettraient 
de sélectionner le programme moteur approprié) alors que les MSNs D2 l’inhiberaient (ou 
bloqueraient les programmes moteurs parasites). En raison d’un manque d’outil permettant de 
manipuler spécifiquement les deux populations de MSNs, cette dichotomie fonctionnelle est restée 
longtemps théorique. Ainsi, en 2006, j’ai décidé de créer une souris transgénique permettant l’ablation 
génétiquement ciblée des MSNs D1 appartenant à la voie directe afin de déterminer leur rôle dans 
différents paradigmes comportementaux. L’approche a consisté à faire exprimer le récepteur humain 
de la toxine diphtérique (DTR) spécifiquement dans les neurones de la voie directe, et à induire la mort 
de ces neurones par apoptose après administration intrastriatale de la DT. Cette technique présente 
l’avantage de contrôler spatialement et temporellement l’ablation de la population visée. Entre les 
premières PCR et la naissance de la première souris transgénique, plus d’un an s’est écoulé … La 
caractérisation des souris au niveau cellulaire et comportementale a été réalisée par Delphine Révy, la 
première étudiante en thèse que j’ai encadrée. 
 
II.3.1 Choix du modèle permettant l’ablation spécifique des MSNs D1 : création des souris 
transgéniques  
Le ciblage a été réalisé en utilisant le promoteur du gène slc35d3 (solute carrier family 35 member D3), 
gène spécifiquement exprimé dans les MSNs D1 par rapport aux MSNs D2 (Lobo et al., 2006). Ce 
modèle de transgénèse additive a été mis au point par le Dr. Hélène Marie (IPMC, CNRS UMR 6097, 
Sophia Antipolis) en collaboration avec Alban de Kerchove d'Exaerde (Université Libre de Bruxelles). 
Hélène Marie a cloné une chimère fusionnelle exprimant le DTR couplé à la GFP dans un chromosome 
bactérien artificiel (BAC) codant pour le gène slc35d3. Le BAC a ensuite été envoyé à l’Institut Pasteur 
à Paris afin d’être microinjecté dans des ovocytes de souris (Francina Langa, CIGM, Institut Pasteur, 
Paris). Nous avons ainsi obtenu 5 souris positives sur les 63 générées. L’obtention de ces 5 souris nous 
a permis de générer 5 lignées distinctes en les croisant avec des souris sauvages C57Bl/6. La 
descendance est donc un mélange de souris exprimant le transgène (DTR+) et de souris ne l’exprimant 
pas (DTR-, utilisées comme contrôles).  
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II.3.2 L’ablation des MSNs D1 a des répercussions sur l’organisation cellulaire du striatum 
Cette partie a été réalisée en étroite collaboration avec le Dr. Pascal Salin dans le laboratoire et a été 
menée en plusieurs étapes (fig. 9): 
- nous avons dans un premier temps utilisé une approche de traçage rétrograde basée sur l’utilisation 
de microbilles fluorescentes rouges injectées dans la SNr. Ces billes sont captées de manière 
rétrograde par les projections striatonigrales et vont marquer uniquement les corps cellulaires des 
MSNs D1. Nous observons que toutes les cellules marquées par celles-ci expriment aussi la GFP 
associée au DTR,  confirmant l’expression spécifique du DTR dans les MSNs D1.  
- nous avons ensuite vérifié si la GFP, associée au DTR, était spécifiquement exprimée dans le striatum 
des souris positives en réalisant une immunohistochimie avec un anticorps anti-GFP. Seules les souris 
positives (DTR+) expriment la GFP au niveau du striatum par rapport aux souris négatives de la même 
portée (DTR-). L’injection de DT dans le striatum par stéréotaxie entraine une baisse significative de 
GFP dans l’hémisphère injecté par rapport à l’hémisphère non-injecté.  
- dans un troisième temps, nous avons réalisé des hybridations in situ et des PCR quantitatives afin de 
quantifier le niveau d’ARNm de différents marqueurs exprimés spécifiquement dans l’une ou l’autre 
des deux populations de MSNs. L’injection de DT chez les souris DTR+ entraine une baisse significative 
de l’expression génique de la SP et des récepteurs dopaminergiques de type D1, spécifiquement 
exprimés par les MSNs D1 alors qu’aucun des marqueurs spécifiquement exprimé par les MSNs D2 
n’est affecté par l’injection de DT.   
 
Figure 9. Expression sélective du DTR-GFP dans les MSNs D1 et impact de l’injection de DT. A : Site d’injection 
des microbilles dans la SNr (échelle : 200 µm) et détection par immunofluorescense de la GFP et des microbilles 
fluorescentes dans le striatum (échelle : 10 µm). B : Immunodétection de la GFP sur une coupe coronale de souris 
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DTR+ 7 jours après injection unilatérale de DT. Cx: cortex, St: striatum, V: ventricle. Echelles : 500 µm (haut) et 20 
µm (bas).  C, D : Hybridations in situ radioactives (échelle : 1 mm) et quantification du niveau d’ARNm de la SP et 
des Enk dans le striatum après injection unilatérale de DT. Student’s t test : *** p < 0.001 vs. uninjected side. E : 
RT-qPCR quantitative de gènes spécifiquement exprimés par les MSNs D1 (SP, Drd1a) et D2 (Enk, Drd2, Adora2a) 
après injection de DT. Student’s t test : ** p < 0.01, *** p < 0.001 vs. uninjected side. 
 
L’ensemble de ces résultats montre que l’injection de la DT engendre une perte spécifique des MSNs 
D1 par rapport aux MSNs D2. Le striatum contient également différentes populations d’interneurones : 
3 types d’interneurones GABAergiques qui expriment des protéines différentes et un type 
d’interneurones cholinergique qui exprime la choline acetyltransferase (ChAT). L’injection de DT 
n’affecte pas les interneurones GABAergiques. Nous avons en revanche observé de façon surprenante 
une baisse significative du nombre d’interneurones cholinergiques (CINs) suite à l’injection de DT. Des 
expériences d’immunohistochimie, d’hybridation in situ et de single-cell RT-PCR ont montré que les 
CINs n’expriment pas le DTR et que leur disparition est spécifiquement observée dans le striatum 
dorsal mais pas dans le noyau accumbens. Nous avons donc émis l’hypothèse que la perte des CINs est 
secondaire à l’ablation des MSNs D1 et que cette dépendance est territoire spécifique. Des expériences 
complémentaires seront nécessaires pour  disséquer les mécanismes responsables de la disparition 
des CINs après ablation des MSNs D1.  
 
II.3.3 L’ablation des MSNs D1 a des impacts comportementaux très divers  
Afin de comprendre les conséquences fonctionnelles de l’absence de la voie striatonigrale, nous avons 
réalisé plusieurs tests comportementaux, certains ont été faits en collaboration avec le Dr. Marianne 
Amalric. Les tests mesurant l’activité locomotrice, l’anxiété et la sensibilisation à la cocaïne ont été 
réalisés chez des souris DTR+ et DTR- ayant reçu des injections bilatérales de DT dans le striatum dorsal. 
Pour le test d’induction des dyskinésies par la L-DOPA, les deux groupes de souris ont été injectées 
unilatéralement avec de la DT dans le striatum dorsal et après lésion unilatéral du système 
dopaminergique nigrostrié. Le niveau d’expression de la SP et de l’Enk a été vérifié à la fin des 
expériences comportementales.  
L’injection de DT altère la locomotion basale et la locomotion induite par la cocaïne 
Le striatum dorsal est impliqué dans la régulation de l’activité motrice ainsi que dans la réponse aux 
psychostimulants. Nous avons donc étudié l’activité locomotrice basale et suite à l’injection de cocaïne 
après ablation des MSNs D1. Nous avons observé d’une part une diminution de l’activité basale (fig. 
10A, inset) et d’autre part une potentialisation de l’activité induite par la cocaïne (fig. 10). 
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L’hypoactivité des souris DTR+ après ablation des MSNs D1 dans le striatum dorsal est en accord avec 
le schéma classique des ganglions de la base qui propose que la voie directe ait un rôle facilitateur sur 
le mouvement et les travaux montrant que l’ablation ou l’activation par optogénétique des MSNs D1 
induit une diminution ou une augmentation, respectivement, de l’activité locomotrice  (Durieux et al., 
2012; Kravitz et al., 2010). Notre étude est en revanche la première à montrer une réponse accrue à 
l’injection aiguë de cocaïne. Nous proposons que cette potentialisation soit due à la disparition des 
CINs plutôt qu’à l’ablation des MSNs striatonigraux. Des expériences permettant une destruction 
spécifique des CINs devraient permettre de confirmer ce résultat intéressant.  
L’injection de DT diminue significativement les dyskinésies induites par la L-DOPA   
Le traitement à la L-DOPA s’avère très efficace dans la MP mais, après une période plus ou moins 
longue selon les patients (10-15 ans), il induit l’apparition de mouvements anormaux involontaires 
appelés dyskinésies. Plusieurs études suggèrent qu’une des causes de l’apparition des dyskinésies 
induites par la L-DOPA serait l’hypersensibilité des récepteurs D1 exprimés sur les MSNs striatonigraux 
(Santini et al., 2009). Pour établir l’implication causale de cette population neuronale dans les 
dykinésies, nous avons testé les souris DTR+ et DTR- dans un protocole d’induction de dykinésies par 
un traitement chronique à la L-DOPA. L’injection de L-DOPA pendant 21 jours à des souris rendues 
préalablement parkinsoniennes par injection de 6-OHDA dans la SNc entraine l’apparition de 
mouvements anormaux qui sont significativement réduits après ablation des MSNs D1 (fig. 11). Ces 
résultats démontrent que les MSNs D1 du striatum dorsal jouent un rôle causal dans l’expression des 
dyskinésies induites par la L-DOPA. 
 
 
 
Figure 10. Réponse locomotrice basale et 
après injection de cocaine de souris DTR- et 
DTR+. A : le graphe illustre le nombre 
d’interruption de faisceau infra-rouge par 
tranche de 5 min pendant une période de 60 
min après injection de saline ou de cocaïne (15 
mg/kg) chez des souris DTR- (n=14 saline et 10 
cocaine)  et DTR+ (n=9 saline et 6 cocaine). 
Inset : moyennes du nombre total 
d’interruption de faisceau infra-rouge 
pendant 60 min. Student’s t test: *** p < 0.001 
vs. DTR- sal or DTR+ sal, # p < 0.05 vs. DTR- sal. 
B : le graphe compare l’activité locomotrice à 
deux doses différentes de cocaïne (5 et 15 
mg/kg). Les données sont exprimées pour 
chaque génotype en pourcentage des souris 
traitées au saline (groupe 5 mg/kg : souris 
DTR-, n=12 saline et 12 cocaïne and souris 
DTR+, n=5 saline et 5 cocaïne; groupe 15 
mg/kg g : souris DTR-, n=14 saline et 10 
cocaïne et souris DTR+, n=9 saline et 6 
cocaïne). Student’s t test: * p < 0.05, ** p < 
0.01 vs. DTR- coc. 
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L’injection de DT diminue significativement l’anxiété   
Un nombre croissant de données suggère que le striatum dorsal, en plus de son rôle dans les 
comportements moteurs, interviendrait aussi dans la régulation des comportements présentant une 
composante émotionnelle et motivationnelle (Balleine et al., 2007). Nous avons donc évalué l’état 
d’anxiété des souris dans le test du labyrinthe en croix surélevé constitué de deux bras ouverts et de 
deux bras fermés par des parois en plexiglas opaque. Le temps passé ainsi que le nombre d’entrée 
dans les bras ouverts (zones anxiogènes) sont significativement plus importants pour les souris DTR+ 
comparés aux souris DTR- démontrant une diminution significative de l’anxiété après ablation des 
MSNs D1 (fig. 12).  
 
 
En résumé, le travail de thèse de Delphine a permis de montrer que l’ablation des MSNs D1 affecte 
peu les autres populations neuronales du striatum à l’exception des CINs. Un faisceau d’arguments 
démontre que la perte des CINs ne serait pas due à un effet direct de la DT sur ces interneurones mais 
serait secondaire à la perte des MSNs D1, mettant en évidence un lien étroit entre ces deux 
populations. D’un point de vue fonctionnel, nos résultats montrent l’implication des MSNs D1 dans la 
régulation de nombreux comportements, tant moteurs qu’émotionnels.   
 
Article  
• Révy D, Jaouen F, Salin P, Melon C, Chabbert D, Tafi E, Concetta L, Langa F, Amalric M, Kerkerian-
Le Goff L, Marie H, Beurrier C (2014). Cellular and behavioral outcomes of dorsal striatonigral neuron 
ablation: new insights into striatal functions, Neuropsychopharmacology, 39(11): 2662-2672. 
Figure 11. Les dykinésies induites 
par la L-DOPA sont réduites après 
ablation des MSNs D1. A : protocole 
expérimental. B : score moyen des 
dyskinésies évalué pendant 120 min 
après injection de L-DOPA au jour 21 
(n=16 DTR- et n=12 DTR+). Student’s 
t test : *** p < 0.001 vs. DTR- mice. C : 
évolution temporelle des dyskinésies 
mesurées toutes les 20 min sur une 
période de 120 min au jour 21 chez 
les souris DTR- (n=16) et DTR+ 
(n=12). Holm-Sidak post test: *** p < 
0.001. 
Figure 12. L’injection de DT diminue 
l’anxiété des souris DTR+.  A : exemple de 
traces illustrant les trajets réalisés par les 
souris DTR+ ou DTR- pendant les 5 min de 
test. On peut noter que dans les 2 cas, les 
souris DTR+ se déplacent plus dans les 
bras ouverts que les souris DTR-. B : 
Quantification du temps passé et du 
nombre d’entrée dans les bras ouverts 
pour chaque groupe. Student’s t test: 
***p<0,001 vs. DTR-. 
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II.4 LES INTERNEURONES CHOLINERGIQUES DU STRIATUM SONT DES ACTEURS ESSENTIELS DANS LA 
PATHOPHYSIOLOGIE DE LA MALADIE DE PARKINSON    
 
Le travail réalisé ci-dessus m’a fait prendre conscience de la nécessité d’allier les approches 
moléculaires/cellulaires à l’électyrophysiologie pour appréhender le rôle d’une population neuronale. 
En outre, nous avons montré de façon tout à fait fortuite et inattendue une particularité des 
interneurones cholinergiques (CINs) dont la survie semblerait dépendre des MSNs D1. Au même 
moment dans le laboratoire, grâce à des expériences de traçage réalisées avec le virus de la rage, 
l’équipe venait de montrer que ces mêmes CINs subissaient un remaniement anatomique important 
en situation parkinsonienne. Après déplétion dopaminergique, le nombre de CINs innervant les MSNs 
D2 augmente alors que les CINs qui contactent les MSNs D1 diminuent (Salin et al., 2009). Ce résultat 
suggérait que les CINs pouvaient participer au déséquilibre des sorties striatales en situation 
parkinsonienne (hyperactivité de la voie indirecte et hypoactivité de la voie directe). La question qui 
s’est alors posée est la suivante : est-ce que ce remaniement anatomique a des impacts fonctionnels 
sur la circuiterie des ganglions de la base et plus particulièrement sur les deux populations de MSNs ? 
La seule expérience qui me semblait pertinente pour répondre à cette question était de comparer la 
réponse des MSNs D1 et D2 à la stimulation d’un nombre donné de CINs en situation contrôle puis en 
situation parkinsonienne. Les techniques conventionnelles d’activation (pharmacologique ou 
électrique) ne permettant pas de cibler spécifiquement une population cellulaire, l’optogénétique m’a 
semblé être l’outil idéal et j’ai décidé de développer cette technique dans le laboratoire. En outre, si 
on connait depuis longtemps le rôle crucial de l’acétylcholine (ACh) dans un grand nombre de 
pathologies liées aux ganglions de la base et notamment dans la maladie de Parkinson, la 
démonstration expérimentale de son implication reste fragmentaire. Malgré leur faible nombre (1-3% 
de la population striatale), les CINs ont une arborisation dendritique très étendue qui les place dans 
une position idéale pour moduler l’activité des deux types de MSNs et donc la sortie du réseau des 
ganglions de la base (Bolam et al., 1986, 1984). L’efficacité des anti-cholinergiques sur les symptômes 
parkinsoniens est un argument supplémentaire renforçant l’idée que l’ACh peut profondément 
moduler les fonctions striatales. Pour établir l’implication causale des CINs dans la maladie de 
Parkinson et disséquer les mécanismes responsables de l’altération cholinergique-dépendante des 
fonctions striatales, nous avons étudié si et comment la manipulation otpogénétique de ces neurones 
affecte la motricité et identifié les substrats neuronaux de l’action des CINs en situation normale et 
parkinsonienne. Ce projet a été financé par l’ANR et nous a permis de recruter un ingénieur, Florence 
Jaouen, qui a grandement participé à la mise en place de l’optogénétique dans le laboratoire. Nous 
avons combiné différentes approches : l’électrophysiologie in vitro (réalisée par moi-même) et in vivo 
(réalisée par Nicolas Maurice dans le laboratoire) et une approche comportementale qui a été faite en 
collaboration avec le laboratoire du Dr. Marianne Amalric.   
 
II.4.1 Contrôle de l’activité des interneurones cholinergiques du striatum par optogénétique 
Pour manipuler sélectivement les CINs nous avons exprimé la  channelrhodopsine-2 fusionnée à la 
mCherry (ChR2-mCherry) ou l’halorhodopsine fusionnée à la TagRFP (eNpHR3.0-RFP) dans les 
neurones exprimant la ChAT en injectant un adénovirus associé (AAV) dont l’expression dépend de la 
cre-recombinase. L’injection de l’AAV contenant les gènes de la ChR2-mCherry ou de l’eNpHR3.0-RFP 
dans le striatum dorsal de souris transgéniques ChATcre/cre nous a permis d’obtenir une proportion 
importante de CINs exprimant soit la ChR2-mCherry soit l’eNpHR3.0-RFP. Au cours de l’étude, nous 
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avons pu nous procurer chez Jackson Laboratory des souris transgéniques qui expriment les opsines 
dans tous les neurones cholinergiques après croisement avec les souris transgéniques ChATcre/cre (souris 
RosaeNpHR/+::ChATcre/+ et RosaChR2/+::ChATcre/+). Nous avons donc mené une partie de la caractérisation 
comportementale sur le modèle AAV alors que la caractérisation électrophysiologique a été effectuée 
sur le modèle Rosa. Dans les deux cas, nous avons vérifié la fonctionnalité des opsines en enregistrant 
l’activité des CINs sur des tranches striatales ou in vivo sur des souris anesthésiées : l’activation de 
l’eNpHR par une lumière orange (589 nm) inhibe la décharge spontanée des CINs alors que l’activation 
de la ChR2 par une lumière bleue (473 nm) déclenche l’émission de potentiels d’action (fig. 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II.4.2 L’inhibition des interneurones cholinergiques du striatum réduit les déficits moteurs 
parkinsoniens 
Nous avons dans un premier temps testé l’effet de la photoactivation et de la photoinhibition des CINs 
sur l’activité locomotrice basale de souris contrôles dans un open-field. Nous n’avons détecté aucun 
effet. Pour déterminer si la modulation des CINS pouvait en revanche affecter les symptômes 
parkinsoniens, nous avons d’abord utilisé un modèle pharmacologique  aigu de l’akinésie 
parkinsonienne, la catalepsie induite par l’injection d’un antagoniste dopaminergique, l’halopéridol. 
L’inhibition des CINs réduit significativement l’état cataleptique des animaux alors que leur activation 
n’a aucun effet. Nous avons ensuite voulu voir si les effets bénéfiques de l’inhibition des CINs pouvaient 
être reproduits dans un modèle lésionnel de la maladie de Parkinson, le modèle 6-OHDA. Deux 
semaines après l’injection de 6-OHDA, les déficits moteurs des animaux ont été évalués dans le test du 
cylindre et dans le test du labyrinthe en croix. Dans le test du cylindre (fig. 14a, b), les souris lésées 
présentent une forte asymétrie dans l’utilisation de leurs pattes avant lors de l’exploration des parois 
du cylindre : l’utilisation de la patte controlatérale à la lésion est fortement réduite, reflétant une forte 
akinésie induite par la 6-OHDA (score d’asymétrie élevé). La photoinhibition des CINs réduit 
partiellement cette asymétrie alors que leur photoactivation n’a aucun effet. Nous avons aussi observé 
un effet bénéfique de la photoinhibition dans le test du labyrinthe (fig. 14c, d) : le biais dans 
l’exploration du bras ipsilatéral à la lésion est fortement réduit pendant l’inhibition des CINs alors que 
l’activation des CINs n’a encore une fois aucun effet.  
 
C D
Figure 13. Expression fonctionnelle de 
l’eNpHR-RFP et de la ChR2-mCherry dans 
les CINs. Une lumière orange (589 nm) 
induit un inhibition des potentiels 
d’action dans les CINs exprimant la 
eNpHR-RFP que ce soit in vitro sur des 
tranches (A) ou in vivo sur des souris 
anesthésiées (C) alors que de brefs pulses 
de lumière bleue (473 nm , 5 ms) 
déclenchent des potentiels d’action dans 
les CINs exprimant la ChR2-mCherry 
enregistrés sur tranches (B) ou in vivo (D).  
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II.4.3 L’inhibition des interneurones cholinergiques du striatum affecte la structure de sortie 
des ganglions de la base uniquement en situation parkinsonienne  
Pour identifier les substrats cellulaires de ces effets anti-parkinsoniens, Nicolas Maurice dans l’équipe 
a enregistré in vivo l’activité de la principale structure de sortie des ganglions de la base, la SNr dans 
des souris transgéniques eNpHR anesthésiées. Nous avons étudié l’effet de l’inhibition des CINs sur 
l’activité électrique spontanée des neurones de la SNr ainsi que sur les réponses évoquées par la 
stimulation corticale. La photoinhibition des CINs normalise les changements de la décharge en 
bouffées induits par la lésion 6-OHDA sans modifier les paramètres non affectés par la lésion (fig. 15a). 
La stimulation corticale déclenche une réponse complexe au niveau des neurones de la SNr qui se 
compose de trois phases : une excitation précoce suivie d’une inhibition et d’une excitation tardive 
(fig. 15b, c). Nos travaux antérieurs (Maurice et al., 1999) ainsi que d’autres études (Ryan and Sanders, 
1994) ont clairement montré que ces trois composantes résultaient de l’activation successive de la 
voie hyperdirecte cortico-subthalamique et des voies striatonigrées directe et indirecte. Sachant que 
l’akinésie parkinsonienne s’accompagne d’une hypoactivité de la voie directe et d’une hyperactivité 
de la voie indirecte, nous avons émis l’hypothèse que l’inhibition des CINs permettait de contrecarrer 
ce déséquilibre. Nous avons montré que la photoinhibition augmente en effet significativement la 
durée de l’inhibition sans affecter les autres composantes de la réponse (fig. 15d, e). Ce résultat 
suggère que l’inhibition des CINs exerce un effet anti-parkinsonien en renforçant la transmission de 
l’information corticale par la voie directe sans affecter la voie indirecte. De façon intéressante, 
l’inhibition des CINs sur des souris non-lésées n’affecte ni l’activité spontanée ni la réponse à la 
stimulation corticale des neurones de la SNr, suggérant que la modulation exercée par les CINs dans le 
striatum est fortement dépendante du niveau de dopamine.  
 
 
Figure 14. L’inhibition des interneurones 
cholinergiques réduit les symptômes 
moteurs parkinsoniens. A : les souris 6-
OHDA présentent une forte asymétrie 
dans le test du cylindre  (6-OHDA  vs. non-
lesioned: ** p<0.01, Fisher PLSD test) qui 
est partiellement réduite par la 
photoinhibition des CINs (ON vs. OFF: # 
p<0.05, Student’s t test). B : la 
photoactivation des CINs n’a pas d’effet 
sur l’asymétrie des souris 6-OHDA. C : le 
biais ipsilatéral des souris 6-OHDA (6-
OHDA vs. non-lesioned: ** p<0.01, one-
way ANOVA) est partiellement corrigé 
par l’inhibition des CINs (ON vs. OFF: # 
p<0.05, paired Student’s t test). D : le 
biais ipsilatéral n’est pas affecté par la 
phtoactivation des CINs. Le cercle sous le 
labyrinthe représente une souris avec le 
côté en rouge injecté par la 6-OHDA. 
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Figure 15. L’inhibition des interneurones cholinergiques normalise la décharge en bouffées des neurones de la 
SNr et renforce la voie directe striatonigrale chez les souris 6-OHDA. A : détection des bouffées avec l’analyse 
Poisson Surprise d’un neurone de la SNr enregistré chez une souris eNpHR 6-OHDA. L’augmentation de la durée 
et du nombre de potentiels d’action dans les bouffées induites par la 6-OHDA (6-OHDA vs. non-lesioned: *p<0.05, 
**p<0.01, Student’s t test) est supprimée par l’inhibition des CINs (6-OHDA ON vs. OFF: #p<0.05, ##p<0.01, Holm-
Sidak test after significant one-way ANOVA). B : représentation schématique des voies projetant sur la SNr qui 
sont activées par la stimulation corticale. 1 : voie hyperdirecte, 2 : voie directe et 3 : voie indirecte. C : Raster et 
PSTH (peristimulus time histogram) de la réponse triphasique évoquée par la stimulation du cortex moteur chez 
une souris eNpHR lésée à la 6-OHDA. D, E : PSTHs moyens de la réponse des neurones de la SNr évoquée par la 
stimulation corticale chez des souris contrôles et lésées à la 6-OHDA. La photoinhibition des CINs  induit une 
augmentation significative de la durée de la composante inhibitrice de la réponse triphasique uniquement chez 
les souris 6-OHDA (**p<0.01, Holm-Sidak test after significant one-way repeated measure ANOVA). 
 
 
II.4.4 L’inhibition des interneurones cholinergiques du striatum affecte de façon différentielle 
l’excitabilité des MSNs de la voie directe et indirecte 
Quelles sont les cibles striatales modulées par les CINs qui pourraient renforcer l’activité de la voie 
directe ? Avant de répondre à cette question fondamentale, il nous a semblé important de déterminer 
les effets de la lésion 6-OHDA sur les CINs eux-mêmes. L’absence de dopamine peut en effet modifier 
l’homéostasie cholinergique dans le striatum mais il n’y a pas de consensus quant aux modifications 
engendrées par un tel changement. Nous avons donc enregistré l’activité des CINs en patch-clamp sur 
des tranches striatales et en extracellulaire in vivo chez des souris contrôles et 6-OHDA. Les CINs sont 
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caractérisés par une activité spontanée régulière et cette activité n’est pas modifiée par la lésion 6-
OHDA en termes de fréquence et de patron de décharge, tant in vitro qu’in vivo. Nous avons en 
revanche observé une augmentation de l’excitabilité des CINs après lésion 6-OHDA qui se traduit par 
une diminution du courant de rhéobase et un shift vers la gauche de la courbe entrée-sortie. Ces 
résultats montrent donc que les CINs ne sont pas hyperactifs per se après lésion dopaminergique mais 
sont plus excitables.  
Nous avons ensuite déterminé les effets de la photoinhibition des CINs sur les MSNs à l’origine des 
voies directe et indirecte. Afin d’identifier le type de MSNs enregistré, nous avons utilisé des souris 
exprimant à la fois la protéine fluorescente tdTomato sous le contrôle du promoteur du récepteur 
dopaminergique D1 exprimé par les MSNs de la voie directe et l’eNpHR dans les CINs. En accord avec 
la littérature, nous avons retrouvé la dichotomie de l’excitabilité des MSNs en situation contrôle : les 
MSNs de la voie directe (D1 MSNs) sont moins excitables que ceux de la voie indirecte (D2 MSNs) (fig. 
16a) (Gertler et al., 2008; Kreitzer and Malenka, 2007). La lésion dopaminergique réduit cette 
différence puisque l’excitabilité des MSNs de la voie directe est spécifiquement augmentée chez les 
souris 6-OHDA (fig. 16a). Lorsque les CINs sont photoinhibés, les deux populations de MSNs émettent 
moins de potentiels d’action mais cet effet inhibiteur est moins marqué sur les MSNs de la voie 
indirecte que sur ceux de la voie directe chez les souris 6-OHDA alors qu’il est équivalent en situation 
contrôle (fig. 16b). Ainsi, l’inhibition des CINs permettrait de restaurer la dichotomie d’excitabilité 
entre les deux populations de MSNs ce qui pourrait expliquer en partie l’effet antiparkinsonien de la 
photoinhibition. Ce résultat est en revanche plus difficile à réconcilier avec le renforcement de 
l’inhibition évoquée par la stimulation corticale dans les neurones de la SNr lié à l’activation des MSNs 
de la voie directe en condition 6-OHDA (fig. 15d, e).  Une hypothèse possible est que l’inhibition des 
CINs affecte in vivo l’intégration dendritique des entrées corticales par les MSNs, paramètre que nous 
n’avons pas mesuré dans nos expériences in vitro.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Impact de la lésion 6-OHDA et de l’inhibition des CINs sur l’excitabilité des MSNs. A : enregistrements 
en courant-imposé montrant la réponse des MSNs des voies directe (D1) et indirecte (D2) à des pulses de courant 
dépolarisant chez une souris contrôle (+400 pA) et 6-OHDA (+450 pA). Le graphe montre la fréquence des 
potentiels d’action en fonction du courant injecté dans les deux populations de MSNs en condition contrôle et 6-
OHDA. B : les enregistrements électrophysiologiques montrent la réponse de MSNs D1 et D2 à des pulses de 
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courant avant (pre, gris) et pendant (light, orange) l’application de la lumière chez des souris contrôles et 6-OHDA. 
Les graphes illustrent la différence dans le nombre de potentiels d’action évoqués avant et pendant l’application 
de la lumière. R représente l’intensité minimale de courant déclenchant un potentiel d’action en condition pre. A 
partir de R, l’intensité du courant augmente de 10 pA. A partir de R+80 pA, les MSNs D2 sont moins inhibés que 
les MSNs D1 pendant l’application de la lumière chez les souris 6-OHDA comme le montre l’interaction 
significative entre la lésion et l’intensité de courant pour les MSNs D2 [F(15,300)=2.39, p<0.05)]. 
 
Pour conclure, nous avons montré dans cette étude que :  
• l’inhibition des CINs dans le striatum dorsal permet de réduire les symptômes moteurs parkinsoniens, 
attestant leur implication causale dans la maladie de Parkinson.  
• l’inhibition des CINs chez les souris parkinsoniennes module de façon différentielle l’excitabilité des 
MSNs des voies directe et indirecte, normalise la décharge pathologique en bouffées des neurones de 
la SNr et augmente le contrôle inhibiteur de la voie directe sur ces mêmes neurones.  
 • en revanche, l’inhibition des CINs chez les souris contrôles n’a pas d’effet sur l’activité locomotrice, 
réduit l’excitabilité des deux populations de MSNs de façon similaire et n’affecte ni l’activité spontanée 
ni les réponses corticales des neurones de la SNr. Le rôle des CINs dans les fonctions motrices est donc 
fortement dépendant du niveau de dopamine.    
 
 
Article  
• Maurice N, Liberge M, Jaouen F, Ztaou S, Hanini M, Camon J, Deisseroth K, Amalric M, 
Kerkerian-Le Goff L, Beurrier C (2015). Striatal Cholinergic Interneurons Control Motor 
Behavior and Basal Ganglia Function in Experimental Parkinsonism, Cell Rep., 13(4):657-666. 
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III. PROJET DE RECHERCHE 
 
Mon projet de recherche dans les années à venir s’inscrit dans la continuité de mon questionnement 
sur le rôle des CINs dans le réseau des ganglions de la base. Après avoir mis en place l’optogénétique 
dans le laboratoire et montré, grâce à cet outil, le rôle fondamental des CINs dans le contrôle moteur 
en situation pathologique (II.4), je voudrais maintenant aborder la fonction des CINs dans la 
planification de l’action et les apprentissages. Pour cela, il me semble important de décortiquer les 
interactions entre trois acteurs essentiels au fonctionnement du réseau des ganglions de la base qui 
sont : les CINs du striatum, les projections thalamostriatales et les synapses corticostriées. 
L’implication respective de chaque partenaire dans les fonctions et les pathologies associées au réseau 
des ganglions de la base a été largement étudiée mais la façon dont ils interagissent reste à démontrer. 
Les changements à long terme de la transmission synaptique corticostriée sont les bases cellulaires 
des apprentissages sensorimoteurs et un dysfonctionnement de cette plasticité corticostriée jouerait 
un rôle fondamental dans l’expression des symptômes parkinsoniens. L’ACh, provenant des CINs, agit 
sur de nombreuses cibles striatales et module de façon complexe la plasticité corticostriée. In vivo, les 
CINs correspondent aux neurones toniquement actifs du striatum qui présentent une pause dans leur 
activité lors de la présentation d’un stimulus saillant pendant les apprentissages par renforcement. Au 
fur et à mesure de l’apprentissage, cette réponse conditionnée semble se synchroniser dans un 
ensemble de CINs. Le complexe centromédian parafasciculaire du thalamus jouerait un rôle clef à la 
fois dans la genèse de la pause et de sa synchronisation. Ces trois protagonistes présentent des 
altérations majeures dans la maladie de Parkinson qui pourraient être à l’origine de certains 
symptômes. Afin d’expliquer les interactions complexes de ce trio, une hypothèse souvent évoquée 
propose que les CINs, en intégrant les informations thalamiques, fournit au striatum des informations 
sensorielles saillantes et peuvent ainsi modifier la transmission corticostriée et donc faciliter 
l’apprentissage. Cette hypothèse reste cependant à démontrer. Le projet que je souhaite développer 
utilisera des techniques de pointe combinant l’optogénétique et l’électrophysiologie que nous avons 
mises en place dans le laboratoire lors de l’obtention de notre dernier contrat ANR. Ces outils se sont 
révélés tout à fait pertinents pour mettre en lumière le rôle des CINs dans le contrôle du 
comportement moteur en situation pathologique. Cependant, une différence fondamentale est la 
façon dont l’optogénétique sera utilisée dans ce projet : les activations/inhibitions de longue durée 
que nous avons appliquées précédemment seront remplacées par des paramètres de photoactivation 
plus physiologiques nous permettant de mimer des patrons d’activité observés in vivo dans les CINs. 
Le Dr. Nicolas Maurice, chercheur au sein de l’équipe avec qui je collabore (cf. notre dernière 
publication : Maurice et al., 2016) apportera sa compétence en électrophysiologie in vivo. Un 
partenaire extérieur, le Dr. Nicolas Mallet (Institut des maladies neurodégénératives, UMR5293 
CNRS/Université de Bordeaux) participera également au projet et nous permettra d’apporter un autre 
niveau d’analyse, l’électrophysiologie sur l’animal éveillé en comportement. L’association de ces 
différentes compétences me semble essentielle pour répondre aux questions suivantes : 
• Quelle est la signification de la pause des CINs pour la plasticité corticostriée ? Cette partie sera 
réalisée in vitro sur des tranches de cerveau dans le laboratoire sous ma direction.  
• Est-ce que les afférences thalamostriatales affectent la plasticité corticostriée ? Cet effet passe-t-il 
par les CINs ? Cette partie sera réalisée in vivo sur des souris anesthésiées et sera menée dans le 
laboratoire sous la responsabilité du Dr. Nicolas Maurice.  
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• La pause des CINs affecte-t-elle les apprentissages associatifs ? Ces expériences seront réalisées par 
le Dr. Nicolas Mallet à l’université de Bordeaux et ne seront pas détaillées dans ce rapport. 
Ce projet a été pré-sélectionné par l’ANR en 2015 et 2016 mais n’a pas été retenu en phase finale. 
J’envisage de le resoumettre cette année. Le projet est détaillé, en anglais, dans les pages suivantes. 
J’encadre en ce moment Gwenaëlle Laverne qui a fait son Master 2 avec moi et qui a débuté sa thèse 
en 2016. Gwenaëlle travaille à plein temps sur ce projet et se charge de tous les enregistrement 
électrophysiologiques sur tranches de cerveaux et participe également à la gestion des souris 
transgéniques. Au-delà de ce questionnement sur le rôle des CINs dans les apprentissages et la 
plasticité corticostriée à long terme, qui constitue le cœur de mon travail, je collabore avec différentes 
personnes de façon ponctuelle sur des questions diverses en leur apportant ma compétence 
d’électrophysiologiste. Je ne détaillerai pas ces différents projets dans le manuscript.  
 
III.1 OBJECTIVES AND HYPOTHESES  
Our driving hypothesis is that the cholinergic interneurons, by integrating thalamostriatal 
information, provide the striatum with behaviorally significant events that, in turn, enable long-term 
changes of corticostriatal transmission. Therefore, the thalamic gating of corticostriatal synaptic 
plasticity via CINs would be critical for sensor-motor transformation, striatal-dependent learning and 
could also be involved in mediating some of the behavioral abnormalities present in Parkinson’s 
disease (PD).  
Despite the fact that cholinergic interneurons (CINs) are well positioned to play an important role in 
the function of striatal circuit, especially in reward-dependent learning, several key questions remain 
unaddressed. Tonically active neurons (TANs) in the striatum, which are likely to be CINs, have been 
shown to have very interesting in vivo temporal dynamics, including a brief pause in their tonic firing 
which is often preceded and/or followed by bursts of activity around the time of salient or reward-
predicting events. This complex response is synchronized among CINs that are widely scattered 
throughout the striatum. For several reasons, including a lack of appropriate tools, most of the studies 
do not replicate this very peculiar endogenous dynamics, hampering a full understanding of CIN 
functions in basal ganglia (BG)-related behaviors. The main strength of our proposal is to use 
innovative cutting-edge techniques, such as optogenetics, transgenic mice and electrophysiological 
recordings (in vitro/in vivo), to test whether a physiologically-relevant pattern in CINs causally 
impacts long-term plasticity. While optogenetics has been used so far to induce prolonged inhibition 
or activation of CINs, we propose here to go a step ahead by using this powerful technique to mimic 
or prevent the typical physiological response of CINs. We will address the following specifics questions: 
first, what are the cellular actions mediated by CINs at the striatal level that could impact changes in 
BG-related behaviors? We will particularly focus on long-term corticostriatal plasticity, thought to be 
the cellular substrate of learning in the BG network. As the two main types of striatal output neurons 
form distinct functional subcircuits, we will identify them by using transgenic mice to determine 
whether CINs differentially affect plasticity in these two populations. Second, does CIN synchronization 
play a crucial role through a modulation of striatal plasticity? If it is increasingly clear that the precise 
timing and synchronous activity of CINs are critical to their function, how it happens in real life is still 
enigmatic. Here, we will decipher how the thalamic centromedian/parafascicular complex (CM/Pf), 
which processes stimuli with attentional value and massively target CINs, contributes to their temporal 
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dynamics and affects corticostriatal plasticity via CINs. Finally, considering that CINs, thalamostriatal 
inputs and corticostriatal plasticity exhibit profound dysfunctions after dopamine depletion, some 
experiments will be extended to the classical 6-OHDA rodent model of PD. These additional 
experiments will help understanding how this trio is affected by dopamine depletion and its causal 
contribution to the physiopathology of the disease. To build a comprehensive system-level view of 
these interactions, our project is focused toward two main objectives: 
- 1: determine the impact of the pause response of CINs on long-term plasticity in direct and indirect 
MSNs. We strongly believe that the effect of CINs on corticostriatal plasticity cannot be apprehended 
without considering the temporal dynamic of their typical pause response, which is closely associated 
with reward-associative learning. We have developed an optogenetic approach enabling us to mimic 
closely the physiological pause response in CINs, in striatal slices. We will therefore be able, by 
combining optogenetics with patch-clamp recordings, to analyze for the first time how a 
physiologically-relevant pattern induced in CINs impacts long-term corticostriatal plasticity in normal 
and parkinsonian conditions. As the differential expression of GPCRs in direct and indirect MSNs may 
reflect important differences in the way neuromodulators control synaptic plasticity, this question will 
be investigated in identified MSNs. 
- 2: decipher whether CM/Pf inputs modulate corticostriatal long-term transmission through CINs.  
Here, our hypothesis is that thalamostriatal inputs modulate corticostriatal long-term plasticity via CIN 
synchronization. We will investigate this issue in vivo in anesthetized mice by combining intracellular 
recordings of MSNs and optogenetic manipulations of CINs to block their recruitment by thalamic 
inputs. This preparation has two main advantages: it preserves the integrity of the thalamostriatal 
system and the “in vivo-like” activity of striatal output neurons that exhibit fluctuations in their 
membrane voltage known as up and down states. These experiments will thus provide crucial cues on 
the impact of the thalamically-driven pause in CINs on corticostriatal synaptic plasticity in vivo.   
To address these issues, our project will be split-up in several tasks undertaken in parallel but all 
converging towards the same goal: underpinning the hypothesis that the thalamically-driven pause 
response in TANs is crucial for reward-related learning through a modulation of corticostriatal 
plasticity. 
 
III.2 SCIENTIFIC BACKGROUND  
III.2.1 The cellular basis of learning in the basal ganglia network: corticostriatal long-term 
plasticity  
A primary function of the BG is the selection of appropriate actions that lead to positive outcome 
(Balleine et al., 2007). At the cellular level, such associative learning is thought to occur through long-
term changes in synaptic strength at corticostriatal synapses. Disruption of this property is a common 
feature of many neurological disorders, both motor (Parkinson’s disease, Huntington disease…) and 
psychiatric (obsessive-compulsive disorder, autism spectrum disorder…). The long-term modulation of 
synaptic transmission efficacy is expressed as long-term potentiation (LTP) and depression (LTD). The 
vast majority of striatal cells are GABAergic projecting neurons, known as medium spiny neurons 
(MSNs), and exhibit both forms of plasticity. They receive massive glutamatergic inputs from the cortex 
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and the thalamus and project to downstream BG nuclei. MSNs can be categorized into two different 
subpopulations, based on their differential expression of G-protein-coupled receptors (GPCRs) and 
axonal projections (Gerfen et al., 1990; Smith et al., 1998). Striatonigral MSNs express D1 dopamine 
and muscarinic M4 acetylcholine receptors and project directly to the BG output nuclei, represented 
mainly in rodents by the substantia nigra pars reticulata (SNr), and are called direct MSNs. In contrast, 
striatopallidal MSNs, also called indirect MSNs, express D2 dopamine and A2A adenosine receptors 
and project indirectly to BG output nuclei via the external globus pallidus and the subthalamic nucleus. 
These pathways are thought to work in an antagonistic way during action selection although recent 
findings suggest cooperative interactions depending on the behavioral context (Cui et al., 2013). Data 
published until now suggest that the mechanisms involved in corticostriatal long-term plasticity are 
roughly similar in both the direct and indirect MSNs (Kreitzer and Malenka, 2008; Lovinger, 2010). 
However, a fundamental difference lies in the way neuromodulators gate plasticity in the two types of 
MSNs (Lerner and Kreitzer, 2011; Lovinger, 2010). Whereas it is now clearly established that the type 
and level of activation of dopamine receptors (D1 vs. D2) present on MSNs play a critical role in the 
control of corticostriatal plasticity (Centonze et al., 2001; Lovinger, 2010; Shen et al., 2008), much less 
is known about acetylcholine (ACh), especially on its differential effect on the two populations of 
MSNs. Both ionotropic nicotinic and metabotropic muscarinic receptors are expressed in the striatum, 
at presynaptic and postsynaptic levels. Pharmacological manipulations of cholinergic receptors have 
been shown to modulate corticostriatal plasticity in vitro (Bonsi et al., 2008; Calabresi et al., 1998, 
1999) but these experiments are far from recapitulating the complex actions of CINs on striatal circuit. 
For instance, it is known that CINs co-release glutamate with ACh and that glutamate can also 
modulate striatal behavioral and cellular functions (Gras et al., 2008; Guzman et al., 2011; Higley et al., 
2011). Determining the resulting effect of all these actions, which could sometimes oppose each other, 
is highly challenging. Although investigating the respective role of ACh and glutamate is beyond the 
scope of this project, we think that direct manipulation of CIN activity as proposed here will give a 
more accurate view of CIN functions. Most importantly, these interneurons exhibit an intriguing 
pattern of activity in response to salient events in vivo and it is very likely that the effects of CINs on 
corticostriatal plasticity depend on the temporal dynamic of their firing at a given moment in a specific 
context. Hence, our understanding of CIN regulation of striatal function cannot be reached without 
considering the very particular features of their activity.  
 
III.2.2 Reward-related learning and striatal cholinergic interneurons   
Learning is a complex process where one needs to use previous experience to guide behavior towards 
actions that have led to positive outcome in the past and away from actions that have led to negative 
outcome. In our daily life, this type of learning requires forming relationships between an action or a 
context and its potential outcome value, whether positive or negative. Such cognitive operation can 
be studied in rodents and primates that are trained to select an action (e.g. pressing a lever) in 
response to a stimulus (e.g. an auditory cue) that has been associated with a certain outcome value 
(e.g. often a reward). While it remains very challenging to record the electrical activity of neurons 
during the initial learning phase of such instrumental task, it is commonly accepted that the 
optimization of action outcome relies on an online associative learning process that is likely to share 
similar cellular basis as the ones described by in vitro synaptic plasticity experiments. In the BG, 
corticostriatal synapses need to be informed about which action will lead to the best outcomes. In 
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other words they need to select the most rewarding actions. Dopamine has long been considered as 
the principal modulatory component, providing “hedonistic” flavor to particular actions and 
participating in action selection. Indeed, a wealth of data has shown that dopamine released by 
substantia nigra pars compacta (SNc) neurons is playing a fundamental role in reward signaling by 
indicating a “reward prediction error” that signals the discrepancy between the prediction of a reward 
and its actual occurrence (Schultz, 2007). This teaching signal is essential to learn the value of stimuli 
in the environment. However, CINs also show very peculiar patterns of firing activity during reward-
related learning. Despite their small numbers (1-3% of striatal cells) and scattered distribution 
throughout the striatum, CINs have dense terminal fields primarily directed to the two populations of 
MSNs that overlap those of dopaminergic projections  (Bolam et al., 1984). Such a particular 
architecture positions them as potent modulators of striatal output. Unlike most striatal neurons 
recorded in vitro, CINs exhibit a regular spiking activity in the absence of synaptic input, demonstrating 
that their activity is autonomously generated (Bennett and Wilson, 1999). Extracellular recordings in 
the striatum also reveal the presence of tonically active neurons (TANs) in vivo, both in rodents and 
monkeys (Apicella et al., 1991; Wilson et al., 1990). The distribution of TANs is similar to that of choline 
acetyltransferase positive neurons, suggesting that TANs and CINs are one and the same (Aosaki et al., 
1995). However, we will use the term TANs when referring to in vivo recordings. In the seminal study 
of Aosaki et al., (Aosaki et al., 1994a) the authors repeatedly paired neutral stimuli with reward 
presentation, and observed that the monkeys learned to respond to those stimuli that predict the 
reward. During acquisition of conditioning, TANs develop a transient suppression (pause) of their tonic 
firing, which is frequently flanked by brief excitations (bursts) in response to salient stimuli. The pause 
tends to be time-locked in TANs recorded at distant sites in the striatum (Aosaki et al., 1995). This 
observation strongly suggests that, besides SNc dopaminergic neurons, the coordinated reponse of 
TANs has also a fundamental role in reward signaling. However, the precise operational mode carried 
out by TANs remains difficult to apprehend. One possible reason to explain the lack of consensus is 
that most past studies have focused on describing the correlatives changes in the electrical activity of 
presumed-CINs during behavior. Key features of the relationship between dopaminergic and 
cholinergic inputs provide clues to their possible functional implications. For instance, the responses 
of CINs and SNc neurons are time-locked and inversely polarized: while dopaminergic neurons respond 
to reward-predicting events by a phasic increase in firing rate, CINs exhibit a coincident pause in their 
tonic activity (Morris et al., 2004). Moreover, the magnitude of dopaminergic responses is modulated 
according to reward probability whereas the pause in CINs seems more stereotyped  (Morris et al., 
2004; Tobler et al., 2005). Despite the apparent importance of CINs in learning, their precise role 
remains difficult to apprehend and a number of unsolved questions remain. First, the function of the 
dual representation of reward-related information by CINs and dopaminergic neurons is still enigmatic. 
Does the response of these two neuronal systems offer different meaning beyond the information 
conveyed by a single neuron type? A main current hypothesis suggests that CINs cooperate with the 
dopaminergic system, but carry a different meaning that has been proposed to teach the BG ‘when’ to 
form new learning as opposed to ‘what’ to learn  (Bradfield et al., 2013; Morris et al., 2004). The pause 
in CIN firing and the resulting drop in ACh would create a permissive temporal window (a “sensitive” 
window) allowing long-term modulation of efficacy at corticostriatal synapses to facilitate learning 
(Deffains and Bergman, 2015). A second puzzling issue is the functional meaning of the brief increase 
in firing that could precede and/or follow the pause. If the pause is reliably observed after presentation 
of a reward-related stimulus, these bursts seem more labile and whether they engage some processes 
critical for learning is still unknown. This aspect needs specific investigation since it may account for a 
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fine temporal tuning of corticostriatal synapses. The early and/or late ACh release occurring during the 
bursts may modulate MSN responses, having a potential effect on the polarity of synaptic changes. 
Finally, another issue concerns the mechanisms responsible for the pause generation and its 
synchronization in CINs. While this matter is still debated, there is however unquestionable evidence 
showing that both dopamine from SNc neurons and the glutamatergic input from the thalamic CM/Pf 
complex are important for its generation (Aosaki et al., 1994b; Matsumoto et al., 2001; Raz et al., 
1996). CM/Pf neurons, which respond to  behaviorally significant sensory events, project to the entire 
striatal complex and massively target CINs in addition to MSNs (Matsumoto et al., 2001). This broad 
thalamic projection pattern might then be able to synchronize the scattered population of CINs but 
how it precisely impacts the striatal circuitry at the cellular level is still elusive. One hypothesis that will 
be addressed in this proposal is that thalamostriatal inputs modulate corticostriatal long-term 
plasticity via synchronizing the pause in CIN firing. The demonstration that activation of thalamic axons 
induces a burst-pause response in CINs, supports this hypothesis (Ding et al., 2010; Doig et al., 2014; 
Threlfell et al., 2012). Nevertheless, the causal relationship of such response and behavior still needs 
to be demonstrated and, more importantly, the impact of the thalamically-driven synchronization in 
CINs on corticostriatal plasticity is still unknown. 
Considering the intimate link between ACh and dopamine, one could wonder what happens in 
pathological conditions in which the dopaminergic system is compromised such as in PD. Besides the 
well characterized impairment of corticostriatal long-term plasticity occurring after dopamine 
depletion (Centonze et al., 2001), there is also compelling evidence implicating CINs and their thalamic 
inputs from CM/Pf in PD pathophysiology. In a recent study from our lab, we demonstrated that 
optogenetic inhibition of CINs reduces parkinsonian motor deficits by, among other things, increasing 
the functional weight of the direct striatonigral pathway (Maurice et al., 2015). Although we employed 
a prolonged optogenetic inhibition in this study that did not replicate the in vivo dynamics of CINs, we 
nonetheless provided an experimental support to the longstanding hypothesis that poses PD as a 
striatal cholinergic disorder. We were also among the firsts to show that CM/Pf lesioning or high-
frequency stimulation reversed some molecular changes induced by dopamine lesion and alleviated 
parkinsonian symptoms (Bacci et al., 2004; Jouve et al., 2010; Kerkerian-Le Goff et al., 2009). The 
positive outcome of CM/Pf inhibition on parkinsonian motor deficits was recently confirmed with a 
chemogenetic approach (Parker et al., 2016). Hence, both CINs and their major input coming from the 
CM/Pf appear as main players in the maladaptive changes following dopamine depletion, highlighting 
the need for a better understanding of their interactions.  
To conclude, the development of the temporally coordinated pause observed in CINs seems critical 
for their function in reward-related learning and is likely to carry a different meaning than the burst 
response of dopaminergic neurons. The thalamostriatal inputs coming from the CM/Pf are well 
positioned to synchronize the pause response among CINs. However, the meaning of such neural 
signal and its overall impact on striatal network, particularly on corticostriatal plasticity and reward-
related learning, is far from being understood. All these processes are altered following dopamine 
depletion and might be determinant in parkinsonian symptom expression. Deciphering how these 
different players interact with each other at the network and behavioral levels is then a key question 
to understand striatal function in health and disease. 
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III.3 MEANS FOR ACHIEVING THE OBJECTIVES 
III.3.1 Generation and impact of the pause responses on corticostriatal long-term plasticity in direct 
and indirect MSNs   
In this task, we will address the following points: can the typical pause response exhibited by CINs in 
vivo be mimicked in vitro? Does it affect corticostriatal long-term plasticity? Does the pause response 
differentially impact direct and indirect MSNs? All the experiments proposed in this section will be 
performed by patch-clamp recordings in striatal slices combined to optogenetics under the supervision 
of C. Beurrier.  
Strategy to mimic the pause response of CINs in vitro 
In vivo, the response of CINs to salient stimuli consisted in a transient reduction in firing rate that could 
sometimes be preceded and/or followed by an increase activity. The initial and late excitations flanking 
the pause are usually designed as burst and rebound, respectively. While the pause is robustly 
observed across different experimental paradigms, the functions of the burst and rebound are still 
enigmatic (Doig et al., 2014). To shed light on this complex multiphasic response, we will trigger the 
pause response in two different ways.  
(1) Burst-pause sequence. In many circumstances, the pause response seems to be a direct result of 
excitatory inputs (e.g. CM/Pf inputs) (Schulz and Reynolds, 2013). This ability is explained, in part, by 
the intrinsic properties of CINs allowing them to generate membrane hyperpolarization following 
excitation (Bennett et al., 2000). We will then first use transgenic mice expressing Channelrhodopsin-
2 (ChR2), a nonspecific cation channel that drives action potential firing under blue-light illumination, 
in cholinergic neurons to drive the pause in CINs (for clarity’s sake, these mice will be subsequently 
referred to as ChR2 mice). Our preliminary data show that in such mice, blue light illumination (473 
nm) evoked not only a burst of spikes but also a subsequent pause in CIN firing (burst-pause sequence, 
fig.17). To our knowledge, this is the first demonstration that a physiologically-relevant burst-pause 
response is induced in vitro in CINs with optogenetics. To check to what extent our optogenetically-
induced response mimics the in vivo response, we will first determine the light parameters allowing to 
best replicate the pause-duration observed in vivo. A second crucial feature to mimic closely the in vivo 
situation is the synchronization of the response among a large population of CINs. Contrary to firing 
manipulation induced by intracellular current injection in individual CIN, optogenetic stimulation 
synchronizes CIN activity in striatal slices as described in a recent paper (Threlfell et al., 2012) and as 
shown in our recordings (fig.17). Another factor that might play a role in the generation of the in vivo 
response is dopamine. In striatal slices, the group of S. Cragg nicely showed that light-evoked firing in 
CINs is able to drive dopamine release from dopaminergic terminals via nACh receptor activation 
(Threlfell et al., 2012). To investigate whether our optogenetically-induced response does so, we will 
test the effects of nAChR or D2 receptor antagonists on the light-evoked pause. Finally to ensure that 
our optogenetically burst-pause sequence is relevant to the thalamically-driven response (as shown in 
our preliminary in vivo recordings, fig.19), we will test whether a similar pause response is elicited in 
CINs by activation of thalamostriatal ChR2-expressing axons. If this point is confirmed, we will use 
direct manipulation of CINs to avoid confounding effect of thalamic activation on MSNs in the following 
experiments. 
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(2) Pause-rebound sequence. In vivo, some studies reported that in response to reward-predicting 
stimuli a substantial proportion of CINs exhibits a pause followed by a rebound without a preceding 
burst (Doig et al., 2014). Oswald et al., (Oswald et al., 2009) demonstrated that two types of inputs can 
trigger the pause: either a burst of spikes or a subthreshold excitatory synaptic input. This result might 
explain the occurrence of a pause without a preceding burst in vivo. However, a main functional 
difference between a burst-pause sequence and a pause-rebound sequence is the level of ACh reached 
around the pause. In another word, is the ACh released during the initial burst or during the rebound 
engages some processes critical for the effect of the pause? To answer this question, we will also drive 
a pause in CINs without a preceding burst by using transgenic mice expressing halorhodopsin (eNpHR), 
a chloride pump that inhibits action potential firing under orange-light illumination. Our data show 
that in such mice, short illumination (500 ms) triggers an inhibition of firing rate followed by an increase 
in activity that closely looks like the pause-rebound sequence described in vivo.  
We will then compare the effects of the two types of optogentically-driven pause (burst-pause or 
pause-rebound) on corticostriatal synaptic transmission (see below). These experiments will bring 
valuable information not only on the function of the pause itself but also on the burst and rebound 
flanking the pause. 
A recent study indicates that the striatum also receives extrinsic cholinergic innervation from the 
brainstem (Dautan et al., 2014). To determine the potential contribution of this extrinsic input, some 
experiments will be done after injecting a Cre-dependent adeno-associated virus carrying ChR2 (pAAV-
Ef1a-DIO-hChR2(H134R)-mCherry) in the striatum or brainstem of ChATcre/cre mice. We already used 
this viral strategy to target cholinergic neurons in our previous paper (Maurice et al., 2015).  
All these experiments, and the following ones, are based on the assumption that optogenetic 
manipulation of CINs modulates ACh release. We think that checking this point is crucial for 
interpreting our data and we propose to implement in our lab fast-scan cyclic voltammetry using 
carbon fiber microelectrodes recently optimize by Asri et al., (Asri et al., 2016) to measure ACh 
concentration in striatal slice.   
 
 
 
 
Figure 17: Optogenetic 
stimulation of ChR2-expressing 
CINs generates a burst-pause 
response. Sample traces of cell-
attached recordings from 2 
different CINs in response to 
pulses (5-ms pulse width, 30 Hz) of 
blue light illumination. As shown 
in the expanded traces on the 
right, synchronization of action 
potentials is achieved with pulses 
of light.     
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Induction of long-term plasticity at corticostriatal synapses and modulation by the light-evoked 
response induced in CINs in normal and parkinsonian mice  
In this task, we seek to induce long-term plasticity at corticostriatal synapses in identified MSNs. As 
conventional high-frequency stimulation protocols might trigger the release of a mixture of 
neuromodulators that is poorly controlled, we will use more physiologically relevant setting such as 
spike-timing-dependent plasticity (STDP) protocols based on the near-coincidence between 
presynaptic input and postsynaptic spiking within a millisecond time scale. As LTD is more reliably 
induced and is the most characterized form of plasticity at corticostriatal synapses, we first focus on 
this form of plasticity. As STDP rules might differ in D1 and D2 MSNs (Paille et al., 2013; Shen et al., 
2008), we will test our protocol in transgenic mice expressing the fluorescent reporter tdTomato in D1 
receptor-containing neurons to identify  MSN subtypes. Our preliminary data obtained in D2 MSNs 
show that we are able to induce STDP LTD according to the protocol described in Shen et al., (2008)  
(fig.18). We are currently testing this protocol in D1 MSNs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We will then test whether the light-induced pause (burst-pause or pause-rebound) in CINs modulates 
LTD STDP in direct and indirect MSNs. ACh can affect plasticity in several ways by changing its polarity, 
the shape of the STDP window and/or the number of trials required to achieve plasticity. In a first step, 
optogenetic stimulation of CINs, as defined above, will be applied during the STDP protocol. In a second 
step, to be even closer to physiological conditions, we will also mimic the patterns recorded during the 
 
Figure 18: Spike-timing-dependent LTD. A: 
Negative timing (post-pre) induction protocol 
(from Shen et al., 2008). Three postsynaptic action 
potentials are elicited by somatic current injection 
(post) and are followed by an EPSP induced by 
stimulation of cortical afferents with a delay of 10 
ms (pre). B: example of individual experiment 
displaying the time course of EPSPs, input 
resistance (Rin) and membrane potential (Vm). 
Traces shown were collected during the baseline 
period (1, dark blue line) and 20 min following the 
induction protocol (2, light blue line). C: Summary 
graph of the average STDP LTD elicited in D2 MSNs 
(n=7). GABAA transmission was blocked by adding 
50 µm picrotoxin in the bath solution. 
39 
 
instrumental associative learning in behaving animals. The exact timing and frequency of optogenetic 
stimulation necessary to modulate STDP will be determined experimentally.  
Among the major changes that occur following dopamine depletion in PD, there is a loss of the pause 
response in TANs and an impairment of corticostriatal synaptic plasticity. To investigate whether these 
two pathological changes are causally linked, we will study the impact of the optogenetically-induced 
response in CINs on long-term plasticity in parkinsonian mice. These experiments will be conducted in 
a mouse model of PD based on the extensive unilateral lesion of dopamine neurons by intranigral 
injection of 6-OHDA. This mice PD model is routinely used in our lab and results in a near-total loss of 
nigral dopaminergic neurons in the injected side and their terminals in the ipsilateral striatum. 
Recordings will be made 2-3 weeks after 6-OHDA injections and the extent of the lesion will be 
systematically assessed by anti-tyrosine hydroxylase immunodetection. We will compare the effect of 
the optogenetically-induced pause in CINs on STDP in direct and indirect MSNs between naive and DA-
depleted mice.  
With these experiments, we expect to show that endogenous manipulation of ACh by our optogenetically-
induced responses modulates corticostriatal STDP. These results might unravel novel findings highly 
instrumental to understand the role of CINs in reward-related learning. All the techniques used in this task 
are available in the lab except fast scan cyclic voltammetry. The technician associated to this project (C. 
Melon) has a strong experience in electrochemical neurotransmitter measurements and will be in charge 
of implementing this technique in the lab. All the transgenic lines necessary to perform this task (and the 
following one) are present in the lab (Maurice et al., 2015). The VGluT2 cre mice to drive ChR2 expression 
in thalamic neurons will be purchased at Jackson lab (stock #: 016963). 
 
III.3.2 Impact of CINs and thalamostriatal system on corticostriatal long-term plasticity in vivo 
in anaesthetized mice  
In this task, we will perform intracellular recordings of MSNs in anesthetized mice as shown in our 
preliminary results (fig. 19) to test whether STDP rules described in vitro operate in vivo. The in vivo 
situation provides an additional level of complexity mainly due to the fact that MSNs are the target of 
continuous barrages of ongoing presynaptic activity that leads to fluctuations in the membrane voltage 
of MSNs known as “up and down states”. A strong synchronization of corticostriatal neurons is 
required for a transition from the down (hyperpolarized) to the up (depolarized) state that could 
trigger action potentials. These naturally occurring spikes backpropagate throughout the neuron, 
potentially interacting with the vast number of dendritically located channels. We will specifically 
address the three following points: (i) how spikes and MSN up/down transitions affect corticostriatal 
plasticity? (ii) does CM/Pf stimulation affect plasticity at corticostriatal synapses and (iii) are CINs 
mediating the thalamic influence? The in vivo recordings combined to optogenetics will be performed 
in anaesthetized mice under the supervision of Nicolas Maurice.  
 
Impact of the spontaneous synaptic activity in vivo on corticostriatal plasticity 
Here, we will determine the experimental conditions that reliably induce, in vivo in anesthetized mice, 
plasticity at corticostriatal synapses in MSNs. In vivo intracellular recordings, that are essential for 
investigating the corticostriatal plasticity, require the use of anesthesia which imposes particular 
activity patterns on MSNs. Barbiturate anesthesia will be preferred to study corticostriatal plasticity 
since: (i) it induces, in MSNs, up and down states that are not as exacerbated as under 
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ketamine/xylazine and (ii) MSNs fire spikes at low frequency as observed in the awake situation. ECoG 
recorded from the dura above the cerebral cortex will be combined with intracellular recordings from 
the MSNs located within the corresponding projection field. Corticostriatal plasticity will be induced 
by post-pre pairing protocols, the presynaptic element being activated by electrical cortical 
stimulation. This stimulation will be driven either by naturally occurring spikes or by transitions from 
down to up states in the postsynaptic element, using a window discriminator. Pre-post pairing 
protocols will use direct current injection into MSNs through the recording electrode. 
 
Impact of thalamostriatal system on corticostriatal plasticity 
STDP depends not only on spike timing but also on multifactors such as neuromodulators, postsynaptic 
voltage (see above) or synaptic cooperativity, which refers to the need for multiple coactive synaptic 
inputs to generate sufficient depolarization or spiking to drive plasticity. The purpose of this part is to 
study whether the CM/Pf input directly or indirectly impacts corticostriatal plasticity in vivo.  CM/Pf 
will be electrically stimulated while using STDP protocols to pair postsynaptic spikes or down to up 
transitions in MSNs with presynaptic cortical inputs as defined above. We will precisely determine the 
impact of the timing, the strength (number of spikes) and the frequency of CM/Pf stimulation relative 
to the activation of the presynaptic element. 
 
Contribution of CINs to the thalamostriatal modulation of corticostriatal plasticity 
CINs are a preferential target of CM/Pf which represents their main excitatory input.  Here, we will 
determine whether and how the microcircuits involving CINs contribute to the gating of corticostriatal 
plasticity by the thalamostriatal system. To answer this question, the impact of CM/Pf stimulation on 
corticostriatal plasticity will be investigated while rendering ineffective the recruitment of CINs by the 
thalamic input. This will be done by optogenetic inhibition of CINs with halorhodopsin (eNpHR mice). 
In CINs, CM/Pf electrical stimulation induces a burst followed by a pause (fig.19B). Our preliminary 
data show that a brief (15 ms) optogenetic inhibition of CINs, 5 ms after CM/Pf stimulation, totally 
shunts the recruitment of CINs by CM/Pf, abolishing not only the burst but also the pause (fig.19B). 
We will also examine whether the sole burst-pause response evoked in CINs by their direct optogenetic 
activation (as described in vitro) mimics the effect of thalamic stimulation on corticostriatal synaptic 
plasticity. 
 
 
 
 
 
 
 
 
 
 
Figure 19: Responses of CINs to electrical 
stimulation of CM/Pf and intracellular 
recording of MSN in vivo. A. Schematic 
representation of the experimental set-up. B. 
Peristimulus time histograms of one eNpHR-
expressing CIN responding to CM/Pf electrical 
stimulation before (left), during (middle) and 
after application of a 15-ms pulse width of 
yellow light. Glu: glutamate.  C. Intracellular 
activity of a single MSN under ketamine-
xylazine anesthesia simultaneously recorded 
with the corresponding ECoG. The membrane 
potential fluctuations consisted of 
depolarizing plateaus (-55 mV, up states) 
interrupted by hyperpolarizing periods (-72 
mV, down states). 
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This part of the work will provide crucial information on two fundamental issues: (i) Does STDP have a 
functional relevance in corticostriatal synapses in vivo? Indeed, although striatal STDP has been shown 
in vitro, whether this process happens in vivo is still unknown and (ii) Does the thalamostriatal system 
impact the strength of corticostriatal synaptic connections via CINs? No STDP studies on MSNs have 
been conducted in vivo so far but literature relative to other synapses (Pawlak et al., 2013) 
demonstrate the feasibility of such approach. All the protocols and transgenic mice used in this task 
are available in the lab. 
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Subthalamic Nucleus Neurons Switch from Single-Spike Activity to
Burst-Firing Mode
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The modification of the discharge pattern of subthalamic nu-
cleus (STN) neurons from single-spike activity to mixed burst-
firing mode is one of the characteristics of parkinsonism in rat
and primates. However, the mechanism of this process is not
yet understood. Intrinsic firing patterns of STN neurons were
examined in rat brain slices with intracellular and patch-clamp
techniques. Almost half of the STN neurons that spontaneously
discharged in the single-spike mode had the intrinsic property
of switching to pure or mixed burst-firing mode when the
membrane was hyperpolarized from 241.3 6 1.0 mV (range,
235 to 250 mV; n 5 15) to 251.0 6 1.0 mV (range, 242 to 260
mV; n 5 20). This switch was greatly facilitated by activation of
metabotropic glutamate receptors with 1S,3R-ACPD. Recur-
rent membrane oscillations underlying burst-firing mode were
endogenous and Ca21-dependent because they were largely
reduced by nifedipine (3 mM), Ni21 (40 mM), and BAPTA-AM
(10–50 mM) at any potential tested, whereas TTX (1 mM) had no
effect. In contrast, simultaneous application of TEA (1 mM) and
apamin (0.2 mM) prolonged burst duration. Moreover, in re-
sponse to intracellular stimulation at hyperpolarized potentials,
a plateau potential with a voltage and ionic basis similar to
those of spontaneous bursts was recorded in 82% of the tested
STN neurons, all of which displayed a low-threshold Ni21-
sensitive spike. We propose that recurrent membrane oscilla-
tions during bursts result from the sequential activation of T/R-
and L-type Ca21 currents, a Ca21-activated inward current,
and Ca21-activated K1 currents.
Key words: tonic and bursting activities of STN neurons in
slices; burst ionic mechanisms; low-threshold spike; Ca21-
dependent plateau potential; intracellular and patch-clamp re-
cordings; Parkinson’s disease
The subthalamic nucleus (STN) is composed of glutamatergic
neurons that control the circuitry of the basal ganglia by modu-
lating the activity of the two principal output structures of the
network: the internal pallidal segment and the substantia nigra
pars reticulata (for review, see Albin et al., 1989; DeLong, 1990;
Parent and Hazrati, 1995; Mink, 1996; Fe´ger et al., 1997). The
importance of this control is exemplified by the various conse-
quences of STN lesion in both control animals and animal models
of Parkinson’s disease.
Electrolytic lesions of the STN in normal monkeys produce a
hyperkinetic syndrome (Whittier and Mettler, 1949). This has
also been reproduced by toxic lesions restricted to the STN,
sparing the fibers of passage (Hammond et al., 1979; Hamada and
DeLong, 1992), transient pharmacological blockade of STN ac-
tivity (Crossman et al., 1984), and high-frequency STN stimula-
tion (Beurrier et al., 1997). All these observations reflect the
importance of the control exerted by the STN in control animals
and provide an explanation for the violent, involuntary move-
ments of the contralateral limbs (termed “hemiballism”) that
occur in STN-lesioned humans (Martin, 1927; Bathia and Mars-
den, 1994). Manipulating STN neurons in animal models of
Parkinson’s disease leads to a very different consequence. In
monkeys treated with the neurotoxic 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), STN lesion (Bergman et al., 1990;
Aziz et al., 1991; Guridi et al., 1996), pharmacological blockade of
the subthalamopallidal pathway (Graham et al., 1990; Brotchie et
al., 1991), or high-frequency stimulation of the STN (Benazzouz
et al., 1993), produce a reduction in motor impairments. These
results suggest that STN constitutes a good therapeutic target for
the treatment of Parkinson’s disease. For this reason, high-
frequency stimulation of the STN is being performed in several
patients suffering from severe parkinsonism and gives very con-
sistent results (Limousin et al., 1995).
To understand how the activity of STN neurons can regulate
the operational mode of basal ganglia, it is essential to determine
in detail the electrical properties of STN neurons and the under-
lying ionic mechanisms in physiological conditions in vitro. Pre-
vious studies have described the responses of STN neurons to
intracellular current pulses (Nakanishi et al., 1987; Overton and
Greenfield, 1995; Overton et al., 1995; Plenz et al., 1997). How-
ever, their ionic basis, as well as those of spontaneous firing
patterns, have not been fully characterized. We now report, with
the use of intracellular and patch-clamp techniques in rat brain
slices, that a substantial proportion of STN neurons can shift from
a regular single-spike mode to a burst-firing mode. We have
analyzed the intrinsic membrane properties underlying this prop-
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erty and propose that this electrical behavior provides a cellular
substrate for the functional role of the STN in controlling move-
ments under normal and altered conditions.
MATERIALS AND METHODS
Slice preparation. Experiments were performed on STN neurons in slices
obtained from 20- to 28-d-old male Wistar rats. Rats were anesthetized
with ether and decapitated. The brain was quickly removed, and a block
of tissue containing the STN was isolated on ice in a 0–5°C oxygenated
solution containing (in mM): 1.15 NaH2PO4 , 2 KCl, 26 NaHCO3 , 7
MgCl2 , 0.5 CaCl2 , 11 glucose, and 250 saccharose, equilibrated with
95% O2 and 5% CO2 , pH 7.4. This cold solution, with a low NaCl and
CaCl2 content, improved tissue viability. In the same medium, 300- to
400-mm-thick coronal slices were prepared using a Vibratome (Campden
Instruments LTD, Loughborough, UK) and were then incubated at room
temperature in a Krebs’ solution containing (in mM): 124 NaCl, 3.6 KCl,
1.25 HEPES, 26 NaHCO3 , 1.3 MgCl2 , 2.4 CaCl2 , and 10 glucose,
equilibrated with 95% O2 and 5% CO2 , pH 7.4. After a 2 hr recovery
period, STN slices were transferred one at a time to an interface-type
recording chamber, maintained at 30 6 2°C and continuously superfused
(1–1.5 ml/minute) with the oxygenated Krebs’ solution.
Electrophysiolog ical recordings. Slices were visualized using a dissecting
microscope, and the recording electrode was precisely positioned in the
STN. Electrophysiological recordings of STN neurons were performed in
current-clamp mode using the intracellular or patch-clamp technique.
Signals were recorded using an Axoclamp 2A (Axon Instruments, Foster
City, CA) in bridge or continuous single-electrode voltage-clamp mode
for intracellular and patch-clamp experiments, respectively.
For intracellular recordings, microelectrodes were pulled from fila-
mented borosilicate glass (BF-100–50-10; Sutter Instruments, Novato,
CA) on a horizontal Flaming–Brown micropipette puller (P-87; Sutter
Instruments). They had a resistance of 150–200 MV when filled with 2 M
potassium acetate. For patch-clamp experiments, recordings were made
using the blind patch-clamp technique in the cell-attached or whole-cell
configuration. Patch electrodes were pulled from filamented borosilicate
thin-wall glass capillaries (GC150F-15; Clarck Electromedical Instru-
ments, Pangbourne, UK) with a vertical puller (LM-3P-A; List Instru-
ments, Darmstadt-Eberstad, Germany) and had a resistance of 10–12
MV when filled with (in mM): 120 Kgluconate, 10 KCl, 10 NaCl, 10
EGTA, 10 HEPES, 1 CaCl2 , 2 MgATP, and 0.5 GTP, pH 7.25.
Drugs. All drugs were purchased from Sigma (St. Louis, MO), except
1S,3R-1-aminocyclopentane-1,3-dicarboxylate (1S,3R-ACPD) purchased
from Tocris Cookson (Bristol, UK) and tetrodotoxin (TTX) and apamin
purchased from Latoxan (Rosans, France). Biocytin and 1,2-bis(2-
aminophenoxy)-ethane- N, N,N9,N9-tetraacetic acid (BAPTA) were di-
luted in the pipette solutions. All other drugs were diluted in the
oxygenated Krebs’ solution and applied through this superfusion me-
dium. Nifedipine and BAPTA-AM were dissolved in dimethylsulfoxide
(final concentration, 0.03–0.5%). For experiments with cobalt (Co 21),
calcium (Ca 21)-free (Ca 21 was substituted for equimolar concentration
of Co 21) or low Ca 21 solutions (0.4 mM with 2 mM Co 21) were used.
Histology. In some experiments, recordings were performed with pi-
pette solution containing biocytin (0.5–1%) to allow the subsequent
identification and morphological analysis of the recorded neurons. The
avidin–biotinylated horseradish peroxidase (ABC complex) reaction was
used to visualize the biocytin-filled neurons. After recording, slices were
fixed for 1–2 d in a solution containing 4% paraformaldehyde and 0.15%
picric acid in phosphate buffer (0.1 M, pH 7.4) at 4°C. After several
rinsings in Tris-buffered saline (TBS; 0.05 M, pH 7.4), the sections were
treated with a mixture of methanol and H2O2 for 30 min, rinsed again in
TBS, and processed for 2 or 3 d with the standard ABC complex
Figure 1. Microphotographs of a biocytin-filled STN neuron at two
magnifications. The labeled neuron is located within the boundaries of the
STN (top) and presents a dense dendritic arborization (top) and numer-
ous spines on dendrites (bottom).
Figure 2. Single-spike mode. A, Tonic and regular activity (single-spike
mode) of an STN neuron, recorded with intracellular techniques at
resting membrane potential and ( B) corresponding interspike interval
histogram (mean interval, 66.1 6 15.6 msec; bin width, 12.5 msec). C,
Discharge frequency histogram of single-spike mode recorded in 41 STN
neurons (mean frequency, 22.3 6 1.5 Hz; bin width, 10 Hz). Spikes in A
are truncated.
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(Vectastain ABC kit, Vector laboratories, Burlingame, CA) at 4°C. After
several washes in TBS, sections were treated with diaminobenzidine as a
chromogen and H2O2 for 5–10 min (DAB substrate peroxidase kit;
Vector Laboratories). The sections were then rinsed several times in
TBS, dehydrated and rehydrated in graded ethanol, stained with cresyl
violet, dehydrated again in graded ethanol, cleared in xylene, and
mounted in Eukitt (053–47505; Labonord, Villeneuve d’Ascq, France).
Data analysis. Current and voltage outputs were displayed simulta-
neously on a storage oscilloscope and a four-channel chart recorder
(Gould Instruments, Longjumeau, France), digitized (DR-890; Neuro-
Data Instruments, New York, NY), and stored on a videotape for
subsequent off-line analysis with pClamp6 software (Axon Instruments).
Values are expressed as mean 6 SEM. Statistical significance was as-
sessed using the Student’s t test (unpaired data). Parameters of the
single-spike and bursting modes were quantified from intracellular and
patch-clamp recordings, respectively.
RESULTS
Morphology and passive membrane properties of
STN neurons
Results were obtained from 141 STN neurons. The soma of
biocytin-filled recorded neurons (n 5 5) were all located within
the boundaries of the STN identified with the cresyl violet stain-
ing technique (Fig. 1A). Soma had diameters of 10–25 mM and
gave rise to four or five dendritic trunks (Fig. 1B). Axons gave
rise to numerous collaterals. Only neurons with an input mem-
brane resistance .100 MV, firing action potentials with an am-
plitude of at least 50 mV, and an afterhyperpolarizing potential
(AHP) at a threshold of 250 mV, were included in the present
study. The resting potential of spontaneously firing neurons was
difficult to establish because of the absence of a stable membrane
potential. The input resistance of STN neurons was 200.2 6 6.8
MV (n 5 88) and not significantly different when measured with
both the patch-clamp and intracellular techniques ( p 5 0.36;
n 5 88).
Firing patterns of STN neurons: single-spike and
burst-firing modes
All tested STN neurons (n 5 83) displayed a tonic discharge of
single spikes (Fig. 2, single-spike mode) that totally disappeared
in the presence of TTX (1 mM, n 5 33 of 33, data not shown).
Among STN neurons, 46% (n 5 38 of 83) were also able to fire
in bursts (burst-firing mode, Fig. 3). These STN neurons switched
from one mode to the other depending on membrane potential
(Fig. 4). Single-spike mode was recorded at membrane potentials
between 235 and 250 mV (241.3 6 1.0 mV; n 5 15), whereas
burst firing was present in the membrane potential range of 242
to 260 mV (251.0 6 1.0 mV; n 5 20) (Fig. 4). These values
represent the threshold potential of spikes in the single-spike
mode (Table 1, parameter 3) and that of bursts in the burst-firing
mode (Table 2, parameter 1). At membrane potentials more
hyperpolarized than 260 to 270 mV, most STN neurons were
silent (Fig. 4). At membrane potentials more depolarized than
230 mV, spike amplitude decreased, and spike frequency in-
creased, leading rapidly to a blockade of STN tonic activity.
Activation of group I and II metabotropic glutamate receptors
(I-IImGluRs) by 1S,3R-ACPD (25 mM) (Nakanishi, 1994; Pin and
Figure 3. Burst-firing mode. Two types of burst mode recorded with
patch-clamp techniques in two different STN neurons: pure burst mode
(A) and mixed burst mode (B), consisting of long bursts (<) separated by
sequences of short bursts (E). C, Spontaneous bursts recorded in the
cell-attached configuration in voltage-clamp mode.
Figure 4. Switch of firing mode according to membrane potential. Pure
burst mode (<) was triggered at resting membrane potential (I 5 0, dotted
line, middle) in a whole-cell-recorded neuron that displayed the single-
spike mode (L) at a more depolarized membrane potential (I 5 10.2 nA,
lef t). At a more hyperpolarized potential (I 5 20.6 nA, right), the cell
became silent. The two bottom traces are taken from the above records
and displayed at an expanded time scale. Spikes of the single-spike mode
in the lef t part are truncated.
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Duvoisin, 1995) induced burst firing in some STN neurons that
bursted poorly in control (n 5 16 of 20, data not shown).
Quantitative characteristics of the two firing modes are sum-
marized in Tables 1 and 2. The single-spike mode was character-
ized by an extreme regularity and a rather high frequency (22.3 6
1.5 Hz; n 5 41; Fig. 2). Burst-firing mode could be divided into
“pure burst mode” consisting of long-lasting bursts of even dura-
tion (Fig. 3A) and “mixed burst mode” alternating bursts of long
and short duration (Fig. 3B). Discharge frequency of long bursts
in the pure burst mode was highly variable (15.0 6 1.4 bursts/min;
range, 7–29 bursts/min; n 5 21). Long bursts (lasting .800 msec)
gave rise to numerous spikes with a “crescendo–decrescendo”
frequency sequence: the first spike was followed by a rapid in-
crease in spike frequency that reached a maximum before the end
Table 1. Quantitative parameters of the single-spike mode
Mean 6 SEM Range Number of cells
Discharge frequency (Hz) 22.3 6 1.5 5/43 n 5 41
1. Spike amplitude (mV) 74.7 6 1.1 57/85 n 5 34
2. Half duration of spikes (msec) 0.65 6 0.03 0.3/1.2 n 5 41
3. Spike threshold (mV) 241.4 6 0.7 234/254 n 5 41
4. V Overshoot (mV) 15.4 6 0.9 6/24 n 5 34
5. V AHP (mV) 260.3 6 0.8 250/276 n 5 41
6. AHP amplitude (mV) 13.8 6 0.5 7.5/20.0 n 5 41
The different parameters were obtained from intracellularly recorded STN neurons. The numbers on the diagram of a single
spike indicate how the different parameters were measured.
Table 2. Quantitative parameters of the burst-firing mode
A. Long bursts (pure mode) B. Long bursts (mixed mode) A vs B
1. Threshold (mV) 250.4 6 1.0 249.1 6 1.2
p 5 0.41(240/260, n 5 20) (245/260, n 5 12)
2. Duration (sec) 1.9 6 0.1 2.1 6 0.2
p 5 0.44(0.8/3.0, n 5 22) (1.0/3.6, n 5 14)
3. V AHP (mV) 261.8 6 0.8 260.8 6 0.9
p 5 0.43(258.0/272.0, n 5 20) (258.0/270.0, n 5 12)
4. AHP Amplitude (mV) 17.7 6 0.7 18.9 6 0.6
p 5 0.23(10.3/25.0, n 5 22) (15.0/22.5, n 5 14)
The different parameters were obtained from patch-clamp-recorded STN neurons. Parameters in column A refer to long
bursts of the pure burst mode, whereas parameters in column B refer to long bursts from the mixed burst mode. Values are
expressed as mean 6 SEM; the range (minimum and maximum values) and the number of cells are indicated in parentheses.
The numbers on the diagram of a long burst indicate how the different parameters were measured.
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of the burst. Frequency then decreased as membrane potential
slowly repolarized during bursts (Fig. 4, right bottom trace). Table
2 recapitulates the quantitative characteristics of the burst-firing
mode. On the basis of the three parameters studied, there was no
statistical difference between long bursts taken from “pure burst”
or from “mixed burst” firing modes (Table 2).
Burst-firing mode was recorded using both patch-clamp and
intracellular techniques. Noteworthy, spontaneous bursts were
also observed in the cell-attached configuration in patch-clamp
experiments (Fig. 3C). However, the relative percentage of burst-
ing neurons varied according to the recording technique, because
burst firing was more often observed in patch-clamp recordings
(48%) than in intracellular recordings (36%). The input resis-
tance of bursting cells was not significantly different from that of
cells that did not burst (195.2 6 9.4 MV and 225.2 6 15.0 MV,
respectively; p 5 0.1; n 5 48; whole-cell recordings).
Ionic basis of burst-firing mode
Pharmacological studies were performed in the whole-cell con-
figuration. TTX (1 mM) suppressed action potentials, but spared
rhythmic membrane oscillations underlying bursts whose dura-
tion was increased by 358 6 76% as compared with control (n 5
5; Fig. 5A). Knowing that Ca 21-dependent mechanisms are often
involved in burst generation, we tested several drugs known to
interfere with Ca21 entry or intracellular free Ca 21 ions. They
all had an inhibitory effect on burst firing. Bath application of
nifedipine (3 mM), an L-type Ca21 channel blocker, largely re-
duced the duration of bursts and even suppressed burst firing (n 5
9) at any potential tested (n 5 4; Fig. 5B). This effect did not
reverse throughout the experiment (1–2 hr). Nickel (Ni21) at a
concentration that preferentially blocks T/R-type Ca21 channels
(40 mM, data not shown) (Fox et al., 1987) had a similar, but
Figure 5. Ionic basis of the burst-firing mode I. A, TTX (1 mM) totally suppressed action potentials evoked during bursts while sparing the rhythmic
oscillations of the membrane potential that underlie bursts. Note the increase in the duration of membrane oscillations in the presence of TTX (from
5.0 6 0.0 sec to 16.4 6 3.1 sec). B, The duration of bursts was irreversibly decreased by an application of nifedipine (3 mM, bottom trace) at all tested
potentials, whereas the single-spike mode was unaffected. Traces in A and B were obtained from two different STN neurons recorded with patch-clamp
techniques in whole-cell configuration. Spikes from the single-spike mode in B are truncated. Calibration is the same for traces of each section.
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reversible effect: it decreased the duration of bursts (n 5 8) at any
potential tested (n 5 3). Finally, bath application of the perme-
able form of the Ca21 chelator BAPTA (BAPTA-AM, 10–50
mM) largely reduced the duration of bursts and even suppressed
burst firing after a delay of ;40 min (n 5 7) at any potential
tested (n 5 4; Fig. 6A).
To analyze whether Ca21-activated K1 currents play a role in
burst repolarization, tetraethylammonium (TEA; 1 mM) was ap-
plied at a concentration that blocks the big conductance Ca 21-
dependent K1 current, but not the delayed rectifier one. The
TEA was applied in combination with apamin (0.2 mM), the
selective blocker of the small conductance Ca21-dependent K1
current (for review, see Sah, 1996). TEA and apamin totally
prevented burst repolarization and suppressed spikes, except a
few early ones (Fig. 6B; n 5 4). The sustained depolarization of
the membrane, resulting from the blockade of Ca21-activated
K1 currents suppressed spikes, probably by inactivating Na1-
channels as already described in cortical neurons (Prince and
Connors, 1986). Short hyperpolarizing current pulses (100 msec,
280 pA) were needed to cut off bursts (Fig. 6B, middle traces). As
the drugs washed out, bursts spontaneously repolarized, although
after a longer duration than in control, and spikes reappeared
(Fig. 6B, bottom trace).
To better understand the Ca21 and Ca21-activated currents
present in STN neurons, their responses to current pulses were
then analyzed.
Figure 6. Ionic basis of the burst-firing mode II. A, Bath application of BAPTA-AM (50 mM) decreased burst duration at any potential tested, although
it spared the single-spike activity (lef t column). B, Simultaneous application of TEA (1 mM) and apamin (0.2 mM) prevented burst repolarization and
locked membrane potential at 230 mV. Repolarizations were obtained by injecting brief hyperpolarizing current pulses (280 pA, 100 msec). After each
repolarizing command, the membrane spontaneously depolarized again (middle trace). As drugs washed out, bursts reappeared, but with a longer
duration (2.9 6 0.1 sec vs 1.7 6 0.2 sec, bottom trace). Traces in A and B were obtained from two different STN neurons with patch-clamp recordings
in whole-cell configuration. Spikes from the single-spike mode in A (on the lef t) are truncated.
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Ionic basis of responses to intracellular current pulses
Injection of depolarizing or hyperpolarizing current pulses in
STN neurons triggered two kinds of responses: a long depolar-
ization that outlasted the current pulse (Figs. 7, 8, plateau poten-
tials) and/or a short depolarizing rebound [low-threshold spike
(LTS); Fig. 9].
The plateau potential
Plateau potentials, as burst-firing mode, were more often ob-
served in whole-cell patch-clamp recordings than in intracellular
recordings (93 vs 62%, respectively). In response to depolarizing
or hyperpolarizing current pulses (100 pA, 100 msec), 86 STN
neurons of the 106 tested (82%) generated long-lasting plateau
potentials (mean duration, 1043.7 6 69.8 msec; range, 300–2500
msec; n 5 52) that gave rise to numerous action potentials (Fig.
7A). Plateau potential duration was measured from the beginning
of the current pulse to the peak of the AHP. During plateaus,
spike frequency increased until the end of the depolarizing cur-
rent pulse and then gradually decreased during the rest of the
plateau phase, thus showing some adaptation (Fig. 7A). Two
different phases were easily identified in the presence of TTX (1
mM): a ramp-like, slow-rising depolarization that corresponded to
the duration of the depolarizing current pulse, and an afterdepo-
larization that outlasted the current pulse (Fig. 7B). Plateau
potentials spontaneously ended with an AHP of 20.6 6 0.8 mV
amplitude (range, 10–35 mV; n 5 52) and could also be termi-
nated by a short hyperpolarizing current pulse (Fig. 7C). AHP
amplitude was measured in the same way as in burst-firing mode
(Table 2). Plateau potentials were triggered within a narrow
range of membrane potentials, between 250 and 275 mV (n 5
43; Fig. 7D), thus showing that they resulted from the activation
of voltage-dependent conductances.
Figure 7. Plateau potentials. A, A short depolarizing (100 pA, 100 msec,
lef t trace) or hyperpolarizing (2100 pA, 100 msec, right trace) current
pulse triggered both a plateau potential (1.8 and 2.6 msec duration,
respectively) that considerably outlasted the duration of the stimulus and
was followed by a prominent AHP (28 and 17 mV amplitude, respective-
ly). B, TTX (1 mM) revealed the presence of two different phases in the
plateau potential: a slow depolarization triggered by the depolarizing
current pulse (50 pA, 200 msec) and an afterdepolarization (267 msec)
triggered at the break of the current pulse. C, Long duration plateau
potential terminated by a short hyperpolarizing current pulse (220 pA,
100 msec). D, Amplitude and duration of the plateau potential according
to membrane potential. In the presence of TTX (1 mM), the same
depolarizing current pulse (100 pA, 100 msec) evoked a plateau potential
in the membrane potential range of 260 to 270 mV. At more depolarized
(240 mV, extreme lef t) or hyperpolarized (280 mV, extreme right) po-
tentials, the amplitude and duration of the plateau potential was consid-
erably reduced. Traces in A, C, and D were obtained with patch-clamp
recordings (whole-cell configuration), and traces in B were obtained with
intracellular recordings. All spikes are truncated.
Figure 8. Ionic basis of the plateau response. A, TTX (1 mM) suppressed
action potentials but not the plateau potential (middle trace) evoked by a
100 pA, 100 msec current pulse (lef t trace). In the presence of TTX, bath
application of nifedipine (3 mM) suppressed the plateau potential (right
trace). B, The duration of the plateau potential was also decreased by bath
application of BAPTA-AM (50 mM). Note that the cell fired some action
potentials during the current pulse (100 pA, 100 msec). C, In contrast, the
plateau potential was significantly increased by simultaneous application
of TEA (1 mM) and apamin (0.2 mM) from 0.5 sec (left trace) to 5.5 sec
(right trace). All traces were obtained with patch-clamp recordings
(whole-cell configuration).
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Ionic currents underlying plateau potentials were analyzed in
whole-cell recordings with the use of channel blockers. TTX (1
mM) suppressed Na1-dependent spikes (n 5 19 of 19) (Fig. 8A,
middle trace) but did not affect the plateau response. A low Ca21
(0.4 mM) extracellular solution containing Co21 (2 mM) com-
pletely suppressed plateau potentials (n 5 5, data not shown). To
determine the type of voltage-gated Ca 21 currents involved,
Ca21 channel blockers were tested. Nifedipine (3 mM) suppressed
plateau potentials (n 5 8; Fig. 8A), whereas Ni21 (40 mM) had no
effect (n 5 5; data not shown). Chelation of intracellular Ca21
with either BAPTA-AM (10–50 mM; n 5 4; Fig. 8B) or BAPTA
in the pipette solution (20 mM; n 5 2; data not shown) suppressed
or decreased the plateau potential duration after ;30 and 20 min,
respectively. These results suggest that both Ca 21 entry through
L-type Ca21 channels and intracellular free Ca21 ions are in-
volved in the generation of plateau potentials. Simultaneous ap-
plication of TEA (1 mM) and apamin (0.2 mM) increased the
duration of plateau potentials by 610 6 297% (n 5 7; Fig. 8C). In
some cells (n 5 2), spikes were suppressed probably as a result of
the sustained membrane depolarization and the consequent Na1-
channels inactivation. Similarly, 1S,3R-ACPD (25 mM) increased
plateau potential duration by 252 6 37% (n 5 10; data not
shown).
The low-threshold spike
A small, transient depolarization triggering a few spikes was
observed at the break of a short hyperpolarizing current pulse in
71% of the STN neurons tested (n 5 66 of 93; Fig. 9). In the
remaining 29% (n 5 27), the small depolarizing rebound was
masked by a plateau potential response. This postinhibitory re-
bound, previously described in STN neurons (Nakanishi et al.,
1987; Overton et al., 1995) and in other preparations (for review,
see Huguenard, 1996), has been called an LTS, because of its
negative threshold compared with that of Na1-dependent spikes.
As illustrated in Figure 9A, LTS amplitude increased with mem-
brane depolarization at the end of the pulse. It is worthwhile
noting the depolarizing sag of the membrane potential, a typical
sign of the presence of the hyperpolarization-activated cation
current (Ih) previously described in STN neurons (Nakanishi et
al., 1987; Overton et al., 1995). Currents underlying LTS inacti-
vated with depolarization as LTS was triggered, but only after
maintaining the membrane at potentials more hyperpolarized
than 284 mV for 300–400 msec (n 5 9; Fig. 9B). LTS inactivation
was also time-dependent, as illustrated in Figure 9C, in which
membrane potential had to be maintained at 285 mV for at least
80 msec to trigger an LTS. LTS was unaffected by TTX (1 mM;
n 5 6; Fig. 9D) but completely disappeared in a Ca 21-free
Co21-containing (2.4 mM) external solution (n 5 3; data not
shown), or in the presence of a low concentration of Ni21 (40 mM;
n 5 5; Fig. 9D). All these results suggest that a rapid voltage-
inactivating, Ni21-sensitive current such as the low-threshold
T/R-type Ca21 current underlies LTS.
DISCUSSION
The main result of our study is that approximately half of the
STN neurons in the slices have the intrinsic property of switching
from single-spike activity to burst-firing mode. To the best of our
knowledge, this type of functional property is unknown in neu-
rons of the various basal ganglia nuclei. It may emphasize the role
of STN neurons in normal and parkinsonian states.
The cascade of currents underlying burst-firing mode
In tonic and bursting modes, STN neurons fire Na1-dependent
action potentials. In burst-firing mode, neurons display cycles of
membrane oscillations (Fig. 10,b–a) separated by slow membrane
depolarizations (Fig. 10,a–b). We have shown that the three
phases of bursts: depolarization (b–c), slowly declining plateau
(c–d), and repolarization to the AHP (d–a), are dependent on
Ca21 entry through voltage-sensitive Ca21 channels. We pro-
pose that the depolarization phase (b–c) results from a low-
threshold T/R-type Ca21 current (IT/R) that depolarizes the
membrane to the threshold potential of the nifedipine-sensitive
L-type Ca21 current (IL ) and then inactivates. The slowly inac-
Figure 9. Voltage dependency and pharmacological properties of LTS.
A, The three superimposed voltage traces show that LTS was recorded at
the break of a hyperpolarizing current pulse (2300 pA, 200 msec) applied
at a membrane potential of 263 mV. Its amplitude and rise time de-
pended on the value of membrane potential at the end of the negative
current pulse: at 278 mV, LTS was not evoked (bottom trace), whereas at
a slightly more depolarized potential (approximately 272 mV, middle
trace) it was present and gave rise to a spike. With increased depolariza-
tion, LTS amplitude increased, and spike delay decreased (top trace). B,
Three superimposed responses to hyperpolarizing current pulses of in-
creasing amplitude (2100, 2250, and 2350 pA) and fixed duration (300
msec) from Vm 5 253 mV. LTS was only evoked when the membrane
was held for 300 msec at a potential more hyperpolarized than 278 mV
for 300 msec. C, Three superimposed voltage traces in response to
hyperpolarizing current pulses of fixed amplitude (2150 pA) and increas-
ing duration (40, 80, and 120 msec). LTS was evoked in a neuron
maintained at 264 mV when the membrane was held at 285 mV for at
least 80 msec during the application of a hyperpolarizing current pulse. D,
In the presence of TTX (1 mM), LTS evoked in response to a hyperpo-
larizing current pulse (2130 pA, 200 msec) from Vm 5 270 mV was not
affected (Control and Wash), whereas it was reversibly suppressed by the
concomitant application of Ni 21 (40 mM). Traces in A, C, and D were
obtained with intracellular recordings, and traces in B were obtained with
patch-clamp recordings (whole-cell configuration). All spikes are
truncated.
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tivating IL depolarizes the membrane to the plateau phase of
bursts during which spikes are evoked (c–d). Spikes amplify Ca21
entry by activating more IL and, possibly, other types of high-
threshold Ca21 currents (Song et al., 1997). The resulting in-
crease in intracellular Ca21 concentration activates the TEA-
and apamin-sensitive Ca 21-activated K1 currents (IK,Ca). The
balance between depolarizing (IL) and hyperpolarizing (IK,Ca)
currents, slightly in favor of the latter, explains the gradual
decline of the plateau (decrescendo phase). When membrane
potential has declined to a certain level, it suddenly repolarizes
(d–a) because of rapid IL deactivation (Reuveni et al., 1993) and
stronger IK,Ca activation. This leads to the peak of AHP, during
which IT/R deinactivates. The membrane then spontaneously de-
polarizes (a–b) as IK,Ca decays because of Ca
21 clearance mech-
anisms. Depolarization to the threshold potential of IT/R initiates
a new cycle. Because BAPTA suppressed burst firing, instead of
blocking burst repolarization by preventing IK,Ca activation, this
suggests the participation of a Ca21-dependent inward current,
such as the nonspecific cationic current (ICAN) in the plateau
phase of bursts (c–d). The progressive activation of this inward
current (together with high voltage-activated Ca21 currents) may
underlie spike acceleration (crescendo phase) during burst and
plateau potential as previously described for bursts of rat thalamic
reticular neurons (Huguenard and Prince, 1992). Finally, Ih (Na-
kanishi et al., 1987; Overton et al., 1995; present study) recorded
in some STN neurons (Fig. 9A) may also participate in the slow
depolarization between consecutive bursts.
Burst-firing mode was observed in whole-cell recordings as well
as in recording configurations in which the intracellular medium
was left intact, such as cell-attached or intracellular recordings.
These results showed that burst firing is a physiological firing
mode of STN cells. This mode was, however, more easily ob-
tained when K1 currents were decreased because of the presence
of gluconate in the pipette solution (Velumian et al., 1997), or
when I-IImGluRs were activated with 1S,3R-ACPD (Nakanishi,
1994; Pin and Duvoisin, 1995). The activation of IL (Chavis et al.,
1995; Russo et al., 1997; Svirskis and Hounsgaard, 1998) or ICAN
(Cre´pel et al., 1994; Gue´rineau et al., 1995; Congar et al., 1997),
and/or the inhibition of K1 currents (Charpak et al., 1990;
Gue´rineau et al., 1994; Schrader and Tasker, 1997) by the stim-
ulation of mGluRs may account for the triggering of burst firing
by 1S,3R-ACPD. Indeed, the presence of mGluRs (subtypes 2, 3,
and 1a) has been reported in the STN neuropile (Martin et al.,
1992; Testa et al., 1998) as well as that of mGluR2 mRNA in STN
neurons (Testa et al., 1994).
The presence of a plateau potential response is a
characteristic of bursting STN neurons
We have shown in the present study that the ionic conductances
underlying bursts and plateau potentials are the same: (1) bursts
and plateau potentials shared the same pharmacological sensitiv-
ity; (2) the same promoting effect of intracellular gluconate and
1S,3R-ACPD was observed in the occurence of bursts and plateau
potentials, and (3) only cells exhibiting a plateau potential were
able to generate bursts, either spontaneously or in response to
1S,3R-ACPD, and the reverse also holds true: STN neurons in
which plateau potentials could not be triggered were not able to
burst. However, this was not the only prerequisite for bursting,
because 76% of cells responding with a plateau potential never
bursted. The only difference is the lack of effect of a low concen-
Figure 10. The hypothetical cascade of currents underlying the different phases of burst-firing mode. See Discussion for explanation.
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tration of extracellular Ni21 on plateau potentials. This can be
explained by the fact that the depolarizing current pulse applied
to trigger the plateau potential replaced the Ni 21-sensitive T/R-
type Ca21 current that normally supported the slow depolariza-
tion between bursts. The other type of triggered response, LTS,
was present in all recorded STN neurons. Therefore, we propose
to distinguish between two populations of STN neurons in vitro,
those that are able to burst and generate LTS and plateau poten-
tials and those that are not able to burst and only respond with an
LTS. We propose that the difference between these two popula-
tions is the presence of the inward currents that underlie the
plateau phase of bursts or the plateau potentials i.e., mainly IL
and ICAN.
Single-spike modes with frequencies comparable to the ones
reported in the present study (Nakanishi et al., 1987; Overton et
al., 1995) have already been described in STN neurons in acute
slices. To our knowledge, burst-firing mode had only once been
recorded in vitro, (in organotypic cultures of STN neurons with
intracellular recording techniques), but their ionic mechanisms
were not analyzed (Plenz et al., 1997). In contrast, evoked re-
sponses similar to the ones reported here have been previously
described. The “slow depolarizing potentials” mentioned by Na-
kanishi et al. (1987) are similar to the plateau potentials we
described, which were triggered when the membrane potential
was in the 250 to 260 mV range. Likewise, the “slow action
potentials” (Nakanishi et al., 1987), “strong rebound bursts”
(Plenz et al., 1997), and the “LTS” (Overton et al., 1995) corre-
spond to the LTS described in the present study. Because these
different studies did not include precise pharmacological charac-
terization, this similarity is based only on the voltage dependence
of the responses. In vivo, both tonic and bursting activities have
been recorded in rat and monkey STN (Hollerman and Grace,
1992; Fujimoto and Kita, 1993; Bergman et al., 1994; Overton and
Greenfield, 1995; Kreiss et al., 1997). However, the switch from
one mode to the other, and the ionic mechanisms of the bursting
mode, have not been observed or analyzed in either of the
preparations.
Functional implications
In a normal in vivo situation, the great majority of rat and monkey
STN neurons present a tonic activity with a frequency varying
from 5 to 65 Hz, and few neurons discharge in bursts (Matsumara
et al., 1992; Wichmann et al., 1994; Overton and Greenfield,
1995). In relation with conditioned arm (Georgopoulos et al.,
1983; Miller and DeLong, 1987; Wichmann et al., 1994) or sac-
cadic eye (Matsumara et al., 1992) movements, a burst of high-
frequency spikes lasting ;200–300 msec is usually recorded after
the onset of the movement. Because we showed in the present
study that bursts or plateau potentials are triggered by membrane
hyperpolarization, the movement-correlated burst of action po-
tentials may result from the activation of inhibitory afferents to
the STN.
The increase in the percentage of bursts in the discharge of
STN neurons is noteworthy after a lesion of the substantia nigra
pars compacta in rats and monkeys in vivo (Hollerman and Grace,
1992; Bergman et al., 1994; Hassani et al., 1996) and in parkin-
sonian patients (Benazzouz et al., 1996; Rodriguez et al., 1997).
The origin of this modification in STN activity in a pathological
situation is still under debate (for review, see Chesselet and Delfs
1996; Levy et al., 1997), although a disinhibition mechanism and
increased activity of glutamatergic STN afferents seem to be
crucial, according to DeLong’s (1990) model. We have in fact
shown that the activation of metabotropic glutamate receptors
that may occur because of increased activity of glutamatergic
STN afferents, strongly favored the bursting mode, as also ob-
served in the hippocampus (Bianchi and Wong, 1995). Bursting
STN neurons may drive target neurons in the internal segment of
the pallidum and in substantia nigra pars reticulata, where an
oscillatory activity or an increase in cytochrome oxidase activity,
a marker of metabolic activity, have been recorded in animal
Parkinson models (Miller and DeLong, 1987; Filion et al., 1988;
Bergman et al., 1994; Nini et al., 1995; Vila et al., 1997; Bergman
et al., 1998) and in parkinsonian patients (Hutchison et al., 1997;
Vila et al., 1997). This suggests that the strong regulation exerted
on STN neurons in control animals is disorganized in animal
models of parkinsonism. This may indeed account for the switch
from a tonic to a bursting mode.
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Slowly inactivating sodium current (INaP) underlies single-spike ac-
tivity in rat subthalamic neurons. J. Neurophysiol. 83: 1951–1957,
2000. One-half of the subthalamic nucleus (STN) neurons switch from
single-spike activity to burst-firing mode according to membrane
potential. In an earlier study, the ionic mechanisms of the bursting
mode were studied but the ionic currents underlying single-spike
activity were not determined. The single-spike mode of activity of
STN neurons recorded from acute slices in the current clamp mode is
TTX-sensitive but is not abolished by antagonists of ionotropic glu-
tamatergic and GABAergic receptors, blockers of calcium currents (2
mM cobalt or 40 mM nickel), or intracellular Ca21 ions chelators.
Tonic activity is characterized by a pacemaker depolarization that
spontaneously brings the membrane from the peak of the afterspike
hyperpolarization (AHP) to firing threshold (from 257.1 6 0.5 mV to
242.2 6 0.3 mV). Voltage-clamp recordings suggest that the Ni21-
sensitive, T-type Ca21 current does not play a significant role in
single-spike activity because it is totally inactivated at potentials more
depolarized than 260 mV. In contrast, the TTX-sensitive, INaP that
activated at 254.4 6 0.6 mV fulfills the conditions for underlying
pacemaker depolarization because it is activated below spike thresh-
old and is not fully inactivated in the pacemaker range. In some cases,
the depolarization required to reach the threshold for INaP activation is
mediated by hyperpolarization-activated cation current (Ih). This was
directly confirmed by the cesium-induced shift from single-spike to
burst-firing mode which was observed in some STN neurons. There-
fore, a fraction of Ih which is tonically activated at rest, exerts a
depolarizing influence and enables membrane potential to reach the
threshold for INaP activation, thus favoring the single-spike mode. The
combined action of INaP and Ih is responsible for the dual mode of
discharge of STN neurons.
I N T R O D U C T I O N
The subthalamic nucleus (STN) is a basal ganglia nucleus
that plays an important role in normal (Matsumara et al. 1992;
Wichmann et al. 1994) and pathological (Bergman et al. 1994)
motor behavior. By way of its glutamatergic projections (Smith
and Parent 1988), STN imposes its rhythm to the two principal
output structures of the basal ganglia, the internal pallidal
segment and the substantia nigra pars reticulata (Fe´ger et al.
1997; Parent and Hazrati 1995). In a normal in vivo situation,
the great majority of rat and monkey STN neurons present a
tonic activity with a frequency varying from 5 to 65 Hz and
few neurons discharge in bursts (Matsumara et al. 1992; Over-
ton and Greenfield 1995; Wichmann et al. 1994). After the
onset of a conditioned movement, a period of high-frequency
spikes is usually recorded (Georgopoulos et al. 1983; Mat-
sumara et al. 1992; Miller and DeLong 1987; Wichmann et al.
1994). In a pathological situation, after a lesion of nigral
dopaminergic neurons, there was an observed increase in the
percentage of bursts in the discharge of STN neurons in rats
and monkeys in vivo (Bergman et al. 1994; Hassani et al. 1996;
Hollerman and Grace 1992) as well as in Parkinsonian patients
(Benazzouz et al. 1996). We previously showed that approxi-
mately one-half of the STN neurons recorded in slices in vitro
have intrinsic membrane properties that allow them to switch
from a tonic to a burst-firing mode in response to membrane
hyperpolarization (Beurrier et al. 1999).
This raises the question as to which conductances are altered by
afferent synaptic inputs to switch the activity of STN neurons
from single-spike to burst-firing mode (or the reverse). It is
desirable to first identify the set of ionic currents that are of
demonstrable importance in regulating the different firing modes.
We previously analyzed the cascade of currents underlying burst
firing mode (Beurrier et al. 1999). The aim of this study was to
build up a picture of the ionic mechanisms of the tonic firing mode
with the use of whole cell recordings of STN neurons in slices, in
current, or voltage-clamp mode. We analyzed the ionic currents
underlying the spontaneous depolarization that during the inter-
spike interval bring the membrane potential from the peak of the
afterspike hyperpolarization (AHP) to the threshold potential of
Na1 spike initiation. We now report that pacemaker depolariza-
tion mainly results from the activation of a subthreshold, slowly
inactivating, TTX-sensitive Na1 current (INaP). We also show that
in approximately one-half of the neurons tested, the hyperpolar-
ization-activated cation current (Ih) blockade hyperpolarizes the
membrane sufficiently to switch STN activity to burst-firing
mode, thus suggesting that the fraction of Ih opened at rest allows
STN neurons to maintain a single-spike mode of activity.
M E T H O D S
Slice preparation
Experiments were performed on STN neurons in slices obtained
from 20- to 28-day-old male Wistar rats. Rats were anesthetized with
ether and decapitated. The brain was removed quickly and a block of
tissue containing the STN was isolated on ice in a 0–5°C oxygenated
solution containing (in mM) 1.15 NaH2PO4, 2 KCl, 26 NaHCO3, 7
MgCl2, 0.5 CaCl2, 11 glucose, and 250 saccharose, equilibrated with
95% O2-5% CO2 (pH 7.4). This cold solution, with a low NaCl and
CaCl2 content, improved tissue viability. In the same medium, 300- to
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400-mm thick coronal slices were prepared using a vibratome (Camp-
den Instruments, Loughborough, UK) and were incubated at room
temperature in a Krebs solution containing (in mM) 124 NaCl, 3.6
KCl, 1.25 HEPES, 26 NaHCO3, 1.3 MgCl2, 2.4 CaCl2, and 10
glucose, equilibrated with 95% O2-5% CO2 (pH 7.4). After a 2-h
recovery period, STN slices were transferred one at a time to an
interface-type recording chamber, maintained at 30 6 2 °C, and
continuously superfused (1–1.5 ml z min21) with the oxygenated
Krebs solution.
Electrophysiological recordings
Slices were viewed using a dissecting microscope and the recording
electrode was precisely positioned in the STN. Electrophysiological
recordings of STN neurons were performed in current or in voltage-
clamp mode using the blind patch-clamp technique in the whole cell
configuration. Patch electrodes were pulled from filamented borosili-
cate thin-wall glass capillaries (GC150F-15, Clarck Electromedical
Instruments, Pangbourne, UK) with a vertical puller (PP-830, Narish-
ige, Japan) and had a resistance of 10 to 12 MV when filled with
solution 1 (see Intracellular solutions).
Intracellular solutions
For current-clamp recordings a K-gluconate-based solution (solu-
tion 1) was used. It contained (in mM) 120 K-gluconate, 10 KCl, 10
NaCl, 10 EGTA, 10 HEPES, 1 CaCl2, 2 MgATP, and 0.5 NaGTP (pH
7.25). To study low-threshold voltage-activated T-type Ca21 current
(ICaT), the 120 mM K-gluconate in solution 1 was substituted for an
equimolar concentration of CsCl and KCl was omitted as was ATP
and GTP to reduce the L-type Ca21 current which is known to be
sensitive to run-down (solution 2). In some experiments the Ca21
chelator 1,2-bis(2-aminophenoxy)-ethane-N,N,N9,N9-tetraacetic acid,
tetrapotassium salt (BAPTA, 10 mM) was added to solution 1 which
contained 80 mM K-gluconate instead of 120 mM to obtain an
osmolarity ;270 mOsm z l21. In this solution, the Ca21 ion concen-
tration was decreased from 1 to 0.1 mM (solution 3). To record Na1
currents, the 120 mM K-gluconate in solution 1 was substituted for an
equimolar concentration of CsCl and KCl was omitted (solution 4).
Extracellular solutions
For voltage-clamp experiments, the Krebs solution contained 1 mM
TTX, 3 mM nifedipine, and 1 mM Cs1 for the ICaT study (solution A).
For the INaP study, 2 mM Co21 and 1 mM Cs1 were added and the
Ca21 ions concentration was decreased from 2.4 to 0.5 mM (solution
B). For the Ih study, 1 mM TTX was added (solution C).
Drugs
All drugs were purchased from Sigma (St. Louis, MO), except
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), D-(2)-2-amino-5-
phosphopentanoic acid (D-APV), and bicuculline which were pur-
chased from Tocris (Bristol, UK). BAPTA was diluted in the pipette
solution. All other drugs were diluted in the oxygenated Krebs and
applied through this superfusion medium. Nifedipine and CNQX were
dissolved in dimethylsulfoxide (final concentration, 0.03–0.3%).
Data analysis
Membrane potential was recorded using an Axoclamp 2A or Axo-
patch 1D amplifier (Axon Instuments, Foster City, CA), displayed
simultaneously on a storage oscilloscope and a four-channel chart
recorder (Gould Instruments, Longjumeau, France), digitized (DR-
890, NeuroData Instruments, NY), and stored on a videotape for
subsequent offline analysis. In voltage-clamp experiments, membrane
currents were amplified by an Axopatch 1D or an Axoclamp 2A, fed
into an A/D converter (Digidata 1200, Axon Instuments), and stored
and analyzed on a PC using pCLAMP software (version 6.0.1, Axon
Instruments). Because different recording solutions were used
throughout the study, corrections for the liquid junction potential were
performed. The correction was 26 mV for the K-gluconate-based
pipette solution as estimated with a 3 M KCl ground electrode (Neher
1992).
R E S U L T S
Data presented here are based on patch-clamp recordings of
155 STN neurons. Neuronal activity was recorded in current-
clamp mode (n 5 57) and subthreshold currents were recorded
in voltage-clamp mode (whole cell configuration, n 5 106).
Characteristics of single-spike activity and pacemaker
depolarization
All STN neurons displayed a single-spike mode of Na1
action potentials (Fig. 1A) that was totally abolished in the
FIG. 1. Single-spike activity of subthalamic nucleus (STN) neurons. A:
dependence on membrane potential. Tonic activity present at resting mem-
brane potential (I 5 0 pA), decreased in frequency at a more hyperpolarized
potential (I 5 25 pA), and stopped (I 5 210 pA). B and C: dependence on
synaptic activity. A bath application of blockers of AMPA/kainate (CNQX),
NMDA (D-APV), and GABAA (bicuculline) receptors and of voltage-activated
Ca21 currents (Co21) did not block single-spike activity. Inset in B shows 2
traces of pacemaker depolarization in control (top) and treated (bottom) con-
ditions. Insets in C show the low-threshold Ca21 spike at the break of a
hyperpolarizing pulse in control (arrow, top) and during Co21 application
(bottom). External Krebs, intrapipette solution 1.
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presence of 1 mM TTX. Action potentials had a mean threshold
of 242.2 6 0.3 mV (range: 245 to 240 mV, n 5 24) and were
followed by an AHP that peaked at 257.1 6 0.5 mV (range:
254 to 262 mV, n 5 25). Between consecutive spikes, the
membrane spontaneously depolarized by ;15 mV from the
peak of the AHP to the threshold potential of the following
spike (Fig. 1B, control inset). By analogy with the pacemaker
activity of cardiac cells, we called this phase “pacemaker
depolarization” (DiFrancesco 1993). The mean frequency was
7.6 6 0.8 Hz (range: 5.0–17.1 Hz, n 5 16) in the absence of
current injection. When cells were hyperpolarized by negative
current injection, approximately one-half of the recorded STN
neurons shifted to burst-firing mode (Beurrier et al. 1999) with
an AHP peaking at 261.8 6 0.8 mV (range: 258 to 272 mV,
n 5 20) whereas the remaining one-half displayed single-spike
mode but at lower frequencies (Fig. 1A). At more hyperpolar-
ized potentials both types of STN neurons were silent
(Fig. 1A).
Single-spike mode was not blocked by a concomitant appli-
cation of CNQX, D-APV, and bicuculline, the respective an-
tagonists of AMPA/kainate, NMDA, and GABAA ionotropic
receptors (Fig. 1B, n 5 6), neither was it suppressed by cobalt
(Fig. 1C, Co21 2 mM, n 5 32). These findings showed that the
TTX-sensitive, voltage-dependent single-spike activity is inde-
pendent of afferent synaptic activity (and particularly activa-
tion of glutamatergic and GABAergic ionotropic receptors).
This raised the possibility that single-spike activity results from
intrinsic voltage-dependent properties of the membrane (i.e.,
from currents underlying the pacemaker depolarization of the
interspike interval that spontaneously brings the membrane
potential from the peak of the AHP to the threshold potential
for Na1-spike initiation). During this phase, the net current is
inward because a decreasing outward current cannot by itself
depolarize the membrane to Na1-spike threshold (Irisawa et al.
1993). Moreover, inward currents are more efficient in depo-
larizing the membrane whereas outward currents are decreas-
ing and membrane resistance is thus increased. More precisely,
increase of resistance depends on the density and deactivation
characteristics (kinetics and voltage dependence) of outward
currents open at the peak of the AHP. The subthreshold inward
currents we analyzed were ICaT, Ca21-activated inward (cat-
ionic) currents (ICAN), INaP, and Ih. To identify which of these
currents was involved, we studied the effects of their pharma-
cological blockade in current-clamp mode and analyzed their
voltage dependence in voltage-clamp mode. Does the mem-
brane reach a level of depolarization sufficient for this current
to be activated during the interspike interval? Does this current
inactivate during repetitive firing?
ICaT
Nickel chloride at a concentration (Ni21, 40 mM) that pref-
erentially blocks T-type Ca21 currents (Huguenard 1996) (Fig.
2B) did not affect single-spike activity (Fig. 2A, n 5 28) but
strongly reduced the rebound potential called low-threshold
Ca21 spike (Nakanishi et al. 1987) seen at the break of a
hyperpolarizing current pulse (Fig. 2A, insets). This is consis-
tent with above observations that single-spike activity was still
present under 2 mM Co21 (Fig. 1C). Voltage-clamp experi-
ments were performed in the presence of L-type Ca21 current
blockers (see METHODS solutions A and 2). Currents were
evoked by step depolarizations to varying test potentials from
a holding potential of 280 mV. A low voltage-activated in-
ward current that had the characteristics of ICaT was recorded;
it activated at 259.3 6 0.7 mV (range: 262 to 255 mV, n 5
10), presented a rather slow kinetic of inactivation (Fig. 2B,
left), and was totally abolished in the presence of 40 mM Ni21
(Fig. 2B, right). After a 7.5-s conditioning step at 259.9 6 2.3
mV (range: 266 to 245 mV, n 5 8), it was fully inactivated
(Fig. 2C). Because ICaT is totally inactivated at potentials
crossed by the membrane during repetitive discharge, it is
unlikely that it participates significantly to the slow pacemaker
depolarization.
Calcium-activated inward currents
BAPTA (10 mM), a Ca21 chelator, was introduced into the
pipette solution (solution 3) to test the participation of Ca21-
FIG. 2. Single-spike activity is not mediated by low-threshold T-type Ca21
current (ICaT). A: a bath application of Ni21 (40 mM) did not affect tonic
activity recorded in current clamp mode though it strongly reduced the am-
plitude of rebound potential evoked at break of a 500-ms hyperpolarizing pulse
to 288 mV (insets). B: inward Ca21 currents recorded in response to 200-ms
depolarizing steps from 262 to 252 mV (2 mV increment, VH 5 280 mV,
left) were strongly depressed by Ni21 (right, step to 252 mV). Inactivation
was fitted with a double exponential (t1 5 13.0 and t2 5 165.7 ms). C: steady
state inactivation curve obtained from current traces shown in inset: 7,500-ms
conditioning prepulses from 280 to 262 mV (2 mV increment) were followed
by a fixed 200-ms step to 250 mV. Currents were normalized (I/Imax) to
maximal current (Imax) recorded at 280 mV. Data were fitted with a smooth
curve derived from the Boltzmann equation (V1/2 of inactivation 5 271.6 mV
and slope factor k 5 4.1, n 5 7). A: external Krebs and intrapipette solution 1.
B and C: external solution A and intrapipette solution 2.
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activated currents such as ICAN, a current that is inward in the
potential range of the pacemaker depolarization (Cre´pel et al.
1994). In agreement with our previous results (Beurrier et al.
1999), BAPTA did not affect single-spike mode (Fig. 3, n 5 5)
although it effectively blocked Ca21-activated inward current
as shown by the strong reduction of the plateau potential
duration evoked by a depolarizing current pulse (Fig. 3, insets).
This suggested that Ca21-activated currents are not absolutely
necessary to sustain single-spike activity. However, they may
be activated by a single spike and contribute to the pacemaker
depolarization.
INaP
INaP is a TTX-sensitive Na1 current that activates below
spike threshold and slowly inactivates (Crill 1996). The role
of INaP on the pattern of discharge in current-clamp record-
ings is difficult to study because the pharmacological sub-
tances that block it (e.g., TTX or QX 314, a derivative of
lidocaine) are also blockers of the Na1 spike. The role of
INaP in the pacemaker depolarization was deduced from the
analysis of its voltage dependence. Two protocols were
used, either a depolarizing ramp (Fig. 4A, speed 5 mV z s21)
or long depolarizing steps (1,500 ms) of increasing ampli-
tude (Fig. 4B). K1 currents were reduced by replacing K1
ions by Cs1 in the pipette solution (solution 4) and by
adding 1 mM Cs1 in the bath medium. Ca21 currents were
suppressed by adding 2 mM Co21 in the bath medium and
by decreasing the external concentration of Ca21 ions (so-
lution B). In response to the voltage ramp, an inward current
that had the characteristics of a persistent Na1 current (INaP)
was recorded; it activated at 254.4 6 0.6 mV (range: 257.2
to 250.3 mV), peaked at 232.9 6 0.8 mV (range: 237.4 to
226.8 mV), had a maximal amplitude of 2211.1 6 8.5 pA
(range: 2266.1 to 2164.2 pA), and was totally abolished in
the presence of 1 mM TTX (Fig. 4A, n 5 13). Because INaP
peaked fast during the ramp protocol, probably because it
came out of voltage control and because INaP can partially
inactivate during the time course of the ramp command, the
voltage step protocol was also tested. From a holding po-
tential of 280 mV, a slowly inactivating Na1 current was
observed (Fig. 4B). It activated from 256.9 6 1.3 mV
(range: 260 to 250 mV, n 5 10) and was totally abolished
in the presence of 1 mM TTX (Fig. 4, B and C). INaP
inactivated slowly (;20%) during a 5-s voltage step at 242
mV (VH 5 260 mV, n 5 5, data not shown). Voltage-
dependent steady-state inactivation was studied with the
protocol shown in Fig. 4D. After 5 s at approximately 250
mV (n 5 13), INaP was one-half inactivated and after 5 s at
230 mV was fully inactivated (Fig. 4, D and E). To ap-
proach the situation during regular spiking, another protocol
FIG. 3. Single-spike activity does not depend on Ca21-activated currents.
BAPTA (10 mM), the Ca21 chelator, was present in the pipette solution.
Single-spike activity was recorded in current clamp mode (whole cell config-
uration) just after breaking through the patch of membrane (control) when
BAPTA had not yet diffused into the cell as shown by the presence of plateau
potential in response to a depolarizing current pulse (inset). Fifteen minutes
later (bottom), plateau potential was strongly reduced (inset) but tonic activity
was still present. External Krebs and intrapipette solution 3.
FIG. 4. Persistent TTX-sensitive Na1 current (INaP). A: current response to
a voltage ramp applied at 5 mV z s21 in absence (control) and presence (TTX)
of 1 mM TTX. Outward current is present in both situations as a result of the
absence of blockers of delayed rectifier K1 current in extracellular medium. B:
currents evoked by 1,500-ms step commands from 270 to 230 mV (from
bottom to top, steps to 260, 255, 250, and 235 mV) in control conditions
(control) and in presence of TTX. C: I-V relationship obtained with a protocol
similar to that in B. Leak and outward currents were subtracted. Current
amplitudes were normalized (I/Imax) to maximal current (Imax) recorded. D:
current responses to a 5-s step to 230 mV preceded by a 5-s conditioning pulse
from 280 to 240 mV (from bottom to top conditioning pulses at 275, 250,
and 240 mV). E: steady-state inactivation curve of INaP obtained with a
protocol similar to that in D. Current amplitudes were measured 300 ms after
onset of depolarization and were normalized (I/Imax) to maximal current (Imax)
recorded (leak was subtracted). Data were fitted with a smooth curve derived
from the Boltzmann equation (V1/2 of inactivation 5 248.8 mV and slope
factor k 5 6.5 mV, n 5 7). External solution B and intrapipette solution 4. Fast
Na1 current was truncated in B and D.
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was tested. A situation where the membrane was rather
depolarized was chosen; from a holding potential of 250
mV (to mimick the AHP), a 1-ms step to 120 mV was
applied (to mimic a spike) and was followed by a 5-s step to
235 mV (to evoke INaP and measure channel availability).
The two steps were separated by an interval of variable
duration (15– 60 ms) at 250 mV (to mimic the interspike
interval) (Fig. 5, left). It was noteworthy that INaP was not
inactivated by the first depolarizing pulse but also that it had
a larger amplitude at shorter intervals. Further increases in
interval duration gave a stable 30% reduction of INaP (Fig. 5,
right). In conclusion, INaP activates in a potential range
crossed by the membrane during the interspike interval and
is not totally inactivated after a spike.
Ih
The cesium-sensitive cation current Ih is turned on by mem-
brane hyperpolarization and is inward (depolarizing) at poten-
tials more hyperpolarized than its reversal potential (approxi-
mately 230 mV) (Pape 1996). In ;50% of the neurons tested
(n 5 5 of 11), adding cesium chloride (Cs1, 1–3 mM) to
external Krebs solution hyperpolarized the membrane by ap-
proximately 212 mV and switched their activity from tonic-
firing to burst-firing mode (Fig. 6A). When positive current was
injected, tonic activity reappeared though Ih was still blocked
(Fig. 6A, bottom right and inset). In the remaining one-half of
the cells, Cs1 did not affect membrane potential or tonic
activity (n 5 6).
Characteristics of Ih were studied in current-clamp and
voltage-clamp modes (solutions C and 1). In response to
long hyperpolarizing currents pulses (500 ms), a time-
dependent, Cs1-sensitive anomalous rectification, seen as a
slowly developing depolarizing sag, was observed (Fig. 6A,
insets). This sag corresponded in voltage-clamp recordings
to a slowly developing inward current that activated at
256.5 6 0.8 mV (range: 260 to 255 mV, n 5 10) in
response to hyperpolarizing steps from a holding potential
of 245 mV and increased in amplitude with membrane
hyperpolarization (Fig. 6, B and C). This current was
strongly depressed in the presence of 1 to 3 mM external
Cs1 (Fig. 6, B and C). From the above results we conclude
that Ih is not essential for a tonic mode of discharge.
However, in some cells it contributes toward maintaining
membrane potential at a more depolarized value where tonic
mode is present.
D I S C U S S I O N
These results show that single-spike activity of STN neurons
is independent of afferent synaptic activity and of Ca21 or
Ca21-activated currents. It mainly results from the persistent
Na1 current, INaP. Moreover, in some neurons a sustained
fraction of Ih exerts a depolarizing influence, enables the mem-
brane potential to reach the threshold for INaP activation and
thus favors the single-spike mode of discharge. The role of INaP
in STN neurons has been deduced from its voltage-dependent
characteristics whereas that of Ih was also deduced from the
effect of its blockade by external Cs1.
FIG. 5. INaP inactivation after a spike. Intensity of INaP in response to a 5-s
depolarizing step to 235 mV was studied at different times (15–60 ms) after
a short (1 ms) depolarizing step to 120 mV (VH 5 250 mV). INaP current
traces (left) and INaP amplitude normalized (I/Imax) to maximal current (Imax)
recorded after interval t 5 15 ms vs. interval duration (right). Data were fitted
with a monoexponential curve. External solution B and intrapipette solution 4.
FIG. 6. Role of Cs1-sensitive Ih current on membrane potential and firing
mode. A: in control conditions, a STN neuron diplayed single-spike activity at
resting membrane potential (I 5 0 pA) and burst firing mode at more hyper-
polarized potentials (top, control). In the same neuron, bath application of Cs1
at resting potential hyperpolarized the membrane by 8 mV and shifted STN
activity to burst firing mode (in the absence of any current injection). Contin-
uous injection of positive current shifted back membrane potential to control
value and to single-spike activity though Cs1 was still present (bottom).
Concomitantly, in the presence of Cs1 the depolarizing sag recorded in
response to a negative current pulse was strongly decreased as well as the
depolarizing rebound seen at the break of the hyperpolarizing pulse; spike was
truncated (inset, left). B: from a holding potential (VH) of 245 mV, a family of
currents was evoked in response to 1,500-ms hyperpolarizing steps from 255
to 2105 mV (10 mV increment, left column) in control conditions (top), after
bath application of Cs1 (middle), and after recovery from Cs1 (bottom). C: I-V
relationship in absence (control) and presence of cesium (1–3 mM). Values of
I are obtained by subtracting value of current at the beginning of trace (F) from
that at end of trace (f). Currents were normalized (I/Imax) to the maximal
current (Imax) recorded at 2115 mV. A: external Krebs and intrapipette
solution 1. B: external solution C and intrapipette solution 1.
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INaP underlies the pacemaker depolarization in the single-
spike mode
We propose that the pacemaker depolarization that precedes
each action potential is mainly mediated by the slowly inacti-
vating Na1 current, INaP. Single-spike mode is voltage-depen-
dent and both action potentials and pacemaker depolarizations
were abolished by TTX, a specific blocker of voltage-sensitive
Na1 currents whereas they were insensitive to blockers of
Ca21 currents. These observations can be linked to voltage-
clamp experiments where a TTX-sensitive inward current re-
corded in all STN neurons tested, activated at voltages clearly
below spike threshold and normally traversed by spontane-
ously firing cells. This current represented INaP because there
was no residual current in the presence of TTX and a contri-
bution of Ca21 currents is most unlikely in the presence of
cobalt and very low concentrations of Ca21 in the extracellular
medium. Interestingly, nonbursting STN neurons were silent at
voltages more hyperpolarized than the INaP threshold of acti-
vation. However, insights into the functional relevance of INaP
for single-spike activity need also to consider its inactivation
properties. INaP could still be evoked a few milliseconds after
a short depolarization that mimicked a spike.
Comparison with other preparations where INaP plays also a
role in spontaneous tonic firing showed that the voltage range
of INaP activation threshold in our experiments is ;5–10 mV
more positive than that found in other central neurons such as
neocortical layer V pyramidal neurons (Stafstrom et al. 1985),
medial entorhinal neurons (Alonso and Llinas 1989), suprachi-
asmatic neurons (Pennartz et al. 1997), Purkinje cells (Llinas
and Sugimori 1980), and hippocampal neurons (French et al.
1990; MacVicar 1985).
ICaT recorded in this study does not play a significant role in
single-spike mode because it is inactivated at potentials where
STN neurons fire tonically. Kinetic of inactivation of ICaT
recorded in this study is close to that described for a T current
mediated by the recently cloned a1l subunit (Lee et al. 1999),
which transcript is highly expresssed in the STN (Talley et al.
1999).
Role of a sustained Ih component
We suggest that a sustained component of the Cs1-sensitive
Ih, open at resting membrane potential, contributes toward
maintaining single-spike firing in some STN neurons. This is
important because the value of membrane potential critically
determines the pattern of firing of STN neurons (Beurrier et al.
1999). Cs1 produced a hyperpolarization that was large
enough to move the cell into the burst mode of action potential
generation. This was only observed for cells that displayed a
plateau potential in control conditions. We have certainly un-
derestimated Ih amplitude and the effects of its blockade with
the use of gluconate ions in the pipette solution. Gluconate ions
give more physiological recordings but are known to inhibit Ih
(Velumian et al. 1997). Moreover, it could also be argued that
external Cs1 also affects delayed and inward rectifier K1
currents. However, because these currents are outward, their
blockade will result in membrane depolarization instead of
hyperpolarization. We can hypothesize that a sustained com-
ponent of Ih as a result of its depolarizing influence moves the
membrane potential from a range of Ca21-mediated burst
activity into a region where it activates INaP and allows a
single-spike mode of discharge. Such a contribution of Ih to
resting parameters has already been described in thalamic relay
neurons, cells that also display two intrinsic modes of dis-
charge depending on membrane potential (McCormick and
Pape 1990; Pape 1996). For the fraction of Ih that is activated
on hyperpolarization and deactivated with depolarization, most
of its depolarizing effect would be efficient at hyperpolarized
potentials when STN neurons are discharging in the bursting
mode. One remarkable feature of Ih channels is the presence of
a cyclic nucleotide binding region that allows Ih to be modu-
lated by second messengers. Cyclic AMP or cyclic GMP
increase Ih channels activities by shifting their activation curve
to more depolarized values (Ludwig et al. 1999; Santoro et al.
1998). The modulation of the voltage dependence of Ih through
the production of cAMP would thus have important conse-
quences on the firing pattern of STN neurons.
We propose that STN activity shifts from burst-firing mode
to single-spike activity in response to a depolarization which
induces inactivation of the calcium conductances such as ICaT
(which cannot generate any more slow membrane oscillations)
and activation of the subthreshold depolarizing currents Ih and
INaP. Conversely, tonic-firing mode would cease once the
membrane is more hyperpolarized than the INaP threshold of
activation. Therefore the increase in the percentage of bursts
recorded in the STN after the experimental lesion of nigral
dopaminergic neurons (Bergman et al. 1994; Hassani et al.
1996; Hollerman and Grace 1992) or in the absence of dopa-
minergic neurons (Plenz and Kitai 1999) would result from a
synaptically driven hyperpolarizing shift of the background
resting potential of STN neurons.
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NOTE ADDED IN PROOF
Since this paper was submitted for publication, a report by Bevan
et al. was published (J. Neurosci. 19: 7617–7628, 1999) showing also
that INaP plays a role in the tonic mode of discharge of STN neurons.
However, the contribution of Ih has not been studied by the authors.
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Beurrier, Corinne, Bernard Bioulac, Jacques Audin, and Con-
stance Hammond. High-frequency stimulation produces a transient
blockade of voltage-gated currents in subthalamic neurons. J Neuro-
physiol 85: 1351–1356, 2001. The effect of high-frequency stimula-
tion (HFS) of the subthalamic nucleus (STN) was analyzed with
patch-clamp techniques (whole cell configuration, current- and volt-
age-clamp modes) in rat STN slices in vitro. A brief tetanus, consist-
ing of 100-ms bipolar stimuli at a frequency of 100–250 Hz during 1
min, produced a full blockade of ongoing STN activity whether it was
in the tonic or bursting mode. This HFS-induced silence lasted around
6 min after the end of stimulation, was frequency dependent, could be
repeated without alteration, and was not synaptically induced as it was
still observed in the presence of blockers of ionotropic GABA and
glutamate receptors or in the presence of cobalt at a concentration
(2 mM) that blocks voltage-gated Ca21 channels and synaptic trans-
mission. During HFS-induced silence, the following alterations were
observed: the persistent Na1 current (INaP) was totally blocked (by
99%), the Ca21-mediated responses were strongly reduced including
the posthyperpolarization rebound (262% in amplitude) and the pla-
teau potential (276% in duration), suggesting that T- and L-type
Ca21 currents are transiently depressed by HFS, whereas the Cs1-
sensitive, hyperpolarization-activated cationic current (Ih) was little
affected. Thus a high-frequency tetanus produces a blockade of the
spontaneous activities of STN neurons as a result of a strong depres-
sion of intrinsic voltage-gated currents underlying single-spike and
bursting modes of discharge. These effects of HFS, which are com-
pletely independent of synaptic transmission, provide a mechanism
for interrupting ongoing activities of STN neurons.
I N T R O D U C T I O N
The observation that deep brain stimulation applied at a
high-frequency (HFS) in the subthalamic nucleus (STN) and its
surgical destruction, both greatly ameliorate motor signs of
Parkinson’s disease in patients, led to the hypothesis that HFS
blocks, partly or completely, the activity of STN neurons. In
keeping with this, HFS in the STN has been shown to signif-
icantly decrease the frequency of extracellularly recorded STN
neurons in rats in vivo (Benazzouz et al. 1997). As STN
neurons are glutamatergic excitatory output neurons (Ham-
mond et al. 1978; Robledo and Fe´ger 1990; Smith and Parent
1988), the immediate consequence of their reduction of activity
could be the decrease of activity in target nuclei [substantia
nigra pars reticulata (SNr) and entopeduncular nucleus/globus
pallidus internal part (EP/GPi)] as observed in 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys and
naive rats (Benazzouz et al. 1995; Burbaud et al. 1994; Hayase
et al. 1996). It has also been suggested that the consequence of
clinical HFS will be to somehow counteract the abnormal
bursting pattern recorded in the STN in animal models of
Parkinson disease (Bergman et al. 1994; Hassani et al. 1996;
Hollerman and Grace 1992; Vila et al. 2000).
To understand the contribution of HFS in pathological con-
ditions, it is clearly essential to determine whether a HFS of the
STN could modify or block the intrinsic activities of STN
neurons and to analyze the underlying mechanisms. This is
best achieved in vitro, as slice preparations enable to better
isolate the various effects of a tetanus on neuronal properties.
In the present study, using patch-clamp recordings of rat STN
neurons in slices, we report that HFS of the STN suppresses the
spontaneous activity of both single-spike and bursting STN
neurons. The effects of HFS are synaptic-independent and are
mediated by a blockade of the voltage-gated currents and
particularly the persistent Na1 (INaP) current and the L- and
T-type Ca21 currents (ICaL and ICaT) that are known to generate
the intrinsic spontaneous discharge modes of STN neurons
(Beurrier et al. 1999, 2000; Bevan and Wilson 1999).
M E T H O D S
Slice preparation
Experiments were performed on STN neurons in slices obtained
from 20- to 28-day-old male Wistar rats. Rats were anesthetized with
ether and decapitated. The brain was quickly removed, and a block of
tissue containing the STN was isolated on ice in a 0–5°C oxygenated
solution containing (in mM) 1.15 NaH2 PO4, 2 KCl, 26 NaHCO3, 7
MgCl2, 0.5 CaCl2, 11 glucose, and 250 saccharose, equilibrated with
95% O2-5% CO2 (pH 7.4). This cold solution, with a low NaCl and
CaCl2 content, improved tissue viability. In the same medium, 300- to
400-mm-thick coronal slices were prepared using a vibratome (Camp-
den Instruments, Loughborough, UK) and were then incubated at
room temperature in a Krebs solution containing (in mM) 124 NaCl,
3.6 KCl, 1.25 N-[2-hydroxyethyl]piperazine-N9-[2-ethanesulfonic
acid] (HEPES), 26 NaHCO3, 1.3 MgCl2, 2.4 CaCl2, and 10 glucose,
equilibrated with 95% O2-5% CO2 (pH 7.4). After a 2-h recovery
period, STN slices were transferred individually to an interface-type
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recording chamber, maintained at 30 6 2°C (mean 6 SD) and
continuously superfused (1–1.5 ml/min) with the oxygenated Krebs
solution.
STN stimulation
The stimulating electrode was positioned in the middle of the STN
identified as an ovoid structure just lying at the border of the basal part of
the cerebral peduncle. Two types of stimulating electrodes were tested:
The bipolar concentric electrode measuring 0.5 mm in diameter (NEX-
100, Rhodes Medical Instruments) used by Burbaud (Burbaud et al.
1994) and Benazzouz (Benazzouz et al. 1995) for the in vivo stimulation
of the rat STN and a much thinner electrode (0.01 mm in diameter) that
we designed to avoid any mechanical lesion of the STN.
Electrophysiological recordings
Slices were visualized using a dissecting microscope and the re-
cording electrode was precisely positioned in the STN. Electrophys-
iological recordings of STN neurons were performed in the current- or
voltage-clamp mode using the blind patch-clamp technique in the
whole cell configuration. Patch electrodes were pulled from fila-
mented borosilicate thin-wall glass capillaries (GC150F-15, Clarck
Electromedical Instruments, Pangbourne, UK) with a vertical puller
(PP-830, Narishige, Japan) and had a resistance of 10–12 MV when
filled with the following (in mM): 120 Kgluconate, 10 KCl, 10 NaCl,
10 ethylene glycol-bis(b-aminoethyl ether)-N,N,N9,N9-tetraacetic acid
(EGTA), 10 HEPES, 1 CaCl2, 2 MgATP, and 0.5 NaGTP, pH 7.25.
Reagents
Drugs were applied by bath. Reagents were procured from Sigma
(St. Louis, MO), except 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX),
D-(2)-2-amino-5-phosphopentanoic acid (D-APV), and bicuculline,
which were purchased from Tocris (Bristol, UK).
Data analysis
Membrane potential was recorded using Axoclamp 2A or Axopatch
1D amplifier (Axon Instruments, Foster City, CA), displayed simul-
taneously on a storage oscilloscope and a four-channel chart recorder
(Gould Instruments, Longjumeau, France), digitized (DR-890, Neuro-
Data Instruments, New York), and stored on a videotape for subse-
quent off-line analysis. During voltage-clamp recordings, membrane
currents were fed into an A/D converter (Digidata 1200, Axon Instru-
ments), stored, and analyzed on a PC using pCLAMP software (ver-
sion 6.0.3, Axon Instruments). Corrections for the liquid junction
potential were performed according to Neher (1992): 26 mV for the
K-gluconate-based pipette solution as estimated with a 3 M KCl
ground electrode.
R E S U L T S
HFS-induced arrest of single-spike or bursting activity
STN activity was recorded in current-clamp mode (whole
cell configuration) for at least 1 min before the HFS was
applied. Using a bipolar concentric stimulating electrode sim-
ilar to that used in rat in vivo (see METHODS), a brief (1 min)
HFS consisting of 100 ms stimuli of 5–8 V amplitude, pro-
duced a blockade of ongoing activity whether it was in single-
spike (Fig. 1) or bursting (Fig. 2) mode. This effect was
frequency dependent (Figs. 1A and 2) with an optimal fre-
quency of 166 up to 250 Hz that produced a full blockade of
the activity (n 5 17). The latency of the HFS-induced silence
could not be determined in detail as during the 1-min stimu-
lation period, artifacts prevented analysis of the activity. Nev-
ertheless as shown in Figs. 1B and 2, above a certain fre-
quency, the onset of the blockade was immediately obvious by
the end of the train. Interestingly, HFS blocked both single
spike (Fig. 1) and burst firing (Fig. 2) modes, suggesting that
its mechanisms do not involve a current(s) that is expressed
only in one type of discharge.
The suppression of STN spontaneous activity was observed
for 5.8 6 0.7 min (range: 1.1–18.0, n 5 31) after HFS. At the
end of the silence period, spontaneous activity slowly recov-
ered in the same mode as before stimulation (Figs. 1B to 6).
During cell silence, membrane potential remained stable at
252.2 6 0.8 mV (range: 240 to 268, n 5 45) for tonic cells
and at 256.2 6 1.4 mV (range: 248 to 261 mV, n 5 8) for
bursting cells. These membrane potentials were significantly
more depolarized than the potentials at which cells were silent
in control conditions: before HFS, cells tested in the tonic
mode were silent at 260.2 6 0.6 mV (range: 249 to 268 mV,
n 5 45, P , 0.001, paired t-test) and cells tested in the bursting
mode were silent at 263.5 6 1.3 mV (range: 256 to 268 mV,
n 5 8, P 5 0.015, paired t-test). This suggested that HFS did
not stop STN cell activity simply by transiently hyperpolariz-
ing the membrane.
Spikes could still be evoked during the silence period in all
tested neurons (n 5 60). However, in half of the cells, spike
threshold was significantly higher during the silence period
FIG. 1. Effect of high-frequency stimulation (HFS) on the spontaneous
single-spike activity of 2 subthalamic nucleus (STN) neurons. A: frequency
dependence of HFS. Applied at 100 Hz, HFS had nearly no posteffect whereas
at 125 Hz it decreased the frequency of tonic activity and at 166 Hz stopped
single-spike activity for 5 min. B: continuous chart recording (top) at slow time
resolution of the activity of an other STN neuron. HFS (250 Hz) stopped
single-spike activity at a potential of 251 mV for 1 min 12 s. Symbols indicate
the parts of the top recording that are shown at an expanded time scale in
bottom traces.
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(239.3 6 1.6 mV, n 5 30) compared with the control
(247.5 6 0.6 mV, n 5 30, P , 0.001; Fig. 3). So was also
input membrane resistance, which was significantly increased
during HFS-induced silence, when tested at Vm 5 265 mV by
applying hyperpolarizing current pulses of 2100/-200 pA am-
plitude (247.2 6 21.1 vs. 226.1 6 16.3 MV, P 5 0.035, n 5
20). A second tetanus, applied after the cell recovered from the
first one, reversibly silenced the cell again (n 5 15). This could
be repeated as long as patch recording could last. Therefore
HFS does depress neuronal activity in slices, and this effect is
short lasting and can be repeated. In subsequent experiments,
we used a thinner electrode designed to avoid any mechanical
lesion of the STN. We chose to use the same parameters of
train duration (1 min) and of bipolar stimuli intensity (5–8 V)
and duration (100 ms) but to vary their frequency in the train
(range 100–500 Hz) to obtain a clear-cut suppression of ac-
tivity during which a long-lasting analysis of currents or spe-
cific responses could be performed.
HFS-induced suppression of activity is independent of
synaptic activity
An important issue was to determine whether effects of the
train were mediated by synaptic transmission. Bath applica-
tions of ionotropic glutamate and GABAA receptor antago-
nists, CNQX (20 mM), D-APV (40 mM), and bicuculline (10
mM) failed to prevent the effects of HFS (n 5 6, Fig. 4).
Furthermore HFS still suppressed single-spike activity when
synaptic transmission was blocked by 2 mM Co21 (n 5 16,
Fig. 5A, top). Since the silencing effect of HFS did not require
Ca21-dependent transmitter release, we tested whether it was
possible to mimic this effect with intracellular stimulation of
the recorded cell. When comparing the two types of HFS
(extracellular and intracellular) in the same tonically active
STN neurons (n 5 8), it appeared that both HFS resulted in a
silence of the cell. However, intracellular HFS had a different
effect on membrane potential: there was a strong hyperpolar-
ization of the membrane at the break of the intracellular pulses
(to 263.2 6 3.1 mV) that declined in about 20 s to 248.1 6
4.1 mV, a potential at which tonic activity recovered (n 5 8,
data not shown). Such an after hyperpolarization and slow
membrane repolarization were never observed after extracel-
lular HFS where membrane potential remained stable during
cell silence (Figs. 1–6).
HFS-induced decrease of voltage-gated currents
We hypothesized that HFS induced a modification of volt-
age-sensitive currents essential for the expression of tonic and
burst-firing modes (Beurrier et al. 2000; Bevan and Wilson
1999). In the tonic mode, the silencing effect of HFS did not
require Ca21 influx since it was still observed in the presence
of 2 mM Co21 nor increase of intracellular Ca21 concentration
since it was present in BAPTA-loaded cells (n 5 4, data not
shown). We therefore tested the effect of HFS on spontaneous
tonic activity and INaP recorded from the same STN neurons by
shifting from current- to voltage-clamp mode before, during,
and after HFS-induced silence. In voltage-clamp mode, in
response to a voltage ramp and in the continuous presence of
Co21, a TTX-sensitive inward current that had the character-
istics of a persistent Na1 current was recorded. It was strongly
reduced during HFS-induced silence (Fig. 5). I-V relationships
before and during HFS-induced silence showed that peak am-
plitude of INaP was reduced by 99% during cell silence as
compared with the control (from 2122.2 6 13.1 to 21.1 6 1.1
pA, n 5 9; Fig. 5, B and C). This effect reversed to 78% of
control (to 292.5 6 9.9 pA, n 5 8) once cell activity recov-
FIG. 2. Frequency-dependent effect of HFS on spontaneous bursting activ-
ity of a STN neuron. Chart recording at slow time base of a bursting STN
neuron (burst firing was evoked by continuous injection of 2150 pA). At 100
and 125 Hz, HFS decreased burst frequency (bottom traces) whereas at 166 Hz
it totally suppressed bursting activity for 1 min and 49 s. Activity then
recovered in burst firing mode. Symbols indicate the parts of the top recording
that are shown at an expanded time scale in bottom traces.
FIG. 3. Increase of threshold potential for Na1-dependent spikes during
HFS-induced silence. Chart recording at low time base of a tonic STN neuron
(top). HFS (250 Hz) stopped single-spike activity at a potential of 248 mV for
1 min 25 s. Bottom: Na1-dependent spikes evoked by a depolarizing pulse of
100 ms, before HFS (a, 80 pA), during HFS-induced silence (b, 100 pA), and
after recovery of activity (c, 80 pA).
FIG. 4. HFS-induced silence is independent of ionotropic synaptic trans-
mission. HFS (500 Hz) reversibly stopped single-spike activity of a STN
neuron for 8 min at 245 mV (control). A 2nd HFS (500 Hz) was applied in the
continuous presence of D-APV, CNQX, and bicuculline (Bic). Single-spike
activity was stopped at 245 mV for 9 min.
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ered. When applied at the end of the experiment, TTX (1 mM)
totally blocked this current, confirming that it was INaP
(Fig. 5A).
Spontaneous bursting mode and ICa were then analyzed.
However, since the recording of Ca21 currents requires the
presence of K1 channel blockers, a procedure incompatible
with the recording of burst firing in current-clamp mode, the
amplitude of Ca21 currents was therefore evaluated from the
evoked potentials they underlie: the rebound depolarization,
also called low-threshold Ca21 spike (LTS), that results from
the activation of a T-type Ca21 current and the plateau poten-
tial that results from the combined action of the nifedipine-
sensitive L-type Ca21 current and a Ca21-activated inward
current (Beurrier et al. 1999). Following HFS, during minutes
of silence, plateau duration was reduced by 62% (from
1119.4 6 150.6 to 425.6 6 111.4 ms, n 5 32) sometimes with
a total suppression of the after spike depolarization (Fig. 6, A,
top and middle, and B, left). Concomitantly, the amplitude of
the rebound potential was reduced by 75.9% (from 8.8 6 0.4
to 2.1 6 0.5 mV, n 5 23; Fig. 6, A, top and bottom, and B,
right). Once cell activity recovered, the effects on plateau
potential duration and on the amplitude of rebound potential
reversed to 66% of control (to 739.4 6 217.9 ms, n 5 18) and
to 39% of control (to 3.4 6 0.8 mV, n 5 14), respectively.
In contrast, the Cs1-sensitive, hyperpolarization-activated
cation current (Ih) was not affected by HFS at potentials
normally traversed by the membrane during tonic firing. It was
FIG. 6. Effect of HFS on Ca21-mediated responses. A, top: HFS (500 Hz)
stopped the activity of a burst-firing STN neuron (at 263 mV). Middle: plateau
potential triggered by a depolarizing current pulse at Vm 5 265 mV (180 pA,
100 ms), lasted 760 ms before HFS (a), lasted 150 ms during cell silence (b,
70 s after HFS), and lasted 520 ms during recovery of bursting activity (c, 17
min after HFS).2 indicates the after spike depolarization (ADP) present in a
and c and absent in b. Bottom: rebound potential (2) recorded at the break of
a hyperpolarizing pulse (280 pA, 500 ms) had an amplitude of 10 mV before
HFS (a), of 2.5 mV during silence (b, 8 min 30 s after HFS), and of 5 mV after
recovery of bursting activity (c, 34 min after HFS). In the same traces, note the
absence of modification of the depolarizing sag that developed during the
current pulse. All recordings were obtained from the same STN neuron. B, left:
histogram of plateau potential duration before (control), during (HFS), and
after (recovery) HFS-induced silence. Right: histogram of rebound potential
amplitude before, during, and after HFS-induced silence. *, comparison with
preceding column; E, comparison with control. *P , 0.05; ** or E E: P ,
0.001; *** or E E E: P , 0.0001.
FIG. 5. Effect of HFS on the persistent Na1 current in the absence of
synaptic transmission. A: HFS (500 Hz) applied in the continuous presence of
Co21 (2 mM) stopped the activity of a tonically firing STN neuron (for 18 min
at 260 mV; top). In response to a 5-mV/s depolarizing ramp from 280 to 210
mV, a slow inward current was recorded before HFS (a), 110 s after HFS (b,
during HFS-induced silence), and 36 min after HFS (c, after recovery of
activity). TTX (1 mM) applied at the end of the experiment totally abolished
the slow inward current as well as the fast ones (c, bottom). B: I-V relationships
of the persistent Na1 current obtained from the same cell in A. The curve
HFS-TTX represents the subtraction of traces Ab–Ac. The curve control-TTX
represents the subtraction of traces Aa–Ac. C: histogram of INaP peak ampli-
tude before (control), during (HFS), and after (recovery) HFS-induced silence.
*, comparison with preceding column; E, comparison with control. * or E:
P , 0.05; **: P , 0.001; ***: P , 0.0001.
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reduced between 280 and 2110 mV (by 26.5% at 290 mV,
n 5 5, Fig. 7). Consistent with these findings on Ih, the
amplitude of the depolarizing sag observed during a hyperpo-
larizing current pulse was not significantly affected (it was
reduced by 4.8%, from 5.21 6 0.82 to 4.99 6 0.80 mV, P 5
0.69, n 5 12; Fig. 6A, bottom).
D I S C U S S I O N
Our results show that HFS blocks the spontaneous activity of
tonic and bursting STN neurons with a mechanism that does
not require Ca21-dependent transmitter release. The silencing
effect of HFS has a short latency, is brief, reversible, can be
repeated several times with little change, and is frequency
dependent. It is mediated by a dramatic reduction of Na1 and
Ca21 voltage-gated currents leading to an interruption of the
spontaneous activities of the neurons. In fact, in single-spike
activity, a TTX-sensitive, persistent Na1 current (INaP), under-
lies the slow pacemaker depolarization that spontaneously de-
polarizes the membrane from the peak of the after spike hy-
perpolarization to the threshold potential for spike initiation
(Beurrier et al. 2000; Bevan and Wilson 1999). In contrast, in
burst-firing mode, the interplay between a T-type Ca21 current
(ICaT), an L-type Ca21 current (ICaL), and a Ca21-activated
inward current, all insensitive to TTX, underlie recurrent mem-
brane oscillations (Beurrier et al. 1999). The blockade of these
subliminal currents can also explain the increase of membrane
resistance observed during HFS-induced silence.
The silencing effect of HFS does not result from the activa-
tion of a local network and is not mediated by the stimulation
of afferents to the STN, since it was still observed in the
presence of blockers of glutamatergic and GABAergic iono-
tropic synaptic transmission and in the presence of cobalt at a
concentration that totally blocked synaptic transmission in the
STN. It was in fact reproduced by direct stimulation of the
recorded STN cell as previously tested by Borde et al. (2000)
in hippocampal CA1 pyramidal neurons. In this preparation, a
low-frequency intracellular stimulation induced a depression of
activity that developed rapidly, was reversible, persisted up to
3 min and was still observed when synaptic transmission was
strongly reduced by the P-type Ca21 channel blocker v-aga-
toxin IVA or enhanced by 4-aminopyridine. The insensitivity
of depression to synaptic blockade indicates little if any in-
volvement of synaptic mechanisms and implies that postsyn-
aptic mechanisms are key factors as observed in the present
study with extracellular HFS. However, mechanisms underly-
ing intracellular stimulation may be different from those un-
derlying extracellular HFS. The silencing effect of intracellular
stimulation is Ca21-dependent since it requires Ca21 influx and
intracellular Ca21 increase in the stimulated cell (Borde et al.
2000), whereas that of extracellular HFS is Ca21-independent
(the present study).
As the pattern of discharge of STN neurons may play an
important role in the physio-pathology of parkinsonism (Berg-
man et al. 1994; Hollerman and Grace 1992), it is tempting to
correlate the present effects of in vitro HFS on the spontaneous
STN activity, to the beneficial effects of high-frequency deep
brain stimulation in the STN of MPTP-treated monkeys
(Benazzouz et al. 1992; Hayase et al. 1996) or parkinsonian
patients (Benabid et al. 1994; Limousin et al. 1998). However,
such a direct correlation needs further experiments. First, clin-
ical HFS is performed in vivo where it could affect the whole
basal ganglia network, at least at the onset of stimulation.
Second, clinical HFS is efficient at lower frequencies (125–185
Hz) than sometimes in vitro HFS does. This could be explained
by the differences in the characteristics of the stimulating
electrode. Finally, beneficial clinical effects are observed dur-
ing the continuous application of the stimulation and only for
a short while after the stimulation, whereas in the present
study, only events that followed the stimulation have been
studied. Nevertheless, the present results give some insights in
the way intrinsic activity of STN neurons can be depressed.
Present address of C. Beurrier: Dept. of Psychiatry and Behavioral Sciences,
School of Medicine, Stanford University, 1201 Welch Rd., Palo Alto, CA
94304-5485.
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Drug addiction is a pathological behavior characterized by com-
pulsive drug seeking and drug ingestion despite severe adverse
consequences. Animal models of addiction mimic several of the
core features of addiction in humans and therefore can be used
to study the neural mechanisms underlying this pathological
form of experience-dependent behavioral plasticity. Because of
advances in molecular neurobiology, much is known about how
drugs of abuse interact with and modify their molecular targets.
Furthermore, the molecular adaptations that occur in specific
brain regions in response to acute and chronic administration
of drugs of abuse are being determined at a rapid pace1. There is
a relative paucity of information, however, about the changes in
synapses and circuits that occur as a consequence of these drug-
induced molecular changes; this information is critical for a
thorough understanding of the neural mechanisms of addiction.
A key feature of addiction is the intensification of drug crav-
ing that occurs in human addicts with repeated drug exposure.
A prominent model for this behavioral change is the long-last-
ing increase in locomotor response to drugs of abuse following
repeated exposures. This increased response, termed behavioral
sensitization, is thought to reflect adaptations in neural circuits
that determine the incentive value of external stimuli rendering
the circuits hypersensitive or sensitized2. Many of the neural
adaptations that have been identified following psychostimulant
administration take place in the mesolimbic dopamine system,
major components of which are the ventral tegmental area (VTA)
and the nucleus accumbens (NAc). Modifications in the VTA are
involved in the induction of behavioral sensitization, and modi-
fications in the NAc are involved in its long-term maintenance3,4.
For example, repeated injection of psychostimulants into the VTA
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A compelling model of experience-dependent plasticity is the long-lasting sensitization to the
locomotor stimulatory effects of drugs of abuse. Adaptations in the nucleus accumbens (NAc), a com-
ponent of the mesolimbic dopamine system, are thought to contribute to this behavioral change.
Here we examine excitatory synaptic transmission in NAc slices prepared from animals displaying sen-
sitization 10–14 days after repeated in vivo cocaine exposure. The ratio of AMPA (α-amino-3-hydroxy-
5-methyl-4- isoxazole propionic acid) receptor- to NMDA (N-methyl-D-aspartate) receptor-mediated
excitatory postsynaptic currents (EPSCs) was decreased at synapses made by prefrontal cortical affer-
ents onto medium spiny neurons in the shell of the NAc. The amplitude of miniature EPSCs at these
synapses also was decreased, as was the magnitude of long-term depression. These data suggest that
chronic in vivo administration of cocaine elicits a long-lasting depression of excitatory synaptic
transmission in the NAc, a change that may contribute to behavioral sensitization and addiction.
induces behavioral sensitization, whereas in sensitized animals,
the injection of psychostimulants into the NAc is sufficient to
elicit sensitized responses (for review, see refs. 3, 4).
Much of the initial work on the adaptations that mediate
behavioral sensitization appropriately focused on pre- and
postsynaptic changes in dopaminergic transmission. Recent-
ly, however, evidence has accumulated that excitatory inputs
to the VTA and NAc are critical. Consistent with the VTA’s
involvement in triggering sensitization, repeated electrical stim-
ulation of excitatory cortical afferents to the VTA induces sen-
sitization that, when elicited by systemic drug exposure, is
blocked by local injection of glutamate receptor antagonists
into the VTA5. Indeed, in vivo administration of cocaine elicits
a robust enhancement of excitatory synaptic transmission in
this structure6. On the other hand, the expression of behav-
ioral sensitization is blocked by inhibiting excitatory synaptic
transmission in the NAc7 or by lesions of the excitatory corti-
cal afferents to this structure8 (but see ref. 9).
What changes occur in the NAc that account for its impor-
tance in behavioral sensitization? The major cell type in the
NAc (>95% of total) is the medium spiny neuron that receives
glutamatergic inputs from a variety of cortical and subcortical
limbic areas, including the hippocampus, prefrontal cortex and
amygdala. Because these neurons have high resting membrane
potentials and are generally quiescent, they depend on these
excitatory inputs to generate output to their main targets, the
VTA and ventral pallidum. It is therefore reasonable to 
hypothesize that changes in the efficacy of these inputs would
have a significant effect on the functioning of mesolimbic
dopamine circuitry and would thereby alter the behavioral
articles
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Synaptic transmission in cocaine-treated mice
To determine whether changes in the efficacy of AMPA receptor
(AMPAR)-mediated synaptic transmission had occurred as a result
of the chronic cocaine treatment, we first measured field EPSPs
from the NAc10 in slices prepared from the animals one day after
the final cocaine challenge. The NAc is commonly divided into
two components, the shell and the core, which are distinguished
both anatomically and functionally11. Therefore, data were divid-
ed according to the location of the recording. Despite using a range
of stimulus intensities, we could not detect any difference in the
size of the field EPSPs in either the shell or core between cocaine-
and saline-treated groups (data not shown).
Differences in the placement of stimulating and recording
electrodes and the density of afferent fibers may be considerable
sources of experimental variability when attempting to measure
differences in synaptic strength between slices. To reduce the slice-
to-slice variability that might have obscured any cocaine-induced
changes in synaptic efficacy, we repeated our analysis using a
more sensitive assay that compared the relative contributions of
AMPARs and NMDA receptors (NMDARs) to EPSCs. This pro-
cedure involved evoking EPSCs while holding cells at +40 mV in
the absence and then in the presence of the NMDAR antagonist
D-APV (50 µM)6 (see Methods). Using this assay, we observed a
decrease in the AMPAR/NMDAR ratio in cells in the NAc shell
from cocaine-treated compared to saline-treated mice (Fig. 2a–c;
cocaine, 0.68 ± 0.09, n = 12; saline 0.97 ± 0.09, n = 9; p < 0.05)
response to a drug of abuse. To test this hypothesis, we exam-
ined excitatory synaptic transmission in slices of NAc prepared
from mice in which behavioral sensitization was induced by
repeated in vivo administration of cocaine. This in vivo
treatment caused a long-lasting depression of synaptic
strength at synapses made by prefrontal cortical afferents
onto medium spiny neurons in the shell of the NAc.
RESULTS
Long-lasting locomotor sensitization to cocaine
To induce behavioral sensitization, we paired repeated
cocaine injections with exposure of the animals to a dis-
tinct test environment. After two days of saline injections
to habituate the animals to the activity box, the immediate
locomotor response to a fixed dose of cocaine (15 mg/kg)
increased dramatically across days of testing (Fig. 1; dis-
tance traveled, day 3, saline, 418 ± 22 cm, n = 51; cocaine,
1176 ± 90 cm, n = 47; day 7, saline, 462 ± 36 cm, n = 51;
cocaine, 3896 ± 191 cm, n = 47; p < 0.001). To test
whether this procedure produced long-lasting sensitiza-
tion, we administered a challenge dose of cocaine to both
saline- and cocaine-treated groups 10 to 14 days follow-
ing the last dose of the initial treatment regimen. Mice
pretreated with cocaine showed a much greater locomo-
tor response to cocaine than did saline-pretreated animals
(cocaine, 4660 ± 204 cm, n = 47; saline, 1556 ± 170 cm,
n = 51; p < 0.001). These results indicate that the initial
five-day exposure to cocaine caused behavioral sensitiza-
tion that lasted for at least two weeks.
Fig. 2. Repeated cocaine administration induces a decrease in the
AMPAR/NMDAR ratio of synaptic currents in the shell but not in
the core of NAc. (a) Sample EPSCs from saline and cocaine-
treated animals. Scale bars, 40 ms and 20 pA. (b, d) Cumulative
probability plots of AMPAR/NMDAR ratio in shell (b) and core (d)
neurons from saline (n = 9 shell; n = 8 core) and cocaine-treated 
(n = 12 shell; n = 7 core) mice. (c, e) Mean AMPAR/NMDAR ratio
in shell (c) and core (e) neurons from saline and cocaine-treated
mice. *p < 0.05.
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Fig. 1. Behavioral sensitization induced by repeated cocaine administra-
tion. Mean (± s.e.m.) locomotor activity in response to saline and
cocaine injections. Locomotor activity was monitored for 15 min imme-
diately following each injection.
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but not in cells in the core (Fig. 2d and e; cocaine, 0.76 ± 0.11, 
n = 7; saline 0.78 ± 0.12, n = 8; p > 0.05).
Because a single dose of cocaine can elicit behavioral sensiti-
zation and an increase in the AMPAR/NMDAR ratio in the VTA6,
we wondered if the single injection of cocaine received by the
saline-treated mice may have affected the AMPAR/NMDAR ratio
and thereby influenced our results. Therefore, in another set of
experiments, mice were given either one cocaine or one saline
injection and AMPAR/NMDAR ratios for shell neurons were
determined the next day. There was no significant difference
between the mean AMPAR/NMDAR ratios of these groups (data
not shown) indicating that, unlike the VTA, a single cocaine expo-
sure does not affect this measurement in the NAc shell.
A decrease in the AMPAR/NMDAR ratio likely reflects a
decrease in AMPAR function and/or number, an increase in
NMDAR function and/or number, or a combination of these.
Such a change, however, does not rule out that changes in trans-
mitter release mechanisms may be induced by in vivo cocaine
exposure as well. To assess whether changes in the probability of
transmitter release (Pr) occurred in the cocaine-treated animals,
we compared the magnitude of the facilitation that occurs in
response to paired-pulse stimulation, a measure that routinely
changes with changes in Pr
12. The paired-pulse ratio did not dif-
fer between cocaine- and saline-treated mice when tested at a
variety of intervals in either shell or core neurons following the
cocaine treatment regimen (Fig. 3), suggesting that significant
changes in Pr did not occur in cocaine-treated mice.
Changes in mEPSC amplitude in cocaine-treated mice
To address whether AMPAR function and/or number was modi-
fied in the NAc shell of cocaine-treated mice, we examined minia-
ture AMPAR-mediated EPSCs (mEPSCs). We found no difference
between cocaine and saline-treated mice in either the frequency
or the amplitude of mEPSCs in shell neurons (Fig. 4). This sug-
gested that the decrease in the AMPAR/NMDAR ratio might be
due to an increase in the function and/or number of NMDARs.
Testing this possibility is difficult because the relatively high fre-
quency of mEPSCs in this preparation (∼7 Hz), the increased
‘noise’ generated by opening of NMDARs by ambient glutamate13
and the slow rise-time of NMDAR events make it problematic to
reliably detect NMDAR-mediated mEPSCs. To circumvent these
problems, we bathed slices in Mg2+-free solution to record 
mEPSCs containing both AMPAR and NMDAR components
using the fast rise-time of the AMPAR component to reliably
detect the mEPSCs. We then applied D-APV and collected AMPAR
mEPSCs from the same cell. Subtracting average mEPSCs in the
presence of D-APV from those collected in its absence yielded an
average NMDAR mEPSC for each cell (Fig. 5a and b). This mea-
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Fig. 4. Repeated cocaine administration had no effect on the amplitude
or frequency of shell AMPAR mEPSCs. (a) Sample traces of mEPSCs in a
shell neuron in a cocaine-treated mouse. Scale bars, 80 ms and 10 pA.
(b, d) Cumulative amplitude (b) and inter-event interval (d) distribu-
tions of shell mEPSCs obtained in cocaine and saline-treated mice 
(n = 400 events per cell, 8 cells in each group). (c, e) Means of mEPSCs
amplitude (c) and frequency (e) p > 0.05.
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Fig. 5. Repeated cocaine administration did not affect
NMDAR mEPSC amplitude or response to NMDA in shell
neurons. (a) Samples of mEPSCs recorded at –65 mV in zero
Mg2+ solution in the absence (top) and presence (bottom) of
D-APV (50 µM) in a cocaine-treated mouse. Scale bars, 100 ms
and 20 pA. (b) Sample averaged traces of mEPSCs obtained in
each condition plus the subtracted trace that yielded an aver-
age NMDAR mEPSC. Scale bars, 10 ms and 2 pA. 
(c) Cumulative probability plot for NMDAR mEPSC amplitude
(n = 9 cocaine; n = 7 saline). (d) Means of NMDAR mEPSCs
amplitude (p > 0.05). (e) Bath application of NMDA (10 µM)
for 30 s elicited similar change in holding current in neurons
held at +40 mV (cocaine, n = 5; saline, n = 4; p > 0.05).
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surement did not differ significantly in shell neurons from
cocaine- and saline-treated mice (Fig. 5c and d), suggesting that
NMDAR function and/or number is not altered at synapses that
contain both AMPARs and NMDARs.
Another plausible explanation for the decrease in the
AMPAR/NMDAR ratio in cocaine-treated mice is that cocaine
causes an increase in the proportion of synapses that contain only
NMDARs, so-called silent synapses14. Such synapses would not
have been sampled in our experiments examining dual-compo-
nent mEPSCs, but may have been recruited when we evoked
EPSCs at +40 mV. An initial finding that led to the proposal of
silent synapses is that the coefficient of variation (CV) of EPSCs
was higher for the AMPAR component of EPSCs relative to the
NMDAR component15. When we examined CV ratios in shell
neurons from cocaine and saline-treated mice, we found that in
13 of 19 cells examined, the AMPAR/NMDAR CV ratio was
greater than 1, suggesting that some synapses on a proportion of
medium spiny neurons may contain only NMDARs. However,
there was no significant difference between the groups in this
ratio (cocaine, 1.39 ± 0.16, n = 11; saline, 1.15 ± 0.09, n = 8; p >
0.05). As a final test to determine whether the function or num-
ber of NMDARs increased in cocaine-treated mice, we bath-
applied NMDA (10 µM, 30 s) and recorded the change in holding
current (Fig. 5e). Again, there was no significant difference
between cocaine and saline-treated groups (cocaine, 82 ± 16 pA,
n = 5; saline, 76 ± 17 pA, n = 4; p > 0.05).
A limitation of our analysis of mEPSCs is that medium
spiny neurons receive excitatory projections from several
sources and there was no way of knowing from which
synapses the mEPSCs were generated. If the changes in
the AMPAR/NMDAR ratio of the evoked EPSC occurred
primarily at the stimulated synapses, presumably those
made by cortical afferents, we may have missed detecting
a change in mEPSCs. To circumvent this problem, we
replaced the Ca2+ in our bathing solution with Sr2+ and
applied short bursts of afferent stimulation that causes
the asynchronous release of vesicles from the set of
synapses that were activated (Fig. 6a)16. Using this tech-
nique, it was possible to preferentially sample mEPSCs
from the same subset of synapses that were activated to
yield the evoked EPSC17. Although no significant differ-
ence in the frequency of asynchronous quantal events
between shell neurons from cocaine and saline groups
was observed (cocaine, 25 ± 3 Hz, n = 11; saline, 
23 ± 2 Hz, n = 12; p > 0.05), the mean amplitude distri-
bution of quantal events in the cocaine group was signif-
icantly shifted to the left compared to the saline group
(Fig. 6b; n = 11, 12; Kolmogorov–Smirnov test; p < 0.05)
and their mean amplitude was also decreased (Fig. 6c)
(cocaine, 12.4 ± 0.4 pA; saline 14.0 ± 0.6 pA, p < 0.05). These
results indicate that AMPAR-mediated quantal events generated
by the synapses activated by cortical afferents are significantly small-
er in the cocaine-treated group, suggesting that the decrease in
AMPAR/NMDAR ratio is due, at least in part, to a reduction in
AMPAR function and/or number specifically at these synapses.
Changes in LTD in cocaine-treated mice
Given that the synapses made by cortical afferents onto medium
spiny neurons can express NMDAR-dependent LTD18, a form of
synaptic plasticity that is associated with a reduction in AMPAR
function and number17,19,20, we predicted that the expression of
LTD would be reduced in cocaine-treated mice. We first tested
whether the triggering of LTD at NAc synapses was significantly
impaired in cocaine-treated mice by delivering an LTD-inducing
train of stimuli (5 Hz, 3 min) while monitoring field EPSPs. This
induced a modest amount of LTD that did not differ between the
two groups (cocaine, 79 ± 6% of baseline, n = 6; saline, 85 ± 5% of
baseline, n = 6; data not shown). To determine whether the mag-
nitude of LTD was reduced, as would be expected if the decrease in
synaptic strength in cocaine-treated mice was due to mechanisms
shared with LTD, we made whole-cell recordings from shell neu-
rons and used a strong LTD induction protocol that generated a
near-saturating amount of LTD (3 bouts of 5 Hz, 
3 min stimulation paired with depolarization to –50 mV). This
elicited robust LTD in saline-treated animals (Fig. 7; 
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66 ± 7% of baseline, n = 7), but much smaller LTD in the
cocaine group (Fig. 7; 84 ± 4% of baseline, n = 8, p < 0.05).
DISCUSSION
Psychostimulant-induced behavioral sensitization is thought
to model some of the core features of addiction2–4, as well
as the development of drug-elicited psychosis21. It is of inter-
est not only because it serves as a model for the pathological
changes that occur as a consequence of repeated exposure
to drugs of abuse but also because it is a robust form of
experience-dependent behavioral plasticity. Indeed, sensi-
tized animals can remain hypersensitive to the locomotor
and rewarding actions of drugs for periods of months to
years2–4. Over the last few years, evidence has accumulated
that modifications in excitatory neural circuitry in the VTA
and NAc may be particularly important in this form of experi-
ence-dependent plasticity. However, excitatory synaptic trans-
mission following repeated drug exposure has not been examined
directly. In this study, we measured excitatory synaptic respons-
es in slices of the NAc prepared from animals in which behavioral
Fig. 6. Repeated cocaine treatment decreased the amplitude of
AMPAR quantal EPSCs in cortical synapses onto NAc shell neu-
rons. (a) Sample traces of evoked EPSCs in the presence of Ca2+
or Sr2+. Scale bars, 50 ms and 10 pA. (b) Cumulative amplitude
distributions of AMPAR quantal EPSCs in Sr2+ solution for saline
and cocaine-treated mice (n = 300 events per cell; saline, n = 11;
cocaine, n = 12). Distributions are significantly different (p < 0.05;
Kolmogorov–Smirnov test). (c) Mean amplitude of quantal EPSCs
in Sr2+ solution for saline and cocaine-treated mice. Cocaine
treatment induced a significant decrease in Sr2+-induced AMPAR
mEPSC amplitude (p < 0.05; t-test).
sensitization was induced by repeated in vivo treatment with
cocaine. We found that cocaine treatment decreased synaptic
strength at excitatory synapses made by cortical afferents onto
medium spiny neurons and that this occurred in the shell region
of the NAc but not in the core. Changes in NMDAR-mediated
synaptic responses and in the probability of transmitter release
were not detected. Consistent with the idea that the cocaine-
induced decrease in synaptic strength shares expression mecha-
nisms with LTD, we found that the magnitude of LTD was
significantly reduced in the cocaine-treated mice.
Our observations are consistent with several previous find-
ings. First, the single-unit responses of NAc neurons to glutamate
are decreased for at least 14 days following a cocaine or ampheta-
mine sensitization regimen22. Although a decrease in AMPAR
function and/or number, as our results suggest, could explain this
result, changes in voltage-dependent conductances following
chronic cocaine exposure23 may also contribute. Second, a
decrease in the levels of the AMPAR subunits, GluR1 and GluR2
is observed in the NAc 14 days following amphetamine-induced
sensitization24,25 (but see ref. 26). Third, the inward current gen-
erated by AMPA/kainate application to acutely dissociated stri-
atal neurons is decreased in cells from animals that have received
chronic cocaine27. Fourth, viral-mediated overexpression of GluR2
in the NAc, a manipulation that would be expected to decrease
AMPAR function, increases behavioral sensitivity to cocaine as
measured by place conditioning28. The functional importance of
articles
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Fig. 7. Repeated cocaine treatment decreased the magnitude of LTD in
shell neurons. (a) Examples of individual experiments in saline (top) and
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a decrease in the strength of excitatory inputs to the NAc is 
supported by the findings that virtually all drugs of abuse decrease
the firing of NAc neurons29 and that such decreases have been
associated with enhanced locomotor activity30. Furthermore, ani-
mals will self-administer glutamate receptor antagonists directly
into the NAc shell31, suggesting that decreases in excitatory drive
are reinforcing. It has been proposed that cocaine-induced behav-
ioral sensitization involves an enhancement, not a depression, of
excitatory synaptic transmission in the NAc4. This conclusion,
however, is based primarily on microdialysis measurements of
extracellular glutamate concentration, an assay that is not a direct
measure of synaptic strength.
The NAc is commonly divided into two regions: the core,
which is considered a functional extension of the dorsal striatum,
and the shell, which is thought to be a transitional region between
the striatum and the extended amygdala32. There is evidence that
the shell is particularly important for mediating the effects of
drugs of abuse as well as behavioral sensitization. Certain drugs
of abuse are preferentially self-administered in the shell compared
to core31,33,34. Similarly, drug-induced increases in extracellular
dopamine levels may preferentially occur in the shell35,36. It has
also been reported that injections of D1 receptor antagonists into
the shell reduce the reinforcing effects of cocaine37. In the con-
text of drug-induced locomotor activity, three weeks after repeat-
ed cocaine exposure, injection of amphetamine into the shell, but
not the core, elicits sensitized locomotor responses38. Conversely,
lesions of the shell markedly impair the locomotor effects of
amphetamine as well as its rewarding properties39. There is also
evidence, however, that excitatory synaptic transmission in the
core is important for the expression of behavioral sensitization3,4
and thus, our results should not be taken to indicate that modifi-
cations in this structure are not also important.
All of our findings are consistent with the hypothesis that chron-
ic in vivo cocaine administration induces a form of LTD that shares
expression mechanisms with the NMDAR-dependent LTD previ-
ously described at these synapses18. We were unable to detect any
change in NMDAR properties but we would caution that our assays
might have been relatively insensitive, especially if such changes are
restricted to synapses formed by a subset of NAc afferents. The rela-
tionship between our findings and the increase in spine density and
proportion of branched spines that occurs following psychostim-
ulant-induced sensitization40,41 is unclear. Although an increase in
spines would suggest that the total afferent input to medium spiny
neurons was increased, nothing is known about the detailed prop-
erties of these new spines. Indeed, if they contained small numbers
of AMPARs or were functionally silent, they could contribute to
our observed decrease in the AMPAR/NMDAR ratio.
We have demonstrated that an LTD-like process in the NAc
may contribute to the reorganization of neural circuitry that
underlies behavioral sensitization to cocaine, and thus may be
an important factor in the development of addiction. Also, the
decrease in the ability of synaptic activity to elicit LTD in the NAc
shell may contribute to the drug-induced behavioral changes.
Together with the recent demonstration of a cocaine-induced
LTP in the VTA6, these results suggest that like other forms of
experience-dependent behavioral plasticity42–46, drug-induced
changes in behavior may be due, at least in part, to modifications
of synaptic efficacy in critical neural circuits. The sort of
approaches taken here should further our understanding of how
the molecular adaptations caused by drugs of abuse lead to the
changes in the behavior of neural circuitry that ultimately must
underlie addiction. Furthermore, because of shared molecular
and circuit mechanisms, drug-induced behavioral changes such
as psychostimulant-induced behavioral sensitization offer rela-
tively simple models for understanding the neural mechanisms
underlying many forms of experience-dependent plasticity,
including learning and memory1–4,47.
METHODS
Treatment regimen and locomotor activity. Male C57/Bl6 mice (24–26
days old) were given intraperitoneal injections of either saline (0.9% NaCl)
or saline with cocaine (15 mg/kg). Immediately following each injection,
horizontal locomotor activity was monitored in open-field chambers (Med
Associates, St. Albans, Vermont) for 15 min. After two days of saline injec-
tions, mice were divided into groups that received five daily injections of
either cocaine or saline. Following 10–14 days without injections, both
groups received cocaine injections and locomotor activity was assessed.
Brain slices were prepared on the following day. All procedures were
approved by the Institutional Animal Care and Use Committee.
Electrophysiology. Sagittal slices of the NAc (200–250 µm) were pre-
pared with a vibratome (Leica, Nussloch, Germany) as described10. Slices
(four per animal) were placed in a holding chamber and allowed to recov-
er for at least 1 h before being placed in the recording chamber and super-
fused with bicarbonate-buffered solution (ACSF) saturated with 95%
O2/5% CO2 and containing 119 mM NaCl, 2.5 mM KCl, 1.0 mM
NaH2PO4, 1.3 mM MgCl2, 2.5 mM CaCl2, 26.2 mM NaHCO3 and 
11 mM glucose (at 28–30°C). Picrotoxin (100 µM) was added to block
GABAA receptor-mediated IPSCs. Cells were visualized using infrared-
differential interference contrast video microscopy. Whole-cell voltage-
clamp recordings were made using an Axopatch1D amplifier (Axon
Instruments, Foster City, California). Electrodes (3–8 MΩ) contained
117 mM cesium gluconate, 2.8 mM NaCl, 20 mM HEPES, 0.4 mM
EGTA, 5 TEA-Cl, 2.5 MgATP, and 0.25 MgGTP, pH 7.2–7.4 
(285–295 mOsm) for whole-cell experiments and ACSF for field record-
ings. Series resistance (10–40 MΩ) and input resistance were monitored
on-line with a 4-mV depolarizing step (50 ms) given with every afferent
stimulus. Medium spiny neurons were identified by their morphology
and high resting membrane potential (–75 to –85 mV).
We examined core neurons in slices in which rostral and caudal limbs
of the anterior commisure as well as caudate/putamen were present.
Shell neurons were examined in medial NAc slices that did not contain
dorsal striatal tissue. Stainless steel bipolar microelectrodes were placed
at the prelimbic cortex–NAc border to stimulate afferents preferential-
ly from the prelimbic cortex. Afferents were stimulated at 0.1 Hz except
where noted. Neurons were voltage-clamped at –80 mV except where
noted. Data were filtered at 1–2 kHz, digitized at 2–5 kHz and collected
on-line using custom software (Igor Pro; Wavemetrics, Lake Oswego,
Oregon). EPSC amplitudes were calculated by taking the mean of a 
1–2 ms (AMPAR EPSCs) or 3–4 ms (NMDAR EPSCs) window around
the peak and comparing this with the mean of an 8-ms window imme-
diately before the stimulation artifact. AMPAR/NMDAR ratios were
computed by taking the average of EPSCs at +40 mV (25–30 EPSCs) in
the absence and presence of D-APV (50 µM). The average response in
the presence of D-APV (AMPAR-only) was subtracted from that seen in
its absence and an average NMDAR EPSC was calculated. The peak of
the AMPAR EPSC was divided by the peak of the NMDAR EPSC to yield
an AMPAR/NMDAR ratio. To compute AMPAR and NMDAR CVs,
short latency (AMPAR; 2–4 ms following stimulus) and long latency
(NMDAR; 45–50 ms following stimulus) amplitude measurements
(25–30 per cell) were made at +40 mV and amplitude variances were
divided by amplitude means after subtracting the variance of the record-
ing noise. Miniature EPSCs (300–600 per cell) were collected in the pres-
ence of either tetrodotoxin (TTX, 1.5 µM) or lidocaine hydrochloride
(0.6–0.8 mM). Dual-component mEPSCs were collected in the addi-
tional presence of 20 µM glycine, in the absence of added Mg2+ and at a
holding potential of –65 mV. In strontium experiments, AMPAR-medi-
ated quantal events were collected during a 400-ms period beginning
50 ms following each stimulus of a 2-Hz, 10-pulse train delivered once
every 30 s in bath solution containing D-APV (50 µM), 2.6 mM MgCl2,
2.5 mM Sr2+ and no Ca2+. Quantal events were analyzed using Mini-
analysis software (Synaptosoft, Decatur, Georgia) with detection para-
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meters set at greater than 4 pA amplitude and less than 3 ms rise time
and verified by eye. For each cell, a random stretch of 300 mEPSCs was
taken for constructing cumulative probability plots and calculating mean
mEPSC amplitudes. LTD was induced by delivering a single train (5 Hz,
3 min; field experiments) or multiple trains (3 × 5 Hz, 3 min, 5 min
inter-train interval) paired with depolarization to –50 mV.
In over 90% of experiments, data acquisition and analysis were per-
formed blindly without knowledge of the treatment history of the
slices. On over 75% of recording days, a similar amount of data was
collected from both cocaine and saline groups. Results are presented
as mean ± s.e.m. Statistical significance was assessed using two-tailed
Student’s t-tests, ANOVA for paired-pulse experiments, or Kol-
mogorov–Smirnov tests for comparing the cumulative probability his-
tograms. Traces in figures have had stimulus artifacts removed and are
averages of 10–12 consecutive responses.
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Brief Communication
Enhanced Inhibition of Synaptic Transmission by Dopamine in the
Nucleus Accumbens during Behavioral Sensitization to Cocaine
Corinne Beurrier and Robert C. Malenka
Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine,
Palo Alto, California 94304
Neural adaptations in the nucleus accumbens (NAc), a key
component of the mesolimbic dopamine (DA) system, are
thought to mediate several of the long-term behavioral se-
quelas of chronic in vivo exposure to drugs of abuse. Here, we
examine whether the modulation of excitatory synaptic trans-
mission by DA in the NAc shell is modified after chronic cocaine
exposure that induced behavioral sensitization. The DA-
induced inhibition of AMPA receptor-mediated synaptic re-
sponses was enhanced in cocaine-treated mice, an effect that
was caused by activation of D1-like receptors. DA did not
enhance NMDA receptor-mediated synaptic responses in
saline- and cocaine-treated mice or in the dorsal striatum of
control mice. We hypothesize that the enhanced inhibitory ef-
fects of DA on synaptic transmission in the NAc are one of a
number of adaptations that contribute to a decrease in excita-
tory drive to NAc after exposure to drugs of abuse.
Key words: addiction; cocaine; dopamine; nucleus accum-
bens; striatum; synaptic transmission; glutamate; AMPA recep-
tors; NMDA receptors
The reinforcing effects of drugs of abuse are thought to be
mediated in part by the release of dopamine (DA) in the me-
solimbic dopaminergic pathway, which projects from A10 dopa-
minergic cell bodies within the ventral tegmental area to the
nucleus accumbens (NAc) (Wise, 1998). Thus, critical questions
for understanding the neural mechanisms responsible for medi-
ating the behavioral effects of drugs of abuse include (1) what are
the effects of DA on synaptic transmission in the NAc and (2) how
are these effects modified by chronic in vivo exposure to drugs of
abuse? GABAergic medium spiny neurons are the major cell type
in the NAc and receive glutamatergic inputs from cortical and
subcortical limbic areas, including the hippocampus, prefrontal
cortex, and amygdala (Groenewegen et al., 1999; Nicola et al.,
2000). Because these cells display very negative resting potentials
(Higashi et al., 1989; Uchimura and North, 1991), they are highly
dependent on these excitatory inputs to generate their outputs.
DA, as well as psychostimulants such as amphetamine, depresses
synaptic transmission at these excitatory synapses via activation
of a D1-like receptor, although the exact mechanism by which this
occurs is contentious (Higashi et al., 1989; Pennartz et al., 1992;
Harvey and Lacey, 1996, 1997; Nicola et al., 1996; Nicola and
Malenka, 1997). Here, we examine how the modulation of exci-
tatory synaptic transmission in the NAc by DA is modified after
chronic in vivo cocaine administration sufficient to elicit behav-
ioral sensitization, a prominent animal model for certain core
features of addiction (Robinson and Berridge, 1993; Wolf, 1998;
Vanderschuren and Kalivas, 2000).
MATERIALS AND METHODS
Treatment reg imen and locomotor activity. Male C57BL/6 mice (22 d)
were given intraperitoneal injections of either saline (0.9% NaCl) or
saline with cocaine (15 mg/kg). Immediately after each injection, hori-
zontal locomotor activity was monitored in open-field chambers (Med
Associates Inc., St. Albans, VT) for 15 min. After an initial 2 d of
receiving only saline injections, mice were randomly divided into groups
that received five daily injections of either cocaine or saline. After 10–14
d without injections, both groups received cocaine injections, and loco-
motor activity was assessed. Brain slices were prepared from these
animals on the following day. Some of these animals (10 of 31 saline
animals; 10 of 43 cocaine animals) were included in our previous study on
behavioral sensitization (Thomas et al., 2001).
Electrophysiology. Sagittal slices of the NAc (200–250 m) were pre-
pared as described previously (Thomas et al., 2001). After a 1 hr recovery
period, slices were placed in a submersion-type recording chamber and
perfused (1.5–2 ml/min) at room temperature with a bicarbonate-
buffered solution (artificial CSF) saturated with 95% O2/5% CO2 and
containing (in mM): 119 NaCl, 2.5 KCl, 1 NaH2PO4, 1.3 MgCl2, 2.5
CaCl2, 26.2 NaHCO3, 11 glucose, and 0.1 picrotoxin.
Cells were visualized with an upright microscope (Zeiss, Thornwood,
NY), and whole-cell voltage-clamp recordings were made using an Axo-
patch 1D amplifier (Axon Instruments, Foster City, CA). Electrodes
(5–8 M) contained (in mM): 117 cesium gluconate, 2.8 NaCl, 20
HEPES, 0.4 EGTA, 5 TEA-Cl, 2.5 MgATP, and 0.25 MgGTP, pH
7.2–7.4 (285–295 mOsm). Field potential recordings were made using
pipettes filled with 1 M NaCl. For perforated-patch experiments, ampho-
tericin B (30 mg/ml) dissolved in DMSO was added to internal solution
(0.02–0.03% final concentration) containing (in mM): 110 cesium glu-
conate, 2.8 NaCl, 20 HEPES, 0.4 EGTA, 5 TEA-Cl, and 20 CsCl.
Experiments were begun only after series resistance had stabilized.
Medium spiny neurons were identified by their morphology and high
resting membrane potential (75 to 85 mV) as monitored at break-in.
Stainless steel bipolar microelectrodes were placed at the prelimbic
cortex–NAc border to stimulate afferents, preferentially from the pre-
limbic cortex at a baseline frequency of 0.1 Hz. Neurons were voltage
clamped at a membrane potential of 80 mV. Series and input resis-
tances were determined with each afferent stimulus and were monitored
for stability throughout each experiment. Data were filtered at 2 kHz,
digitized at 5 kHz, and collected on-line using custom software (Igor Pro;
Wavemetrics, Lake Oswego, OR). Evoked response amplitudes were
calculated by taking the mean of a 1 msec window around the peak and
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comparing this with the mean of an 8 msec window immediately before
the stimulation artifact. To simultaneously monitor AMPA receptor
(AMPAR) and NMDA receptor (NMDAR) EPSCs, cells were rapidly
depolarized to 40 mV and held for 1–3 min before beginning afferent
stimulation to allow voltage-dependent conductances to inactivate com-
pletely. AMPAR EPSCs were measured on the rising phase of the
EPSCs at a time point that was minimally affected (10%) by applica-
tion of D-APV, on average 6.1 msec (n  32) after the simulation artifact
(see Fig. 4 A). The NMDAR EPSC was measured 250 msec after the
stimulation artifact, a time at which there was no AMPAR-mediated
component. AMPAR/NMDAR ratios were calculated by averaging
10–20 consecutive responses immediately before or at the end of DA
application and making measurements as described above. The data in
Figure 2 were collected and analyzed in a blind manner. Results are
presented as mean  SEM. Statistical significance was assessed using
two-tailed Student’s t tests. Traces in figures have had stimulus artifacts
removed and are the average of 10–20 consecutive responses.
Drugs. All drugs were purchased from Sigma-RBI (St. Louis, MO)
except cocaine hydrochloride (Stanford Health Services Pharmacy, Palo
Alto, CA) and D-APV (Tocris Cookson, Ballwin, MO). Stock solutions
of dopamine hydrochloride, R()-7-chloro-8-hydroxy-3-methyl-1-phenyl-
2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride [R()-()-SCH-23390],
1-[2-(bis[4-fluorophenyl]methoxy)ethyl]-4-(3-phenylpropyl)piperazine-
dihydrochloride (GBR-12909), and cocaine hydrochloride were made in
water and applied through the superfusion medium. Sodium metabisul-
fite (final concentration, 50 M) was added to the dopamine solution.
Cocaine for in vivo injections was dissolved in NaCl (0.9%).
RESULTS
Long-lasting locomotor sensitization to cocaine
in mice
To induce behavioral sensitization, we paired repeated cocaine
injections with exposure of the animals to a distinct test environ-
ment. After 2 d of saline injections to habituate the animals to the
activity box, the locomotor response to a fixed dose of cocaine (15
mg/kg) increased dramatically across days of testing (Fig. 1) (day
3 distance traveled: saline, 463.5  31.1 cm, n  31; cocaine,
1329.5 111.1 cm, n 43; day 7 distance traveled: saline, 484.6
54.8 cm, n  31; cocaine, 3843.9  185.5 cm, n  43; p  0.0001).
To test whether this procedure produced long-lasting locomotor
sensitization, we administered a challenge dose of cocaine to both
saline- and cocaine-treated groups 10–14 d after the last dose of
the initial treatment regimen. Mice pretreated with cocaine
showed a much greater locomotor response to cocaine than did
saline-pretreated animals (Fig. 1) (cocaine, 4384.9  212.8 cm,
n  43; saline, 1535.3  159.1 cm, n  31; p  0.0001). These
results indicate that the initial 5 d exposure to cocaine caused
behavioral sensitization that lasted for 2 weeks.
Increased inhibition of excitatory synaptic
transmission by dopamine in sensitized mice
The NAc is commonly divided into two components, the shell
and the core, which can be distinguished both anatomically and
functionally (Zahm, 1999). Previous work found modification of
excitatory synaptic transmission after chronic cocaine treatment
in the shell but not in the core of the NAc (Thomas et al., 2001).
Therefore, all recordings were made in the NAc shell. In initial
experiments, we used whole-cell recordings to monitor AMPAR-
mediated EPSCs (AMPAR EPSCs) and applied a concentration
of DA (75 M) that reliably elicits a depression of synaptic
transmission in the NAc (Nicola et al., 1996). We found that there
was no difference between slices from saline- and cocaine-treated
mice at the end of the 10 min DA application (Fig. 2A,D)
(cocaine,26.9 4% change from initial baseline, n 12; saline,
25.8  3.7%, n  12; p  0.05). However, the effect of DA
washed out much more slowly in the cocaine group (Fig. 2A)
(between 5 and 11 min after washout: cocaine,13.7 4.8%, n
12; saline, 1.7 4%, n 12; p 0.05). Because slices are exposed
to concentrations of DA 75 M during the washout, this differ-
ence in washout rate may reflect the fact that lower concentra-
tions of DA had a greater effect in cocaine-treated mice. To test
this possibility, we applied a lower concentration of DA (20 M)
that had a minimal effect on slices from saline-treated mice (Fig.
2B–D) (3.9 4.5%, n 9). In contrast, this same concentration
of DA caused a significant depression of synaptic transmission in
slices from cocaine-treated animals (Fig. 2B–D) (19.9  4.9%,
n  10, p  0.05). These results indicate that the chronic in vivo
cocaine treatment enhanced the inhibitory actions of DA on
excitatory synaptic transmission in the NAc shell.
Synaptic actions of DA in cocaine-treated mice are
caused by D1-like receptors
DA receptors are commonly subdivided into two classes: (1)
D1-like receptors (D1 and D5) and (2) D2-like receptors (D2, D3,
and D4) (Sibley and Monsma, 1992; Civelli et al., 1993; Jarvie and
Caron, 1993). The inhibition of excitatory synaptic transmission
by DA in the NAc appears to be mediated primarily by a D1-like
receptor (Higashi et al., 1989; Pennartz et al., 1992; Nicola et al.,
1996). To address whether D1-like receptors also mediate the
synaptic actions of DA after in vivo cocaine treatment, we made
extracellular field potential recordings (fEPSPs) and tested the
ability of the specific D1 receptor antagonist SCH-23390 (10 M)
to antagonize the inhibitory actions of DA (20 M). As observed
using whole-cell recordings, the inhibition of fEPSPs by DA was
greater in slices from the cocaine treatment group (Fig. 3A)
(cocaine,17.8 2.1%, n 28; saline,5.4 2.2%, n 11; p
0.01). This depressant action of DA in the cocaine group was
significantly reduced by SCH-23390 (Fig. 3B) (first DA applica-
tion, 25.5  4.9%; second application in the presence of SCH-
23390,8.5 3.5%; n 6; p 0.05), indicating that as is the case
in untreated animals (Higashi et al., 1989; Pennartz et al., 1992;
Nicola et al., 1996), this action of DA is mediated in large part by
D1-like receptors that presynaptically depress glutamate release
(Nicola et al., 1996, 2000; Nicola and Malenka, 1997).
The enhanced inhibition of excitatory transmission by DA in
Figure 1. Repeated cocaine administration induces behavioral sensitiza-
tion. Mean  SEM acute locomotor activity in response to saline and
cocaine injections is shown. Locomotor activity was monitored for 15 min
immediately after each injection.
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the cocaine-treated group could be explained by some modifica-
tion of the D1-like DA receptors (e.g., increase in receptor
number and/or function) or by a change in the DA transporters
(DATs) that might influence the effective concentration of DA
when it is applied to the slices (e.g., decrease in DAT number
and/or function). To help distinguish between these possibilities,
we examined whether the selective DAT inhibitor GBR-12909
(300 nM) enhanced the synaptic actions of DA. If it did, it would
suggest that the level of DAT activity in our slices could limit the
effective concentration of DA. However, in saline-treated mice,
GBR-12909 (300 nM) did not significantly affect the synaptic
depression elicited by DA (30 M; n  4; data not shown). These
results indicate that DATs do not influence the effective concen-
tration of exogenous DA achieved in the slices. Therefore, it is
very unlikely that the enhanced inhibition of excitatory synaptic
transmission by DA in cocaine-treated mice is caused by a reduc-
tion in DAT number and/or function.
Lack of a postsynaptic effect of DA on
NMDAR-mediated EPSCs
It has been suggested that the inhibitory effects of D1 receptor
activation in the NAc are the consequence of a DA-induced
enhancement of NMDAR-mediated responses (Harvey and
Lacey, 1997), an action of DA that has also been reported to
occur in the dorsal striatum (Cepeda et al., 1993; Levine et al.,
1996). To determine whether DA modulation of NMDAR-
mediated responses is affected by chronic in vivo cocaine treat-
ment, we simultaneously measured the effect of DA on NMDAR-
and AMPAR-mediated EPSCs by holding the cell at 40 mV
(Fig. 4A) (see Materials and Methods). If DA, via a postsynaptic
action, potentiates NMDAR-mediated EPSCs (NMDAR EPSCs)
but not AMPAR EPSCs, then the presynaptic DA-induced de-
pression of NMDAR EPSCs should be less than that for AMPAR
EPSCs, and the ratio of AMPAR- to NMDAR-mediated synaptic
currents should decrease during DA application. If DA has no
postsynaptic effect, the AMPAR/NMDAR ratio should remain
constant throughout the experiment. In slices from saline-treated
mice, DA (75 M) depressed AMPAR- and NMDAR-mediated
responses to the same degree (Fig. 4B) (AMPAR, 33.7  7.6%;
NMDAR,44.8 5.4%; n 8; p 0.05), as reflected by the lack
of change in the AMPAR/NMDAR ratio in the presence of DA
(Fig. 4E) (control, 2.9  0.56; DA, 3.31  0.69; n  8; p  0.05).
We then repeated the same experiments in cocaine-treated mice
to see whether this might reveal an effect of DA on NMDAR-
mediated responses. Again, the depressant action of DA on
AMPAR- and NMDAR-mediated EPSCs was not significantly
different (Fig. 4B) (AMPAR, 28.5  5.4%; NMDAR, 38.1 
3.6%; n 15; p 0.05), and no change in the AMPAR/NMDAR
ratio was induced by DA (Fig. 4E) (control, 3.25  0.47; DA,
3.68  0.53; n  15; p  0.05).
Although the previous work in the NAc also used standard
whole-cell recording techniques (Harvey and Lacey, 1997), we
were concerned that the lack of effect of DA on NMDAR EPSCs
may be caused by dialysis, so-called washout of some intracellular
components that are necessary for the postsynaptic effects of DA.
Figure 2. Chronic cocaine treatment
enhances inhibitory actions of DA on
AMPAR EPSCs. A, Summary graph of
the effects of DA (75 M) in saline (n 12
cells, 8 mice) and cocaine-treated (n 12
cells, 9 mice) mice. B, Sample experi-
ments from saline (top) and cocaine-
treated (bottom) mice displaying the ef-
fect of 20 M DA. Sample traces were
collected at the times indicated on the
graph. Calibration: top, 50 msec, 100 pA;
bottom, 50 msec, 200 pA. C, Summary
graph of the effects of DA (20 M) in
saline (n  9 cells, 7 mice) and cocaine-
treated (n  10 cells, 5 mice) mice. D,
Magnitude of inhibition of AM PAR
EPSCs by DA in saline and cocaine-
treated mice (*p  0.05).
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Therefore, we repeated the same experiment in slices from con-
trol mice using perforated-patch recording techniques. Again, the
inhibition of AMPAR- and NMDAR-mediated EPSCs induced
by DA (100 M) was similar (Fig. 4C) (AMPAR, 26.8  12.6%;
NMDAR, 19.7  16.3%; n  5; p  0.05), and, thus, there was
no effect on the AMPAR/NMDAR ratio (Fig. 4E) (control,
2.18  0.2; DA, 2.16  0.29; n  5; p  0.05). In a final attempt
to determine whether DA potentiates NMDAR EPSCs, we
tested its effects in the dorsal striatum, an area of the brain in
which DA does not have a presynaptic action (Calabresi et al.,
1987, 1995; Nicola and Malenka, 1998). Consistent with these
previous results, DA (30–75 M) did not affect AMPAR EPSCs
(Fig. 4 D) (5.5  3.8%; n  4). However, it also did not affect
NMDAR EPSCs (Fig. 4 D) (5.9  2.9%; n  4) or the
AMPAR/NMDAR ratio (Fig. 4 E) (control, 1.73  0.35; DA,
1.77  0.42; n  4; p  0.05). Thus, we were unable to observe
any postsynaptic effect of DA on NMDAR-mediated synaptic
responses in either the NAc or the dorsal striatum.
DISCUSSION
A prominent rodent model for some key features of addiction
is the long-lasting increase in the acute drug-induced locomo-
tor response after repeated exposure to psychostimulants
(Robinson and Berridge, 1993; Wolf, 1998; Vanderschuren and
Kalivas, 2000). This increased response, termed behavioral
sensitization, is thought to reflect modifications in the me-
solimbic DA system, especially in dopaminergic and glutama-
tergic synaptic transmission (Wolf, 1998; Vanderschuren and
Kalivas, 2000). In a previous study, we examined basal excita-
tory synaptic transmission in the NAc during behavioral sen-
sitization and found that chronic in vivo cocaine exposure
caused a long-lasting depression of synaptic strength in the
NAc shell (Thomas et al., 2001). Here, we examine whether
this same treatment protocol affects the modulation of excita-
tory synaptic transmission by DA. This is of particular interest
because chronic psychostimulant administration appears to
enhance DA release in the NAc in response to subsequent
challenge injections of drug, an effect that is observed even
after relatively long periods of abstinence after the initial
psychostimulant administration (Robinson et al., 1988; Kalivas
and Duffy, 1993; Pierce and Kalivas, 1995; White and Kalivas,
1998).
We find that the presynaptic inhibitory action of DA is en-
hanced in cocaine-sensitized animals, and that this effect is me-
diated by a D1-like receptor, as found previously in control
animals (Pennartz et al., 1992; Nicola et al., 1996; but see
O’Donnell and Grace, 1994). The lack of effect of GBR-12909, a
DAT inhibitor, on the synaptic action of DA indicates that en-
hancement of the presynaptic effect of DA is probably not attrib-
utable to some downregulation of DAT activity. Instead, the
change appears to be caused by a modification in the number
and/or function of the presynaptic D1-like receptors. Consistent
with this hypothesis is the finding that chronic cocaine adminis-
tration increases the inhibitory action of D1 agonists on the
single-unit responses of NAc neurons (Henry and White, 1991),
and that an enhancement of the presynaptic effects of DA has also
been reported after chronic treatment with methamphetamine
(Higashi et al., 1989).
Because DA has been reported to enhance NMDAR-
mediated responses in both the NAc (Harvey and Lacey, 1997)
and the dorsal striatum (Cepeda et al., 1993; Levine et al.,
1996), we also examined whether this action of DA is modified
by chronic in vivo cocaine exposure. Surprisingly, however, we
saw no effect of DA on NMDAR EPSCs in either control or
sensitized mice, even when perforated-patch recording tech-
niques were used. Furthermore, we saw no effect of DA on
AMPAR or NMDAR EPSCs in the dorsal striatum. In addi-
tion to species differences (mice vs rats), one important differ-
ence between our experiments and previous ones is that we
monitored the NMDAR EPSC at 40 mV, a holding potential
at which all voltage-dependent conductances are inactivated. If
the enhancement of NMDAR-mediated responses observed in
previous work was caused by a modulation of such conduc-
tances by DA, under our recording conditions, we would not
expect to see any effect. Indeed, DA modulates a number of
different voltage-dependent conductances in striatal cells
(Nicola et al., 2000), and blockade of L-type Ca 2 channels
eliminates the DA-induced enhancement of NMDAR-
mediated responses in dorsal striatal cells (Cepeda et al.,
1998). Therefore, we conclude that DA does not directly mod-
ulate NMDAR function in medium spiny neurons in either the
NAc or dorsal striatum, although via modulation of voltage-
dependent conductances, DA may have important indirect
effects on NMDAR-mediated currents. Because we did not
examine and compare isolated NMDAR EPSCs, we cannot
state whether the cocaine exposure modified the properties of
NMDARs, as has been observed with chronic morphine treat-
ment (Martin et al., 1999); e.g., dramatic cocaine-induced
changes in the kinetics of the AMPAR EPSC or NMDAR
Figure 3. The DA-induced depression of excitatory synaptic transmis-
sion in cocaine-treated mice is mediated by D1-like receptors. A, Sum-
mary graph showing effects of DA (20 M) on field EPSPs in saline (n 
11 slices, 8 mice) and cocaine-treated (n  28 slices, 20 mice) mice.
Sample traces were collected at the times indicated on the graph. Cali-
bration: 4 msec, 0.1 mV. B, Summary of experiments in which DA (20 M)
was applied to slices from cocaine-treated mice first in the absence and
then in the presence of SCH-23390 (10 M; n  6 slices, 6 mice). fEPSP
amplitudes were renormalized when SCH-23390 was applied to minimize
possible effects of experimental drift.
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EPSC might obscure a direct postsynaptic effect of DA on
NMDAR EPSCs. It is also conceivable that the strong depo-
larization of the cells caused them to release some substance
that obscured this effect of DA. However, to account for our
results, such an action must have lasted 10 min, because we
routinely obtained a minimum of a 10 min baseline before
applying DA.
The functional significance of the enhancement of the inhibi-
tory synaptic actions of DA in the NAc shell after chronic in vivo
cocaine exposure remains to be determined. We would suggest it
is likely one of a number of modifications of synaptic and cellular
function in the NAc contributing to behavioral sensitization.
Interestingly, many of the reported effects of chronic in vivo
cocaine exposure would be expected to decrease net excitatory
drive to medium spiny neurons (Henry and White, 1991; White et
al., 1995; White and Kalivas, 1998; Wolf, 1998; Thomas et al.,
2001), an action that might sensitize the rewarding or incentive
value of drugs of abuse (Wise, 1998; Robinson and Berridge,
2000).
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Cellular and Behavioral Outcomes of Dorsal Striatonigral
Neuron Ablation: New Insights into Striatal Functions
Delphine Re´vy1,5, Florence Jaouen1,5, Pascal Salin1, Christophe Melon1, Dorian Chabbert1,
Elisiana Tafi2, Lena Concetta2, Francina Langa3, Marianne Amalric4, Lydia Kerkerian-Le Goff1,
He´le`ne Marie2,6 and Corinne Beurrier*,1
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(CNRS), UMR 7288, Marseille Cedex 9, France; 2The European Brain Research Institute, Roma, Italy; 3Institut Pasteur, Mouse Genetics
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The striatum is the input structure of the basal ganglia network that contains heterogeneous neuronal populations, including two
populations of projecting neurons called the medium spiny neurons (MSNs), and different types of interneurons. We developed a
transgenic mouse model enabling inducible ablation of the striatonigral MSNs constituting the direct pathway by expressing the human
diphtheria toxin (DT) receptor under the control of the Slc35d3 gene promoter, a gene enriched in striatonigral MSNs. DT injection into
the striatum triggered selective elimination of the majority of striatonigral MSNs. DT-mediated ablation of striatonigral MSNs caused
selective loss of cholinergic interneurons in the dorsal striatum but not in the ventral striatum (nucleus accumbens), suggesting a region-
specific critical role of the direct pathway in striatal cholinergic neuron homeostasis. Mice with DT injection into the dorsal striatum
showed altered basal and cocaine-induced locomotion and dramatic reduction of L-DOPA-induced dyskinesia in the parkinsonian
condition. In addition, these mice exhibited reduced anxiety, revealing a role of the dorsal striatum in the modulation of behaviors
involving an emotional component, behaviors generally associated with limbic structures. Altogether, these results highlight the
implication of the direct striatonigral pathway in the regulation of heterogeneous functions from cell survival to regulation of motor and
emotion-associated behaviors.
Neuropsychopharmacology advance online publication, 9 July 2014; doi:10.1038/npp.2014.121
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INTRODUCTION
The basal ganglia (BG) are key neural substrates that control
motor and reward-associated behaviors. Their dysfunction
is associated with several disorders, including Parkinson’s
disease (PD), schizophrenia, and drug addiction (Cenci,
2007; Graybiel, 2000; Lobo and Nestler, 2011). As the main
BG input, the striatum is thought to be an important site for
mediating many of the maladaptive processes responsible
for these devastating neurological disorders.
The striatum is classically delineated into dorsal (dorsal
striatum) and ventral (nucleus accumbens) territories,
involved in cognitive/motor and emotional/motivational
functions, respectively. However, interconnections and
other crosstalk, in particular involving the dopamine
systems, provide an anatomical basis for a multifunctional
interface (Haber et al, 2000). The dorsal striatum receives
heavy dopaminergic input from the substantia nigra pars
compacta (SNc), and dysfunction of dopamine signaling is
implicated in almost all BG-associated disorders. The major
striatal targets of dopamine afferents are the GABAergic
medium spiny neurons (MSNs) which constitute 95% of
the striatal population. The remaining neurons, comprising
approximately 5% of the total number of striatal neurons,
are made up of different subtypes of GABAergic interneur-
ons and of cholinergic interneurons. Despite being few in
number, cholinergic interneurons are crucial for the tuning
of striatal output owing to their dense terminal fields
primarily directed to the two populations of MSNs that
overlap those of dopaminergic neurons (Bolam et al, 1984).
The two types of MSNs are distinguished depending on
their projections and expression of distinct set of proteins.
MSNs that project primarily to the substantia nigra pars
reticulata (SNr), so-called direct-pathway or striatonigral
MSNs, express the dopamine D1 receptor, substance P (SP)
and dynorphin, whereas MSNs that project to the globus
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pallidus (GP), so-called indirect or striatopallidal MSNs,
express the dopamine D2 receptor and enkephalin (Enk)
(Gerfen et al, 1990; Smith et al, 1998). Because of the
differential expression of dopamine receptors, the striatoni-
gral and striatopallidal MSNs are thought to have opposing
but balancing roles on BG output and behaviors (Albin et al,
1989; DeLong, 1990).
Recent advances in cell-type-specific technologies have
provided a wealth of data allowing a more comprehensive
understanding of MSNs roles in drug addiction (Durieux
et al, 2009; Durieux et al, 2012; Ferguson et al, 2011;
Lobo et al, 2010), cognitive functions (Hikida et al, 2010;
Hikida et al, 2013; Nishizawa et al, 2012; Tai et al, 2012;
Yawata et al, 2012), and parkinsonian physiopathology
(Kravitz et al, 2010). Here, we developed a new inducible
model of diphtheria toxin (DT) receptor-mediated
ablation to further explore the functional implications of
striatonigral MSNs of the dorsal striatum. For behavioral
characterization, we first focused on motor function linked
to disturbed striatal dopamine tone, cocaine-induced
locomotion, and L-DOPA-induced dyskinesia (LID), which
are associated with selective and robust molecular changes
in striatonigral MSNs, including ERK signaling (Bertran-
Gonzalez et al, 2008; Santini et al, 2009). Acute response to
psychostimulant has been investigated using amphetamine
in a model of striatonigral MSNs ablation restricted to
subterritories of the dorsal striatum (Durieux et al, 2012),
and direct demonstration of dorsal striatonigral MSNs
involvement in LID, a major complication of the most
common pharmacotherapy of PD, is still lacking. We
next moved to non-motor function as accumulating
evidence suggests that, in addition to sensorimotor infor-
mation processing, the dorsal striatum might also mediate
emotional/motivational functions classically ascribed to
the ventral striatum (Balleine et al, 2007). We focused
on anxiety behavior, notably because SP and dynorphin,
two molecules released by striatonigral MSNs, have
been implicated in the regulation of anxiety (Ebner and
Singewald, 2006; Van’t Veer and Carlezon, 2013).
The results show that ablation of striatonigral MSNs
impacts heterogeneous functions from motor- and emo-
tional-associated behaviors to region-specific regulation of
cholinergic homeostasis.
MATERIALS AND METHODS
Generation of Transgenic Mice
The human Diphtheria Toxin Receptor-green fluorescent
protein (DTR-GFP) cDNA was inserted in front of the
endogenous ATG in exon 1 of the Slc35d3 gene in a 196-
kilobase mouse bacterial artificial chromosome (BAC)
(RP23-344M6) by homologous recombination using the
recombineering plasmid pL451. DNA from the modified
BAC was purified and microinjected into pronuclei of
fertilized mouse eggs (B65JL/F1) to generate transgenic
founders (Mouse Genetics Engineering Center, Institut
Pasteur). A total of five transgene-positive founders were
obtained and were bred with C57Bl/6 mice. Offspring
consisted of an equal number of DTR-expressing mice
(DTRþ ) and of DTR non-expressing mice (DTR ).
Stereotaxic Injections
All animal experimental procedures were carried out in
strict accordance with local rules concerning the use of
laboratory animals (authorization no.B 13-464) and with the
recommendations of the EEC (2010/63/UE) for care and
use of laboratory animals and conformed to the ethical
guidelines of the French Ministry of Agriculture and Forests
(Animal Health and Protection Veterinary Service).
Surgery was performed on 8–12 week-old mice under
xylazine/ketamine anesthesia (intraperitoneal injections,
10 and 100mg/kg, respectively). All stereotaxic coordinates
are listed in Supplementary Table S1. DT, (Calbiochem,
Darmstadt, Germany) was diluted to a concentration
of 0.5 ng/ml, and 1 ml was injected at two sites either
into the dorsal striatum or into the nucleus accumbens.
For retrograde tracing, 1 ml of fluorescent microbeads
(Life Technologies, Saint-Aubin, France) were injected
into the SNr. For dopaminergic lesion, mice received one
unilateral injection (1.5 ml) of 6-hydroxydopamine hydro-
chloride (6-OHDA; 2.7mg/ml; diluted in 0.9% sterile NaCl
containing 0.1% ascorbic acid; Sigma-Aldrich, St Quentin-
Fallavier, France) into the SNc.
Quantitative In Situ Hybridization and Dopamine
Transporter Autoradiography
Radioactive in situ hybridization histochemistry was
performed as described previously (Salin et al, 2002).
Probes were 44–56 mer synthetic oligonucleotides selected
on the basis of the sequence of Tac1 (which encodes SP;
hereafter called SP), Penk (which encodes Enk; hereafter
called Enk), GAD 67, and tyrosine hydroxylase (TH) and
were 30-end-labeled by terminal deoxynucleotide trans-
ferase with 35S-dATP. 3H-mazindol was used as a ligand to
label dopamine transporter sites. Briefly, after appropriate
washes, sections were incubated with 15 nM [3H]-mazindol
(DuPont NEN Research Products, Boston, MA; specific
activity, 17 Ci/mmol) in a Tris buffer containing 0.3mM
desipramine to block the noradrenalin uptake sites.
Quantitative RT-PCR
The uninjected and injected dorsal striatum of three DTRþ
mice injected with DT into the dorsal striatum were
punched separately. Specific primers for the different genes
of interest were designed using the Universal ProbeLibrary
(ProbeFinder version 2.5 for mouse, Roche Diagnostics)
and chosen intron-spanning when possible (Supplementary
Table S2). Total RNA (170 ng) was reverse transcribed for
5min at 25 1C, 30min at 42 1C and 5min at 85 1C using
iScript Reverse Transcription Supermix for RT-qPCR (BIO-
RAD). A Bio-Rad CFX96 cycler was used with the following
cycling parameters: 1 cycle at 95 1C for 8min, 40 cycles at
95 1C for 15 s followed by 60 1C for 1min. Samples were run
in three replicates for each gene. Relative target gene
concentration was calculated using the 2DDCt method
(Livak and Schmittgen, 2001), which uses normalization to
b-actin endogenous reference gene (as described in Lobo
et al, 2006) and normalization to calibrator sample (here,
uninjected dorsal striatum side).
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Dual Fluorescence In Situ Hybridization
Two-color fluorescent in situ hybridization was performed
with a mixture of fluorescein-labeled antisense riboprobe for
ChAT or SP and a digoxigenin-labeled riboprobe for DTR.
After appropriate pretreatments, sections were incubated
at 65 1C overnight in the hybridization mix containing
400 ng/ml of both probes. After posthybridization washes,
sections were incubated for 5 h with anti-Fluorescein-POD
(HRP) (1/300) (Roche-Applied Science), and the fluorescein
probe was visualized in green with fluorescein-tyramide
reagent (TSA Plus PerkinElmer Life Sciences). After
inactivating the HRP conjugate of the anti-Fluorescein-
POD antibody (3% H2O2), the digoxigenin probe was then
visualized in red with anti-digoxigenin-POD antibody
(1/300) followed by cyanine-3-tyramide reagent.
Immunohistochemistry
Mice were perfused transcardially with ice-cold 4% paraf-
ormaldehyde in 0.1M phosphate-buffered saline (PBS, pH
7.4). After overnight postfixation, brains were protected in a
PBS solution containing 30% sucrose and frozen. Cryostat
sections (40mm) were incubated overnight at 4 1C with
primary antibodies and then incubated with the appropriate
secondary antibodies (Supplementary Table S3).
Data Analysis
Analysis of DT-mediated effects in the striatum was per-
formed on 4–6 coronal sections per animal extending from
AP¼ þ 1.54 to 0.14 relative to bregma according to the
mouse stereotaxic brain atlas of Paxinos and Franklin
(Second edition, 2001).
Single-Cell RT-PCR
Coronal striatal slices (250mm) from DTRþ mice were
prepared and recorded as previously described (Beurrier
et al, 2009). After cell-attached and whole-cell recordings,
the cell content was aspirated, expelled into a test tube where
the RT reaction was performed overnight at 40 1C. The
single-cell RT-PCR protocol used here was adapted from
Lena et al (1999) to simultaneously detect the expression of
DTR-GFP and ChAT mRNAs. Genomic DNA amplification
was systematically assessed using a NMDA receptor gene
intron (NR1 subunit, GRIN1) as genomic control (Supple-
mentary Table S4). The cDNAs were first amplified by 20
PCR cycles (94 1C, 1min; 60 1C, 1min; 72 1C, 1min) using
5U of Taq polymerase (Qiagen, Hilden, Germany), and
10 pmol of different sets of primers (Supplementary Table
S3) were added (final volume, 100ml). Second rounds of PCR
(40 cycles as described above) were then performed using
6ml of the first PCR product as a template (final volume
50ml). Each cDNA was amplified individually using its
specific primer generating PCR fragments of 406, 323 and
162 bp for DTR-GFP, ChAT and GRIN1 introns, respectively.
Behavioral Tests
Mice were group-housed (2–5 mice/cage) and maintained
on a 12 : 12-h light–dark cycle (0700 hours lights on) with
ad libitum food and water available.
Locomotor activity. Locomotor activity was monitored in
individual activity chambers (11.2 cm 20.7 cm) housed
within a sound-attenuating cubicle and under homogenous
light illumination (Imetronic, Pessac, France). Each cham-
ber was equipped with four infrared photobeams located
1.5 cm above floor level, two at the rear and two at the front
of the chamber. Mice were given i.p. injections of saline
(0.9% NaCl) for the first 3 testing days to habituate them to
the injections, handling, and activity chambers. On the
fourth day, mice of each genotype were divided into two
groups receiving either i.p. injections of saline (0.9% NaCl)
or cocaine hydrochloride (5 or 15mg/kg; Sigma-Aldrich).
Locomotor activity was monitored immediately afterwards
for 60min. The number of beam breaks was recorded in
5-min bins.
L-DOPA-induced dyskinesia. Mice received unilateral DT
injection into the dorsal striatum ipsilateral to the 6-OHDA-
injected side. Fifteen days later, they received a single daily
injection of L-DOPA (20mg/kg) and benserazide hydro-
chloride (10mg/kg) for 21 days. The abnormal involuntary
movements (AIMs) were assessed by two investigators blind
of subject genotype for 1min every 20min from 20 to
120min after the last injection on day 21. Axial, limb, and
orolingual AIMs were scored using a previously established
scale from 0 to 4 for each AIM subtype (Lundblad et al,
2004), and the sum of the three scores, defined as dyskinesia
score, was determined for each animal (maximal score, 12).
Locomotive AIM was expressed as the number of contral-
ateral rotations per minute for each animal.
Open field. The open-field chamber (50 50 cm2 with
a 30 cm-high white plastic wall) was virtually divided into
a central field (center, 25 25 cm2) and an outer field
(periphery). The open-field test consisted of a 5-min session
and was conducted under dim lighting conditions (12 Lux).
Individual mice were placed in the center of the field, and
the paths of the animals were recorded by a video camera.
The distance traveled in the different zones was analyzed by
a video-tracking software (Viewpoint Life Sciences, Lyon,
France).
Elevated plus maze. The apparatus is elevated 50 cm
above the floor and consisted of four arms (6 cm 37 cm),
two enclosed by 18 cm-high white plastic walls and two
open. Light intensity was 12 Lux in open arms and 4 Lux in
closed arms. Each trial began with the placement of the
mouse in the maze center, facing an open arm. The paths
of the animals were recorded for 5min by a video camera.
The distance traveled and the numbers of entries in the
open and closed arms were quantified by a video-tracking
software (Viewpoint Life Sciences). Mice were tested in the
levated plus maze 1 day after the open-field test.
Statistical Analysis
Data are presented as mean±SEM. Statistical analyses
(SigmaStat, v3.1) were performed using the unpaired
Student’s t-test. A nonparametric test (test of Mann–
Whitney) was used if the normality or equal variance test
failed. Two-way repeated-measured ANOVA followed by
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Holm–Sidak post tests was used for analyzing time profiles
of AIM scores. A significance of po0.05 was required for
rejection of the null hypothesis.
RESULTS
Generation of Slc35d3DTR-GFP Transgenic Mice
To ablate striatonigral MSNs, we used the human DTR, the
activation of which by DT induces cell apoptosis. We first
checked the ability of the fusion DTR-GFP construct to
induce cell death in vitro. In wild-type cultured hippocam-
pal neurons expressing DTR-GFP fusion, administration
of DT triggered apoptosis of GFP-positive cells (Supple-
mentary Figure S1A). To specifically ablate striatonigral
MSNs, we chose to drive the expression of the DTR-GFP
construct under the control of a highly enriched striatoni-
gral MSNs gene, Slc35d3 (Heiman et al, 2008; Lobo et al,
2006), using the BAC-based strategy (Supplementary
Figure S1B). Transgenic mice were generated by injecting
the recombined BAC into the pronuclei of hybrid C57Bl/
6CB1 F1 fertilized oocytes, which were then implanted
into pseudopregnant females. The five Slc35d3DTR-GFP
transgenic founders obtained (hereafter named DTR mice)
were outbred with C57Bl/6 mice. One founder did not breed
correctly and was discarded from the study. In the four
remaining lines, GFP-positive cells were detected in the
striatum of DTRþ mice (Supplementary Figure S1C) with a
virtually indistinguishable expression pattern. Intrastriatal
DTR-GFP protein levels assessed by western blotting were
also similar in all the four lines (data not shown). We next
determined in which cell type DTR-GFP was expressed.
Retrograde fluorescent microbeads were injected into the
SNr (Figure 1a), a main target of striatonigral MSNs. The
colocalization of GFP-positive soma in the striatum with
microbeads confirmed the expression of DTR-GFP by
striatonigral MSNs (Figure 1a). The drastic reduction in
GFP fluorescence after DT injection into the dorsal striatum
of DTRþ mice indicated an efficient ablation of DTR-GFP-
positive cells in vivo (Figure 1b). The decrease in GFP
fluorescence was observed in the rostro-caudal extent of the
dorsal striatum while the ventral part (nucleus accumbens)
was preserved (Supplementary Figure S2A). Time course
analysis showed that the decrease in GFP fluorescence was
progressive from day 1 to day 7; over day 7, the ablation was
maximal and did not evolve anymore (Supplementary
Figure S2B). All the following experiments were performed
around 15 days after DT injection after stabilization of the
ablation.
Ablation of Striatonigral MSNs by DT Injection
To test the specificity of striatonigral MSNs ablation, we
analyzed markers of the different striatal populations using
in situ hybridization, RT-qPCR, or immunohistochemistry
15 days after unilateral intrastriatal DT injection into the
dorsal striatum. None of the markers examined was altered
in the DT-injected side vs uninjected side in DTR mice.
DTRþ mice showed strongly reduced SP mRNA, a specific
marker of striatonigral MSNs, while Enk mRNA, a specific
marker of striatopallidal MSNs, was unchanged (Figure 1c
and d). Among the four lines, line 4 was selected for
subsequent experiments, because it showed the highest
decrease of SP mRNA ( 66.3% vs uninjected side,
po0.001). RT-qPCR analysis confirmed the significant
reduction of SP ( 0.59-fold vs uninjected side, po0.01)
and also showed a pronounced decrease in the expression of
dopamine D1 receptor (Drd1a:  0.76-fold vs uninjected
side, po0.001), another gene specifically expressed
by striatonigral MSNs. In contrast, three genes enriched in
striatopallidal MSNs (dopamine D2 receptor Drd2, Enk and
Adenosine A2A receptor Adora2a) were not affected by
DT injection, confirming the specificity of the ablation
(Figure 1e). The levels of cAMP-regulated phosphoprotein-
32 (DARPP-32), a protein expressed in both populations
of MSNs, were also significantly reduced by 39.2% (data not
shown).
Knowing that MSNs project to the SNc (Gerfen, 1984), we
examined THmRNA levels in the SNc of DT-injected DTRþ
mice and found that it was not altered by striatonigral MSNs
ablation (data not shown). We then sought to determine
the effect of intrastriatal DT on the two main targets of
striatonigral and striatopallidal MSNs, the GABAergic
neurons of the SNr and GP, respectively. We examined
intraneuronal mRNA levels of the GABA synthesis enzyme
GAD67 as an indirect index of GABA neuron activity.
GAD67 mRNA expression was increased in the SNr of
DTRþ mice (þ 18.2% vs uninjected side, po0.05), consis-
tent with overactivity of this structure due to removal
of the inhibitory control exerted by striatonigral MSNs
(Figure 1f). In contrast, there was no change in GAD67
mRNA expression in the GP. Altogether, these data
demonstrate that the DTRþ transgenic mice are a reliable
and effective model to specifically ablate striatonigral vs
striatopallidal MSNs and that this ablation has a functional
impact on BG output.
The striatum contains three categories of GABAergic
interneurons with specific cytochemical markers, parvalbu-
min, calretinin, or neuropeptide Y/NADPH-diaphorase, and
one population of cholinergic interneurons expressing
choline acetyltransferase (ChAT) (Kawaguchi, 1993). The
density of neurons stained for parvalbumin, calretinin,
or NADPH-diaphorase was unaffected by DT injection,
whereas the density of ChAT-expressing neurons was
decreased by 42.7% (po0.01; Figure 2). To exclude down-
regulation of ChAT expression, we examined the effect of
DT on another protein also specifically expressed by striatal
cholinergic interneurons, the type A tyrosine kinase
receptor (TrkA) (Holtzman et al, 1992). The density of
TrkA-positive cells in the DT-injected side of DTRþ mice
was decreased to a similar level than ChAT-positive cells
( 41.2% vs uninjected side, po0.01; Figure 2). In
DTR mice, DT injection did not affect ChAT-positive
cells’ density (uninjected side: 44.20±4.11, injected side:
43.01±3.25, n¼ 4 DTR , p¼ 0.83), excluding a peculiar
sensitivity of this population to DT compared with other
striatal populations.
How one can explain the loss of cholinergic interneurons?
Two possibilities: (1) DT injection mediates direct ablation
of ChAT-positive neurons; and (2) loss of striatonigral
MSNs in the dorsal striatum indirectly interferes with
the survival of cholinergic interneurons. To distinguish
between these two possibilities, we performed a series of
control experiments. Using double staining experiments, we
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performed a thorough examination of DTR expression in
cholinergic interneurons. We found no colocalization
between GFP and ChAT proteins in the striatum of DTRþ
mice (Figure 3a). Using double in situ hybridization, we
found no expression overlap between ChAT and DTR,
whereas all SP-expressing cells were DTR positive
Figure 1 Selective expression of DTR-GFP in striatonigral neurons and impact of DT injection. (a) Left: injection site of fluorescent microbeads indicated by
the arrow in the SNr. Scale bar, 200mm. SNr: substantia nigra pars reticulata. Right: combined immunofluorescence detection of GFP-expressing striatal
neurons and retrograde labeling of striatonigral MSNs 7 days after injection of fluorescent microbeads into the SNr of DTRþ mice. The microbeads
colocalized with GFP. Scale bar, 10mm. (b) Striatal GFP immunodetection on a DTRþ coronal brain section 7 days after unilateral DT injection into the
striatum showing the loss of GFP expression in the injected side (left) compared with the uninjected side (right). Scale bars, top: 500mm and bottom: 20mm.
Cx: cortex, St: striatum, V: ventricle. (c, d) Radioactive in situ hybridizations and quantification of striatal SP (c) and Enk (d) mRNA levels 15 days after unilateral
DT injections into the striatum of DTR (n¼ 6) and DTRþ (n¼ 10) mice. Arrows indicate the injected side. Scale bar, 1mm. Data are reported as optical
density values and expressed as percentage±SEM. Student’s t-test: ***po0.001 vs uninjected side. (e) Quantitative RT-qPCR for genes specifically expressed
in striatonigral (SP, Drd1a) or in striatopallidal MSNs (Enk, Drd2, Adora2a). Three DTRþ mice were unilaterally injected with DT into the dorsal striatum, and
the total RNA samples from this area were collected in the injected and uninjected side. Results were calculated for each sample relative to the expression of
the endogenous reference gene, b-actin, and fold change was determined using the 2DDCt method. Student’s t-test: **po0.01, ***po0.001 vs uninjected
side. (f) Photomicrographs taken under dark-field epi-illumination illustrating intraneuronal GAD 67 mRNA levels in the SNr and GPe of DTRþ mice, 15 days
after DT injections. Scale bar, 100mm. Quantitative analysis of the number of silver grains per neurons in the SNr (left) (n¼ 5 DTR and 5 DTRþ ) and
GPe (right) (n¼ 5 DTR and 6 DTRþ ). Data are expressed as percentage±SEM. Student’s t-test: *po0.05 vs uninjected side.
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(Figure 3b). To further confirm the lack of expression
of DTR in cholinergic interneurons, we used single-cell
RT-PCR. MSNs and cholinergic interneurons were identi-
fied by their distinctive morphological features and firing
patterns recorded in cell-attached mode: MSNs have small
soma and do not fire action potentials, whereas cholinergic
interneurons have large soma and are the only striatal cells
in slices that discharge spontaneously. ChAT mRNA
was never detected in neurons expressing DTR (n¼ 9),
and DTR mRNA was never detected in the neurons
expressing ChAT (n¼ 8) (Figure 3c). Altogether, these
results demonstrate that the loss of cholinergic interneurons
is not due to a direct effect of the toxin but is rather an
indirect consequence of striatonigral MSNs ablation. This
hypothesis is further strengthened by the time course
analysis of cell loss we performed from 1 up to 22 days post-
DT injection. We found that the loss of ChAT-positive cells
was positively correlated to the loss of GFP fluorescence
(reflecting MSNs ablation) and that a critical threshold of
striatonigral MSNs ablation (440%) is required to impact
cholinergic interneurons’ viability (Figure 3d). Finally, as
the nucleus accumbens is very similar to the dorsal striatum
in terms of cellular composition, we examined the effect of a
full ablation of striatonigral MSNs by injecting DT into both
regions in the same mouse. Cholinergic interneurons in
the dorsal striatum were significantly decreased (po0.001)
while those located in the nucleus accumbens were not
affected (p¼ 0.12), showing that cholinergic interneurons
dependence on striatonigral MSNs is territory specific
(Figure 3e).
Behavioral Characterization
Behavioral experiments were conducted on G3 mice 15±3
days after intrastriatal DT injection in the dorsal striatum.
Injections were made bilaterally except for LID (unilateral
injection in the dopamine lesioned side). Animals included
in the behavioral analyses were selected a posteriori based
on marked reduction of SP mRNAs determined by in situ
hybridization in the dorsal striatum ( 63.27±2.78%,
n¼ 27 DTRþ mice, po0.001). In addition, we also quanti-
fied the level of SP mRNAs in the nucleus accumbens in
animals used in the open-field and elevated plus maze tests
and found no significant change ( 11.10±4.91%, n¼ 10
DTRþ mice, p¼ 0.07). Performances of DTRþ mice were
compared with their control DTR littermates.
Basal and cocaine-induced locomotion is altered in
DT-injected DTRþ mice. The dorsal striatum is involved
in the regulation of motor activity and motor response to
psychostimulants. We therefore examined basal locomotor
activity and drug-induced locomotion after cocaine
injection, a drug of abuse that increases locomotion by
potentiating dopamine signaling. DTRþ mice exhibited
significantly reduced basal locomotion during the 60-min
test duration compared with DTR mice (po0.05)
(Figure 4a). When acutely challenged with 15mg/kg cocaine,
both DTR and DTRþ mice showed an increased activity
compared with their respective saline-injected group (DTR
cocaine: þ 134.90% vs DTR saline, po0.001; DTRþ
cocaine: þ 302.24% vs DTRþ saline, po0.001) (Figure 4a).
To be unbiased by the hypolocomotion of DTRþ mice, the
cocaine-induced locomotor activity was normalized for each
genotype to the respective basal activity recorded in saline-
injected mice. The locomotor response to cocaine observed
in DTRþ mice greatly exceeded the one observed in DTR
mice (þ 71.83% vs DTR mice, po0.01). To further confirm
the hypersensitivity of DTRþ mice to cocaine, we tested the
effect of a lower dose of cocaine in another two groups of
mice. A similar enhancement of the locomotor response to
cocaine 5mg/kg was found in DTRþ mice (þ 72.90% vs
DTR mice, po0.05; Figure 4b).
L-DOPA induced dyskinesia are strongly reduced in
DT-injected DTRþ mice. Dyskinesia is a common
complication of L-DOPA pharmacotherapy in PD, affect-
ing a large majority of patients within a few years from
treatment onset. LID are associated with biochemical
Figure 2 Consequences of striatonigral neuron ablation on striatal
interneurons. (a) Coronal sections from DTRþ mice unilaterally injected
with DT were stained 15 days after injections for specific markers of
GABAergic interneuron subpopulations (parvalbumin, PV; NADPH dia-
phorase to identify NPY interneurons, calretinin, CR) and for two markers
of cholinergic interneurons (choline acetyltransferase, ChAT; type A
tyrosine kinase receptor, TrKA). Scale bars, 50 mm. (b) Quantitative
analyses illustrate the density of positive cells in the injected and uninjected
sides (n¼ 4 DTRþ ). Data are expressed as mean±SEM. Student’s t-test:
**po0.01 vs uninjected side.
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alterations of the striatonigral pathway. We therefore
examined whether LID expression was affected in DT-
injected DTRþ compared with DTR mice rendered hemi-
parkinsonian by unilateral intranigral injection of 6-OHDA
(Figure 5a). Strong and equivalent dopaminergic denerva-
tion of the striatum ipsilateral to the lesioned side
was measured in both DTR ( 95.5% vs uninjected
side, po0.001) and DTRþ ( 94.9% vs uninjected side,
po0.001) mice (Figure 5b). After a chronic 21 days of treat-
ment with L-DOPA, DTR mice exhibited robust AIMs,
which were strongly reduced in DTRþ mice both for
dyskinesia ( 67.1%, po0.001) and contralateral rotations
( 78.4%, po0.001) (Figure 5c). The reduction of
AIMs was observed at every time points over the 120-min
scoring period following the last L-DOPA injection
(repeated-measures ANOVA: genotype effect, F(1,26)
¼ 22.32, po0.001; time effect, F(5,130)¼ 50.21, po0.001;
genotype time interaction, F(5,130)¼ 18.51, po0.001;
Figure 5d). These results provide direct evidence that
striatonigral MSNs ablation can inhibit the expression of
LID.
DT-injected DTRþ mice show anxiolytic behavior. The
limbic-related connections of the dorsal striatum raise the
possibility of its involvement in emotional processing.
To test this hypothesis, we assessed our transgenic mice
in behavioral paradigms involving an anxiety component:
the open field and the elevated plus maze. Mice display
anxiety-related behaviors in open spaces; therefore,
increased time spent in the central zone of the open field
or in the open arms of the elevated plus maze is interpreted
Figure 3 Absence of DTR expression in cholinergic interneurons and characteristics of cholinergic interneuron loss. (a) Double immunofluorescence
labeling demonstrated that DTR, revealed by GFP expression (green), does not colocalize with choline acetyltransferase (ChAT) which labels the cholinergic
interneurons (red). Scale bar, 50mm. (b) Dual in situ hybridization showing that DTR (red) is not expressed in ChATþ cells (green, top, arrows) but
colocalized with SP (green, bottom). Scale bars, 25mm (top) and 10 mm (bottom). (c) Agarose gels of the single-cell RT-PCR products from two individual
neurons whose electrical activity, recorded in cell-attached mode, is illustrated on the right. DTR-GFP mRNA (406 bp) is detected in a silent cell identified as
MSN (top) but not in a spontaneous firing cell identified as cholinergic interneuron (bottom) that indeed expresses ChAT mRNA (323 bp). Cells are negative
for the NR1 gene intron showing no contamination of the cytoplasm by genomic DNA. (d) The percentage of cholinergic interneurons’ (revealed by ChAT
staining) and striatonigral MSNs’ (revealed by GFP staining) loss, quantified at different time points after unilateral DT injection, is highly correlated. (e) GFP
(left) and ChAT (right) immunodetection on a DTRþ coronal brain section 15 days after unilateral DT injection into the dorsal striatum and the nucleus
accumbens. Scale bars, left: 500 mm; right: 50mm. Quantitative analyses illustrate the density of ChAT-positive cells in the dorsal striatum and the nucleus
accumbens (n¼ 6 DTRþ ). Cx: cortex, St: striatum, NAc: nucleus accumbens. Data are expressed as percentage±SEM. Student’s t-test: ***po0.001 vs
uninjected side.
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as reduced anxiety. DT-injected DTRþ mice showed
marked increase in the time spent in the central zone of
the open field (po0.05) as well as in the time spent
(po0.001) and number of entries (po0.01) in the elevated
plus maze (Figure 6). These changes reflect reduced anxiety
and not a motor impairment as the total distance traveled
during the 5-min test period was similar for DTR and
DTRþ mice in the open-field (DTR : 2958.04±202.53mm,
n¼ 17; DTRþ : 2487.03±264.37mm, n¼ 10; NS) and in the
EPM (DTR : 2094.1±96.7mm, n¼ 17; DTRþ : 2014.8±
116.3mm, n¼ 10; NS).
DISCUSSION
In the present study, we achieved inducible striatonigral
MSNs’ ablation by using cell-type specific expression of
DTR and revealed three original results: (i) a region-specific
Figure 4 DT injection alters basal and cocaine-induced locomotion.
(a) Line graphs illustrate the number of beam breaks in 5-min bins
over a 60-min period after saline or cocaine (15mg/kg) injections for
DTR (n¼ 14 saline and 10 cocaine) and DTRþ (n¼ 9 saline and 6
cocaine) mice. Inset shows the group means±SEM of total beam breaks
for the 60-min test period. Student’s t-test: ***po0.001 vs DTR sal or
DTRþ sal, #po0.05 vs DTR sal. (b) Bar graphs comparing the loco-
motor response to two different doses of cocaine (5 and 15mg/kg). Data
are the mean number of beam breaks measured during 60min and
are expressed for each genotype as the percentage±SEM of respective
saline-treated mice (5mg/kg group: DTR mice, n¼ 12 saline and 12
cocaine and DTRþ mice, n¼ 5 saline and 5 cocaine; 15mg/kg group:
DTR mice, n¼ 14 saline and 10 cocaine and DTRþ mice, n¼ 9 saline
and 6 cocaine). Student’s t-test: *po0.05, **po0.01 vs DTR coc.
Figure 5 L-DOPA-induced dyskinesia are dramatically reduced after
striatonigral neurons ablation. (a) Time course of L-DOPA-induced
dyskinesia. (b) Autoradiographic image and quantitative analysis of
3H-mazindol binding showing the extensive loss of dopamine terminals
in the striatum ipsilateral to the 6-OHDA injected side (*) (n¼ 16
DTR and 12 DTRþ ). Data are expressed as the percentage±SEM.
Student’s t-test, ***po0.001 vs controlateral side. Scale bar, 1 mm.
(c) Dyskinesia score (left; sum of the mean scores for axial, orolingual, and
forelimb AIMs over 120min; maximum 12) and locomotive AIM
(right; mean number of contralateral rotations per minute over 120min)
after L-DOPA injection on day 21 of chronic treatment (n¼ 16
DTR and 12 DTRþ ). Data are expressed as mean±SEM. Student’s t-
test, ***po0.001 vs DTR mice. (d) Time profile of axial, limb and
orolingual dyskinesia scored every 20min over a 120-min period after
L-DOPA injection at day 21 in DTR (n¼ 16) and DTRþ (n¼ 12) mice.
Data are reported as mean±SEM. Two-way RM ANOVA: Genotype:
F(1,26)¼ 22.32, po0.001; time: F(5,130)¼ 50.21, po0.001; genotype
time:, F(5,130)¼ 18.51, po0.001, Holm–Sidak posttest: ***po0.001.
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regulation of cholinergic interneurons homeostasis by
striatonigral MSNs, (ii) a causal implication of striatonigral
MSNs in L-DOPA-induced dyskinesia, and (iii) the involve-
ment of the dorsal striatum in the regulation of anxiety
behavior.
We chose to express DTR under the control of the Slc35d3
gene promoter based on two studies using FACS (fluores-
cence-activated cell sorting) and TRAP (translating
ribosome affinity purification) that identified Slc35d3 as
the most striatonigral-enriched gene with a restricted
expression to the striatum (Heiman et al, 2008; Lobo
et al, 2006). Accordingly, intrastriatal injection of DT into
the dorsal striatum triggered not only the elimination of a
majority of striatonigral MSNs but also of a portion of
cholinergic interneurons. We performed a series of experi-
ments suggesting that the cholinergic loss, which occurred
specifically in the dorsal but not in the ventral striatum, is
the consequence of striatonigral MSNs’ ablation. Another
study, in which ablation of striatonigral MSNs is also
obtained by DTR activation, reported no change in the
number of striatal cholinergic interneurons after DT
injection (Durieux et al, 2012). In this study, DTR expre-
ssion in striatonigral MSNs is achieved by crossing iDTR
mice (in which DTR expression is under the control of the
ubiquitous Rosa26 promoter but is prevented by a loxP-
flanked STOP cassette) with D1-Cre mice. Knowing that
transgene expression level is highly dependent on the
promoter used to drive its expression, we can assume that
DTR level is quite different in the two models. This might
also explain the difference in the efficient DT dose between
the two studies (0.5 ng/ml vs 0.1 ng/ml in Durieux et al, 2012);
indeed 0.1 ng/ml did not produce significant ablation in our
model (not shown). Level of DTR expression might impact
the degenerative process, as for instance the kinetics of
striatonigral MSNs death and glial reactivity, and diffe-
rently affect cholinergic interneurons. Reliance of striatal
cholinergic survival on non-cell autonomous processes,
involving for instance sonic hedgehog signaling from
dopaminergic projections, was recently demonstrated in
the adult brain (Gonzalez-Reyes et al, 2012). In our case, SP
released by striatonigral MSNs might be a good candidate to
support such pro-survival function as: (i) the presence of
numerous SP positive axonal terminals making synaptic
contact with dendrites of cholinergic neurons suggests an
intimate relationship between these two populations (Bolam
et al, 1986), (ii) SP biological functions are mediated by the
NK1 receptor, which is almost exclusively expressed by
cholinergic interneurons in the striatum (Elde et al, 1990;
Gerfen, 1991), and (iii) NK1 receptor activation triggers
pro-survival pathways crucial for the maintenance
of some neuronal populations (Chu et al, 2011). The
differential effects of DT in the striatum and nucleus
accumbens open interesting questions and suggest that
the cholinergic interneurons have distinct properties in
each territory. Further experiments, which are beyond the
scope of this study, will be necessary to investigate this
region-specific interaction between striatonigal MSNs and
cholinergic interneurons.
Our behavioral data showing reduced locomotion in
DT-injected DTRþ mice confirm the BG model of the direct
pathway promoting movement and are consistent with
recent studies reporting that optogenetic activation or
specific ablation of striatonigral MSNs enhances and
reduces locomotion, respectively (Durieux et al, 2012;
Kravitz et al, 2010). The increase in GAD 67 mRNA level
in the SNr of DT-injected mice further supports the view
that hypolocomotion results from overactive BG outflow
subsequent to removal of the inhibitory influence exerted
by striatonigral MSNs. In contrast to basal locomotion,
our transgenic mice unexpectedly displayed an increase in
cocaine-induced activity. Indeed, previous studies reported
decreased locomotor response to acute injection of psycho-
stimulants after specifically inhibiting synaptic transmis-
sion in striatonigral MSNs (Hikida et al, 2010) or ablating
these neurons in the striatum (Durieux et al, 2012).
Differences in the psychostimulant used or the area of the
striatum targeted is unlikely to account for such a
discrepancy, suggesting that our phenotype might not be
the direct consequence of striatonigral damage. Interest-
ingly, an increased sensitivity to acute cocaine has been
Figure 6 Anxiety is reduced after striatonigral MSNs’ ablation. Representative paths (a, c) and quantification showing the time spent in the central zone of
the open field (b) as well as the time and the number of entries in the open arms of the elevated plus maze (d) for DTR (n¼ 17) and DTRþ (n¼ 10)
mice. Data are expressed as the percentage±SEM of the total time. Student’s t-test: *po0.05, ** po0.01, ***po0.001 vs DTR mice.
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reported after elimination of cholinergic cells in the dorsal
striatum or the nucleus accumbens (Hikida et al, 2001; Sano
et al, 2003), suggesting that the loss of striatal cholinergic
interneurons rather than ablation of striatonigral MSNs
might be responsible for the potentiation of cocaine-
induced locomotor response.
LID, a major side effect of chronic L-DOPA treatment in
PD, are associated with molecular changes occurring
specifically in striatonigral MSNs (Santini et al, 2009). Our
data, showing that striatonigral MSNs ablation prevents the
development of LID, provide direct evidence for the causal
role of these neurons in LID. This antidyskinetic effect is in
agreement with the one obtained after genetic inactivation
of DARPP-32 in striatonigral MSNs (Bateup et al, 2010). The
shift in ERK activation from MSNs to cholinergic inter-
neurons described after long-term exposure to L-DOPA
(7 weeks) suggests that the cholinergic interneurons might
also be involved in LID expression (Ding et al, 2011). Here
the beneficial effect of striatonigral MSNs ablation on LID
was observed as early as 7 days post-L-DOPA treatment
(not shown), a time where ERK activation in cholinergic
interneurons is not yet turned on (Ding et al, 2011).
Thus our results support a primary role of striatonigral
MSNs in the development of dyskinesia and also suggest
that therapeutic strategies based on manipulation of
dopamine-dependent signaling in the striatum should target
the striatonigral MSNs for an efficient clinical approach to
prevent LID.
Accumulating evidence suggest that the dorsal striatum
might also be involved in emotional and motivational
processing (Balleine et al, 2007). Here we found that DT-
injected DTRþ mice exhibited reduced anxiety in the open-
field and elevated plus maze tests. Considering that SP is of
relevance in the regulation of emotional states, including
anxiety-related behavior (Ebner and Singewald, 2006), and
that striatonigral MSNs are the main source of SP in
the striatum, our result suggest a role for striatal SP in the
regulation of anxiety. Consistent with the anxiolytic
effect of striatonigral MSNs ablation, pharmacological
blockade or genetic deletion of NK1 receptors produced
anxiolytic-like effects (File, 1997; Santarelli et al, 2001).
As NK1 receptors expressed by cholinergic interneurons
are important mediators of SP action in the striatum,
the loss of this striatal population in our model is likely to
accentuate the anxiolytic effect. SP is widely distributed in
the brain and the SP-sensitive areas commonly implicated
in the control of anxious states are part of the limbic system
(Davis et al, 2010). Although the dorsal striatum has limbic
connections through the dopamine system (Haber et al,
2000), its involvement in anxiety behavior is quite
novel and highlights the plurality of neuronal substrates
underlying this behavior. Interestingly, dynorphin, another
peptide specifically expressed by striatonigral MSNs, has
been implicated in anxiety and might thus participate
to the reduced anxiety exhibited by the DT-injected
transgenic mice (Schwarzer, 2009; Van’t Veer and
Carlezon, 2013).
Altogether, our data reveal an intimate relationship
between striatonigral MSNs and cholinergic interneurons
in the dorsal striatum and provide experimental evidence
for the implication of these populations not only in
dopamine-dependent motor behaviors but also in the
control of anxiety, emphasizing the functional overlap
between the dorsal striatum and the nucleus accumbens.
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Despite evidence showing that anticholinergic drugs
are of clinical relevance in Parkinson’s disease (PD),
the causal role of striatal cholinergic interneurons
(CINs) in PD pathophysiology remains elusive.
Here, we show that optogenetic inhibition of CINs
alleviates motor deficits in PD mouse models,
providing direct demonstration for their implication
in parkinsonian motor dysfunctions. As neural corre-
lates, CIN inhibition in parkinsonian mice differen-
tially impacts the excitability of striatal D1 and D2
medium spiny neurons, normalizes pathological
bursting activity in the main basal ganglia output
structure, and increases the functional weight of
the direct striatonigral pathway in cortical informa-
tion processing. By contrast, CIN inhibition in non-
lesioned mice does not affect locomotor activity,
equally modulates medium spiny neuron excitability,
and does notmodify spontaneous or cortically driven
activity in the basal ganglia output, suggesting that
the role of these interneurons in motor function is
highly dependent on dopamine tone.
INTRODUCTION
Parkinson’s disease (PD) is a debilitating neurodegenerative
movement disorder resulting from the loss of nigral dopami-
nergic (DA) neurons that project massively to the striatum, the
main basal ganglia input structure. The hypokinetic parkinsonian
syndrome is thought to be the consequence of opposite
changes in the activity of the two populations of GABAergic stria-
tal projection neurons, also called medium spiny neurons
(MSNs), which control the basal ganglia output nuclei, mainly
the substantia nigra pars reticulata (SNr) in rodent. Dopamine
D1 receptor-expressing MSNs (D1 or direct MSNs), giving riseCto a monosynaptic inhibitory projection (direct pathway) onto
SNr, become hypoactive, whereas dopamine D2 receptor-ex-
pressing MSNs (D2 or indirect MSNs), at the origin of a polysyn-
aptic projection with excitatory influence onto SNr (indirect
pathway), become hyperactive (Albin et al., 1989; Mallet et al.,
2006). This imbalance leads to pathological activation of SNr, re-
inforcing its inhibitory tone onto the thalamocortical circuit and,
hence, on motor cortical outflow. The pathological changes in
the activity of the two striatal pathways, whose functional rela-
tionship with movement control is still debated (Calabresi
et al., 2014; Cui et al., 2013), may involve profound reorganiza-
tions within the striatal circuitry.
Striatal cholinergic interneurons (CINs), which correspond to
the tonically active neurons recorded in vivo, constitute 1%–
3% of all striatal neurons. Despite being few in numbers, they
are the main source of acetylcholine (ACh) within the striatum,
and their dense terminal fields are primarily directed to MSNs
(Phelps et al., 1985). The improvement of parkinsonian tremor
by both DA agonists and anticholinergic drugs led to the DA-
ACh balance hypothesis, where DA and ACh are believed to
play opposite roles in the striatum (Barbeau, 1962). This clinical
observation particularly underlines the functional impact of ACh
as DA levels fall. There is indeed compelling evidence showing
that DA depletion triggers complex alterations in striatal cholin-
ergic signaling and activity (Aosaki et al., 1994; Ding et al.,
2006), leading, among other things, to morphofunctional alter-
ations of striatal output neurons (Pisani et al., 2007; Shen et al.,
2007). However, whether and how this cholinergic-dependent
disruption of striatal properties contributes to motor symptoms
in PDand affects basal ganglia circuitry remain an openquestion.
The diversity of cholinergic receptors expressed in the stria-
tum, located both at the presynaptic and postsynaptic levels
(Goldberg et al., 2012), suggests that CINs exert complex and
powerful influence on striatal functioning and, hence, on basal
ganglia outflow. An additional level of complexity in understand-
ing cholinergic regulation of striatal function comes from recent
studies showing the following: (1) CINs co-release glutamate
able to evoke fast glutamatergic responses in MSNs (Higleyell Reports 13, 657–666, October 27, 2015 ª2015 The Authors 657
Figure 1. Photoinhibition of CINs rReduces Haloperidol-Induced Catalepsy and Relieves Parkinsonian-like Motor Deficits
(A) Experimental design. Mice received haloperidol (0.25 mg/kg) and the latency to step down the bar was measured 20min later, then every 10min, with a 120-s
cutoff. Light was turned on (blue light: 10 Hz, 25-ms pulse width; yellow light: continuous illumination) for 3 min when placing the mice on the bar and was turned
off afterward for 7 min, until next measure.
(B) Yellow light reduced haloperidol-induced catalepsy in eNpHR-RFP mice versus RFP mice (*p < 0.05, **p < 0.01, U-Mann-Whitney after significant Kruskal-
Wallis test), whereas blue light illumination in ChR2-mCherry mice had no effect versus mCherry mice (p = 0.3).
(legend continued on next page)
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et al., 2011), (2) CIN activation can drive GABA release from
dopaminergic terminals (Nelson et al., 2014; Tritsch et al.,
2014) and neuroptide Y-expressing interneurons (English et al.,
2011), and (3) their synchronous activation triggers striatal DA
release (Threlfell et al., 2012). While we do not know yet how
these different actions are coordinated in vivo, these results sug-
gest that DA/ACh interactions are more complex than the tradi-
tional antagonistic model would predict. Therefore, the contribu-
tion of CINs to basal ganglia function cannot be fully understood
unless an approach mimicking the diversity of their actions is
used. Optogenetics that allows precise control of circuit func-
tion, was, for example, used successfully to demonstrate the
role of CINs in the nucleus accumbens during cocaine condition-
ing (Witten et al., 2010).
Here, using a combination of optogenetic, behavioral, and
electrophysiological approaches, we demonstrate a major role
of CINs in PD pathophysiology. We show that selective inhibition
of CINs alleviates motor deficits and corrects dysfunctions at the
main input and output stages of the basal ganglia network in PD
mouse models, with a preferential action on the direct striatonig-
ral pathway.
RESULTS
Inhibition of Striatal Cholinergic Interneurons Reduces
Parkinsonian-like Motor Deficits
We expressed ChR2-mCherry or eNpHR-RFP in choline acetyl-
transferase (ChAT)-expressing neurons by injecting a Cre-
dependent adeno-associated virus (AAV) carrying the opsins or
their reporter genes into the dorsal striatum of ChATcre/cre mice
(subsequently referred to as ChR2-mCherry and eNpHR-RFP
mice). Quantifying the proportion of neurons expressing opsins
that were also ChAT positive and vice versa demonstrated the
specificity and efficiency of the targeting strategy (Figure S1).
Recordings of optogenetically identified CINs in striatal slices
and anesthetized mice showed that opsins were functional
(Figure S2).
CIN photoinhibition or photoactivation had no significant ef-
fect on locomotor activity of non-lesioned RFP, eNpHR-RFP,
mCherry, and ChR2-mCherry mice in an open field (Figure S3A).
To determine whether CINs affect parkinsonian akinesia, the
effects of CIN modulation were examined in the haloperidol-
induced catalepsy model (Figure 1A). The eNpHR-RFP haloper-
idol-treated mice removed their forepaws from the bar signifi-
cantly faster under yellow illumination than did the RFP-treated
mice (Figure 1B). Consistently, yellow light restored head move-(C) Light partially restored headmovements in eNpHR-RFPmice (ON versus OFF p
way ANOVA), but not in ChR2-mCherry mice or in control RFP and mCherry mic
(D) In the cylinder test, 6-OHDA mice showed marked forelimb asymmetry compa
test after significant ANOVA). (Left) This asymmetry was significantly improved by
Light did not affect asymmetry in RFP control mice (n = 7–8 per group). (Right) The
(**p < 0.01, Fisher’s LSD test after significant ANOVA) was not affected by blue
mCherry (ON versus OFF: ns, Student’s t test) mice (n = 7–8 per group).
(E) (Left) Ipsilateral turn bias induced by 6-OHDA lesion in the cross maze (6-OHD
photoinhibition in eNpHR-RFPmice (ON versus OFF: #p < 0.05, paired Student’s t
not affect the ipsilateral turn bias induced by 6-OHDA lesion (6-OHDA versus non
mice (ON versus OFF: ns, Student’s t test, n = 12 per group). In (D) and (E), contin
10 Hz for blue light. Circle under the cross maze symbolizes a mouse with the 6
Cments in a light-locked manner in haloperidol-injected eNpHR-
RFP mice, demonstrating a robust anti-akinetic action of CIN
inhibition (Figure 1C). In contrast, ChR2-mCherry mice under
blue illumination exhibited a long-lasting cataleptic state, similar
to mCherry mice (Figures 1B and 1C).
We next tested whether CIN inhibition could alleviate motor
dysfunction in the 6-hydroxydopamine (6-OHDA) lesional model
of PD. Unilateral 6-OHDA injection into the substantia nigra pars
compacta (SNc) resulted in a near-total loss of DA cells after
2 weeks. In the cylinder test (Figure 1D), RFP and mCherry
non-lesioned mice used their two forepaws indifferently during
exploratory rearing (asymmetry score close to zero). The
6-OHDA lesions produced a significant shift toward ipsilateral
forepaw use due to contralateral forelimb akinesia. Photoinhibi-
tion of CINs ipsilateral to the lesioned side in eNpHR-RFP mice
induced a significant reduction in the asymmetry score. In
contrast, CIN photoactivation in ChR2-mCherry 6-OHDA mice
did not affect asymmetry (Figure 1D). In the cross maze test (Fig-
ure 1E), the 6-OHDA-induced bias toward ipsilateral turns, which
reflects sensorimotor neglect, was significantly reduced by CIN
inhibition in eNpHR-RFPmice, while CIN activation had no effect
in ChR2-mCherry mice. The non-selective muscarinic receptor
antagonist scopolamine (1 mg/kg) also reduced the asymmetry
in the cylinder and cross maze tests in 6-OHDA mice (Figures
S3B and S3C). Finally, we examined the effect of CIN photoinhi-
bition on L-DOPA-induced dyskinesia, amain side effect of long-
term DA treatment. CIN inhibition in eNpHR-RFP mice failed to
affect the severity of dyskinesia once expressed (Figure S4).
Taken together, these data show that CIN inhibition has no effect
on spontaneous locomotion and L-DOPA-induced dyskinesia in
our lesion and treatment conditions, but significantly alleviates
parkinsonian-like motor deficits.
Inhibition of Striatal CINs Regulates the Basal Ganglia
Output Structure in Parkinsonian Condition Only
A leading hypothesis on the origin of motor dysfunction in PD is
that DA loss induces abnormal bursting activity in basal ganglia
output nuclei, leading to pathological inhibitory tone onto the
thalamocortical circuit that disrupts motor planning and execu-
tion. We tested whether striatal CIN inhibition modifies the activ-
ity of SNr neurons recorded in vivo in anesthetized transgenic
eNpHR mice. CIN photoinhibition in non-lesioned animals did
not affect spontaneous activity of SNr neurons (Table S1). The
6-OHDA mice showed altered burst firing, with significant in-
creases in burst duration and number of spikes per burst (Fig-
ure 2A). CIN photoinhibition normalized these changes, withoutreceding light: *p < 0.05, **p < 0.01, paired Student’s t test after significant two-
e (n = 10–13 per group).
red to non-lesioned mice (**p < 0.01, Fisher’s least significant difference [LSD]
yellow light in eNpHR-RFP mice (ON versus OFF: #p < 0.05, Student’s t test).
significant forelimb asymmetrymeasured in 6-OHDA versus non-lesionedmice
light illumination in ChR2-mCherry (ON versus OFF: ns, Student’s t test) and
A versus non-lesioned: **p < 0.01, one-way ANOVA) was partially corrected by
test), but not in RFP control mice (n = 14 per group). (Right) Photoactivation did
-lesioned: **p < 0.01, one-way ANOVA) in ChR2-mCherry mice nor in mCherry
uous illumination was for 5 min with yellow light and 25-ms pulse width was at
-OHDA-injected side in red. Errors bars, SEM.
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Figure 2. Photoinhibition of CINs Normal-
izes SNr Burst Firing and Strengthens the
Inhibitory Influence of the Striatonigral
Direct Pathway in 6-OHDA Mice
(A) Detection of bursts according to Poisson
Surprise analysis in a spontaneously firing SNr
neuron recorded in 6-OHDA transgenic eNpHR
mice. The histograms show that the 6-OHDA
induced increases in burst duration and number of
spikes per burst (6-OHDA versus non-lesioned:
*p < 0.05, **p < 0.01, Student’s t test) were
normalized by CIN photoinhibition (light was
delivered for 1 min; 6-OHDA ON versus OFF: #p <
0.05, ##p < 0.01, Holm-Sidak test after significant
one-way ANOVA). Non-lesioned mice, n = 18 cells
from six mice; 6-OHDA mice, n = 13 cells from six
mice.
(B) Schematic representation shows pathways
activated by cortical stimulation that project to SNr
neurons. Cx, cortex; Str, striatum; GPe, external
globus pallidus; STN, subthalamic nucleus.
(C) Raster plot and peristimulus time histogram
(PSTH) show the typical triphasic response
evoked by motor cortex stimulation in one SNr
neuron recorded from a 6-OHDA transgenic
eNpHR mouse.
(D and E) Population PSTHs of the cortically
evoked responses recorded in SNr neurons in
non-lesioned (D, n = 17 cells from six mice) and
6-OHDA (E, n = 7 cells from five mice) mice.
The same neuron was recorded before (pre,
gray line) and during (light, orange line) CIN
photoinhibition. Light was delivered for 1 s at
the beginning of each trial. PSTHs are aligned
on the beginning of the inhibitory component
(red lines) and the light-shaded colors represent
SEM. CIN photoinhibition induced a significant increase of the inhibitory component duration only in 6-OHDA mice, as illustrated by the box plots
(insets) (**p < 0.01, Holm-Sidak test after significant one-way RM ANOVA). Errors bars, SEM.modifying the parameters unaltered by the lesion (firing fre-
quency and burst recurrence) (Table S1).
Next, to examine whether CINs influence the processing of
cortical information through the trans-striatal pathways, we
recorded the responses of individual SNr neurons to cortical
stimulation (Figures 2B and 2C). As previously reported, such
stimulation triggers a complex response composed, in most
cases, of an early excitation followed by an inhibition and a late
excitation, which has been attributed to the respective activation
of the hyperdirect corticosubthalamic, the direct and indirect
striatonigral pathways (Maurice et al., 1999; Ryan and Sanders,
1994; Sano et al., 2013; Tachibana et al., 2008). Because the
characteristics of the evoked responses greatly vary among cells
depending on the stimulation (e.g., location and number of stim-
ulated fibers) but remain stable in a given cell over time, compar-
isons were made for a same cell under successive light condi-
tions and not between cells from 6-OHDA versus non-lesioned
mice. CIN photoinhibition had no effect on cortical information
transfer in non-lesioned mice, whereas, in 6-OHDA mice, it
increased the duration of the inhibitory component of the tripha-
sic response without significantly affecting the excitatory com-
ponents (Figures 2D and 2E; Table S2). Since parkinsonian aki-
nesia is classically associated with overactive indirect pathway660 Cell Reports 13, 657–666, October 27, 2015 ª2015 The Authorsand hypoactive direct pathway, our results suggest that CIN in-
hibition might partially restore balance in striatal outputs by
increasing the functional impact of the direct pathway. In
contrast, CIN photoinhibition had no effect on SNr spontaneous
activity and cortical information transfer in non-lesioned trans-
genic eNpHR mice.
Dopamine Depletion Affects the Intrinsic Excitability
of D1 MSNs
We first determined whether CINs themselves were affected by
6-OHDA lesion, as there is no consensus on whether CIN activity
or striatal ACh release increases in PD models. Optogenetically
identified CINs recorded either in slices or in anesthetized mice
exhibited similar firing frequency in non-lesioned and 6-OHDA
conditions (Figure 3), showing that they are not hyperactive in
our experimental conditions. However, CINs were more excit-
able in slices from 6-OHDA mice, as illustrated by a lower rheo-
base current (non-lesioned: 137.7 ± 16.7 pA, n = 17; 6-OHDA:
87.1 ± 16.5 pA, n = 17; p < 0.05, Mann-Whitney test).
We then tested whether CIN modulation of striatal functions
could be altered in PD state, by examining its impact on iden-
tified D1 and D2 MSNs that form the direct and indirect striatal
projection systems, 2–3 weeks after 6-OHDA lesion. The
Figure 3. Impact of 6-OHDA Lesion on CIN Electrophysiological
Properties
(A) Spontaneous activity from a CIN recorded in cell-attached configuration.
Histograms show the mean firing rate and coefficients of variation (CV = firing
rate SD/firing rate mean) in non-lesioned (n = 12 cells) and 6-OHDA (n =
20 cells) transgenic eNpHR mice (ns, Mann-Whitney test).
(B) Action potential characteristics of CINs recorded in non-lesioned (n =
13 cells) and 6-OHDA (n = 22 cells) mice. No significant differences were
observed between the two groups (ns, Student’s t test).
(C) Spontaneous activity and optogenetic identification of a CIN recorded
in vivo. Histograms show themean frequency rate and CVs (firing rate SD/firing
rate mean) in non-lesioned (n = 8 cells) and 6-OHDA (n = 7 cells) transgenic
eNpHR mice (ns, Mann-Whitney test). Errors bars, SEM.
Cresting membrane potentials of D1 and D2 MSNs were similar
in non-lesioned and 6-OHDA mice (data not shown). However,
in non-lesioned mice, D2 MSNs were more excitable than D1
MSNs, in agreement with previous reports (Gertler et al.,
2008; Kreitzer and Malenka, 2007; Figure 4A). After DA deple-
tion, D2 MSN excitability was not changed, while that of D1
MSNs greatly increased. D1 MSNs fired at higher frequency
at each depolarizing current step, and the rheobase current
was significantly lower in 6-OHDA versus non-lesioned mice
(Figure 4). These results show that DA depletion reduces the di-
chotomy between D1 and D2 MSN excitability by increasing D1
MSN excitability.
Striatal CINs Differentially Modulate the Excitability
of D1 and D2 MSNs in Parkinsonian Condition
Changes in intrinsicmembrane excitability can occur either inde-
pendently or in concert with changes in synaptic inputs. As
cortical inputs strongly drive MSN activity and are modulated
by presynaptic muscarinic receptors (Herna´ndez-Echeagaray
et al., 1998; Malenka and Kocsis, 1988; Pakhotin and Bracci,
2007), we investigated whether CIN inhibition affects cortico-
striatal transmission. Recordings were made 2–3 weeks after
6-OHDA lesion in transgenic eNpHR/D1 mice expressing both
eNpHR in CINs and the fluorescent reporter tdTomato in DA
D1 receptor-containing neurons (Figure S5A). In non-lesioned
mice, excitatory postsynaptic currents (EPSCs) were not signifi-
cantly altered by CIN inhibition, both in D1 and D2 MSNs (D1
MSNs, light versus pre-light: 325.99 ± 57.92 pA versus
311.16 ± 53.47 pA, not significant [ns], paired Student’s t test,
n = 14 cells; D2 MSNs, light versus pre-light: 214.98 ±
30.07 pA versus 214.59 ± 26.44 pA, ns, paired Student’s t test,
n = 11 cells) (Figure S5B). In contrast, CIN inhibition in 6-OHDA
mice significantly potentiated EPSCs in both D1 and D2 MSNs
(D1 MSNs, light versus pre-light: 262.22 ± 24.93 pA versus
240.76 ± 23.84 pA, p < 0.05, Wilcoxon test, n = 15 cells; D2
MSNs, light versus pre-light: 231.06 ± 34.00 pA versus
198.06 ± 24.07 pA, p < 0.05, Wilcoxon test, n = 9 cells) (Fig-
ure S5B). This potentiation was blocked by scopolamine
(10 mM) (data pooled for D1 and D2 MSNs: light versus pre-light:
181.24 ± 35.92 pA versus 178.31 ± 33.35 pA, ns, paired Stu-
dent’s t test, n = 8 cells, data not shown). These results show
that CIN inhibition potentiates corticostriatal transmission onto
both D1 and D2MSNs in parkinsonian condition. Therefore, cor-
ticostriatal transmission is unlikely to contribute to a differential
impact of CIN inhibition on D1 and D2 MSNs.
In the healthy striatum, cholinergic modulation facilitates the
firing of MSNs through M1 receptors (Galarraga et al., 1999;
Goldberg et al., 2012; Pisani et al., 2007). What happens after
chronic DA depletion is still unclear. We therefore examined
whether and how CIN photoinhibition impacts MSN excitability
in non-lesioned and 6-OHDAmice. D1 and D2MSNs fired signif-
icantly less action potential during light illumination in both non-
lesioned and 6-OHDA mice (Figures 5A and 5B). However, while
the magnitude of firing inhibition was similar in D2 and D1 MSNs
in non-lesioned mice, firing inhibition was weaker in D2 MSNs
compared to D1 MSNs in 6-OHDA mice (Figure 5C). This result
shows that D2 MSNs are less sensitive to CIN inhibition than
D1 MSNs after DA depletion.ell Reports 13, 657–666, October 27, 2015 ª2015 The Authors 661
Figure 4. Impact of 6-OHDA Lesion on D1 and D2 MSN Excitability
(A) Current-clamp recordings showing the responses of D1 and D2 MSNs to
depolarizing current pulses in non-lesioned (+450 pA) and 6-OHDA (+400 pA)
mice. Summary graph illustrates the number of action potentials as a function
of injected current in D1MSNs (non-lesioned mice, n = 14 cells; 6-OHDAmice,
n = 23 cells) and D2 MSNs (non-lesioned mice, n = 13 cells; 6-OHDA mice, n =
13 cells).
(B) Bars graph shows the mean rheobase current in D1 MSNs (non-lesioned
mice, n = 14 cells; 6-OHDA mice, n = 23 cells) and D2 MSNs (non-lesioned
mice, n = 13 cells; 6-OHDA mice, n = 13 cells) (**p < 0.01, ***p < 0.001, Holm-
Sidak test after significant one-way ANOVA). Errors bars, SEM.DISCUSSION
Although ACh is undeniably a critical player in striatal func-
tioning, the role of CINs in PD pathophysiology has remained un-662 Cell Reports 13, 657–666, October 27, 2015 ª2015 The Authorssolved. We tackled this issue by combining optogenetics with
in vitro and in vivo electrophysiology and behavioral analyses.
We first showed that selective inhibition of CINs in the dorsal
striatum reduces parkinsonian motor dysfunction in pharmaco-
logical and lesional PD models, attesting to their causal involve-
ment in PD symptomatology. This provides a functional support
for the long-standing hypothesis that poses PD as a striatal
cholinergic disorder. Second, we identified several physiological
parameters affected by CIN inhibition in the parkinsonian condi-
tion at both the input (striatum) and output (SNr) levels of the
basal ganglia network. In addition, we found that CIN inhibition
does not significantly impact basic motor function nor the
spontaneous and cortically driven activity of SNr neurons in
non-lesioned mice. This lack of effect in SNr is consistent with
previous results from selective CIN ablation (Sano et al., 2013).
Also, CIN inhibition does not modify the severity of dyskinesia
in 6-OHDAmice. Altogether, these data suggest that CIN actions
are highly dependent on DA tone.
CIN inhibition in vivo efficiently alleviates parkinsonian deficits
measured after 6-OHDA lesions and neuroleptic-induced cata-
lepsy, two different models widely used to assess motor symp-
toms reminiscent of parkinsonian akinesia. As neural correlates
of PD symptoms’ improvement by CIN inhibition, our in vivo re-
cordings showed that it normalized the 6-OHDA-induced
changes in SNr burst firing. Over the last few years, an abundant
literature has clearly reported that parkinsonism is associated
with increased bursting activity in the basal ganglia, including
SNr (Lobb, 2014; Rivlin-Etzion et al., 2006; Wichmann et al.,
1999). Even though themechanisms leading to this abnormal ac-
tivity are still elusive, its normalization by efficient antiparkinso-
nian treatments, such as dopatherapy or subthalamic nucleus
deep brain stimulation (Brown, 2003; Degos et al., 2005; Eusebio
et al., 2011), suggests that such change may contribute impor-
tantly to the development of the behavioral manifestations of
the disease. Thus, it is likely that the decrease in burst activity
of SNr neurons elicited by CIN inhibition contributes to the
improvement of parkinsonian symptoms that we observed in
6-OHDAmice. Future studies will be required to understand fully
how CINs influence SNr burst firing in PD.
The second effect of CIN inhibition revealed by our in vivo re-
cordings in 6-OHDA mice was an increase in the inhibitory
component of the cortically evoked triphasic response in SNr
neurons, suggesting that CIN silencing strengthens the inhibitory
influence of the direct striatonigral pathway in parkinsonian con-
dition. Although the relationship between the activity of the direct
and indirect pathways and movement generation is still under
debate, it has been demonstrated that specific activation of D1
MSNs by optogenetics efficiently relieves parkinsonian deficits
(Kravitz et al., 2010). In this context, it is likely that the increased
duration of the cortically evoked inhibition induced by CIN inhibi-
tion contributes importantly to the improvement of parkinsonian-
like motor symptoms induced by DA depletion.
What are the striatal targets modulated by CINs that could
mediate their preponderant action on basal ganglia function in
PD state?We showed that CIN inhibition in 6-OHDAmice poten-
tiates corticostriatal transmission onto both types of MSNs.
However, our recordings in the SNr of 6-OHDA mice clearly
showed that CIN inhibition increases the cortically evoked
Figure 5. Photoinhibition of CINs Differentially Decreases D1 and D2 MSN Excitability in 6-OHDA Mice
(A and B) The graphs illustrate the decreased excitability of MSNs during light illumination versus pre and post conditions in non-lesioned (A, top; D1 MSNs:
F(2, 572) = 55.26, p < 0.0001, n = 12; B, top; D2 MSNs: F(2, 524) = 37.97, p < 0.0001, n = 11, linear regression analysis) and 6-OHDA (A, bottom; D1 MSNs:
F(2, 953) = 209.72, p < 0.0001, n = 20; B, bottom; D2MSNs: F(2, 524) = 17.09, p < 0.0001, n = 11, linear regression analysis) mice. R is theminimal current intensity
to trigger a spike in pre-light condition. From R, current intensity increased by +10-pA increment.
(C) (Top) Representative traces showing the responses to 500-ms depolarizing current steps (R+80 for D1MSNnon-les., D2MSNnon-les., andD2MSN 6-OHDA)
and R+110 (D1 MSN 6-OHDA). Light was delivered 200 ms before and continued 200 ms after the 500-ms depolarizing current step. (Bottom) The graphs show
the difference in the number of action potentials evoked in pre versus light conditions in D1MSNs (left; non-les., n = 12; 6-OHDA, n = 20) and D2MSNs (right; non-
les., n = 11; 6-OHDA, n = 11). There is a significant effect of current intensity in D1 MSNs (F[15,450] = 3.67, p < 0.005) and D2 MSNs (F[15,300] = 2.02, p < 0.01).
FromR+80 pA, D2MSNs in 6-OHDAmice are less inhibited during light illumination, as shown by a significant interaction between lesion3 current intensity for D2
MSNs (F[15,300] = 2.39, p < 0.05), but not for D1 MSNs. Errors bars, SEM.
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inhibition linked to the activation of the direct (D1) pathway, but
not the late excitation linked to the activation of the indirect
(D2) pathway. The high degree of convergence of the direct
pathway at the level of the SNr (48 striatal neurons converge
into one SNr cell; Smith et al., 1998) may explain how a modest
increase in corticostriatal transmission onto D1 MSNs impacts
the cortically evoked inhibition in the SNr. In contrast, complex
information processing at each stage of the polysynaptic indirect
pathway might minimize the outcome of EPSC potentiation on
D2 MSNs.
Another interesting result of our study is that DA depletion
tends to erase the dichotomy in MSN excitability by inducing a
specific increase in D1 MSN excitability. A recent study also re-
ported increased D1 MSN excitability after DA lesion, but asso-
ciated with a slight decrease in D2 MSN excitability (Fieblinger
et al., 2014), whereas we failed to detect any change for D2
MSNs. This apparent discrepancy might be due to different
lesion models or post-lesion delay, since opposite changes in
D2 MSN excitability have been described after acute or chronic
DA depletion (Day et al., 2006; Fieblinger et al., 2014; Shen et al.,
2007). Elevated excitability in D1MSNsmight be considered as a
homeostatic response counteracting the decreased activity trig-
gered by the loss of dopaminergic excitatory drive on these neu-
rons. However, if we assume that the dichotomybetween D1 and
D2 MSN excitability is a fundamental process for normal striatal
function, making both MSNs more alike after DA depletion might
be more harmful than beneficial. In favor of this hypothesis, we
showed that CIN inhibition decreases the excitability more in
D1 than in D2 MSNs after DA depletion, whereas it has similar
impact on the two populations in control condition. Thus,
restoring the dichotomy between D1 and D2 MSN excitability
might be one component of the anti-parkinsonian effect of CIN
inhibition. What happens following DA depletion to explain the
reduced sensitivity of D2 MSNs to CIN inhibition remains an
open and challenging question. It will be also interesting to inves-
tigate whether the cholinergic projection from the brainstem to
the striatum (Dautan et al., 2014) cooperates with CINs to modu-
late striatal output.
Our results show that CINs are critical players in the host of
cellular and synaptic changes induced inMSNs by DA depletion.
Without excluding indirect pathway contributions, our findings
point to CIN control of the direct striatonigral pathway as a
critical component involved in the control of striatal output and
motor dysfunction in PD state. These results should stimulate
the development of therapeutic strategies targeting striatal CIN
activity in PD.
EXPERIMENTAL PROCEDURES
Mice
All procedures were approved by the French National Ethical Committee (45-
29102012) and were in accordance with the recommendations of the Euro-
pean Commission (2010/63/EU) for care and use of laboratory animals. See
the Supplemental Experimental Procedures for a detailed description of the
mice used.
Stereotaxic Surgery
All coordinates were adapted from themouse stereotaxic atlas by Paxinos and
Franklin (2001) with bregma and dura as references. See the Supplemental
Experimental Procedures for details.664 Cell Reports 13, 657–666, October 27, 2015 ª2015 The AuthorsIn Vitro Electrophysiology
Patch-clamp recordings on brain slices and data analysis were performed as
described in the Supplemental Experimental Procedures. Excitation of opsins
was achieved with a light-emitting diode source (Spectra light engine, Lumen-
cor) connected to a 3-mm liquid core fiber. Statistical analyses were per-
formed using paired or unpaired Student’s t test. Nonparametric tests
(Mann-Whitney test for unpaired data or Wilcoxon test for paired data) were
used if the normality or equal variance test failed. For multiple group compar-
isons, one- or two-way ANOVA was used. We applied the log2 transformation
to make the data normal if necessary. Linear regression analysis was used to
compare the effect of CIN inhibition on MSN excitability. A significance of p <
0.05 was required for rejection of the null hypothesis.
Behavioral Testing
All behavioral analyses were conducted on littermates that entered the study
at around 3–5 months of age. See the Supplemental Experimental Proce-
dures for a detailed description of the behavioral tests. For open field,
data were analyzed using two-way ANOVA followed by paired Student’s t
test, when appropriate. For haloperidol-induced catalepsy, median latencies
(±semi-quartile) were compared among groups over time using the nonpara-
metric Kruskal-Wallis test, followed by U-Mann-Whitney for pairwise com-
parisons at each time. Head movements were summed for the 3-min ON
periods and compared to those measured 3-min OFF periods, using a
two-way ANOVA. For cylinder and cross maze tests, data were analyzed us-
ing one-way ANOVA, followed by Student’s t test. For L-DOPA-induced
dyskinesia, data were analyzed by two-way repeated-measures (RM)
ANOVA with opsins (eNpHR-RFP versus RFP) as between factor and time
as within factor.
In Vivo Recordings in Anesthetized Mice
Extracellular recordings in the striatum and the SNr were performed as
described in the Supplemental Experimental Procedures. The patterns of
cortically evoked discharges in the same SNr neuron were analyzed before,
during, and after CIN photoinhibition in the striatum. Results are given as
means ± SEM of the individual responses per condition. Spontaneous activity
in the three conditions was compared using one-way ANOVA followed by
comparison versus pre-light condition (Holm-Sidak method). Cortically
evoked responses of the same SNr neurons in the three light conditions
were compared using one-way RM ANOVA, followed by comparison versus
pre-light condition (Holm-Sidak method).
Histology and Immunohistochemistry
For primary antibody exposure, brain sections were incubated overnight at
4C in rabbit anti-RFP (1/1,000, tebu-bio, 600-401-379) and goat anti-ChAT
(1/100, Millipore, AB144P) for colocalization experiments and in mouse anti-
tyrosine hydroxylase (1/1,000, Millipore, MAB318) to control DA lesion. Sec-
tions were then incubated, respectively, in Alexa Fluor 555 donkey anti-rabbit
(1/500, Invitrogen, A31572), Alexa Fluor 488 donkey anti-goat (1/500, Invitro-
gen, A11055), and Alexa Fluor 555 donkey anti-mouse (1/500, Invitrogen,
A31570) for 1 hr 30 min at room temperature. Rabbit anti-GFP (1/500, Invitro-
gen, A11122) and Alexa fluor 488 donkey anti-rabbit (1/500, Invitrogen,
A21206) were used the same way to reveal eNpHR expression in transgenic
mice.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.09.034.
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Figure S1, Related to Supplemental Experimental Procedures: Specific expression of opsins in CINs (A 
and B) and topography of RFP staining in eNpHR-RFP-injected mice (C). 
(A, B) Left, histograms represent the mean coexpression in the whole dorsal striatum in eNpHR-RFP 
(n=2) or ChR2-mCherry (n=2) mice. Virtually all opsin-expressing neurons were ChAT-positive. The 
majority of neurons that expressed ChAT also expressed eNpHR-RFP (71.0 ± 2.9 %) or ChR2-mCherry 
(64.7 ± 2.6 %). Right, quantification of co-expression of RFP and mCherry and ChAT 
 
immunofluorescence from two bilaterally eNpHR-RFP-injected and ChR2-mCherry-injected mice, from 
the rostral-to-caudal ends of the dorsal striatum (from +1.42 to +0.02 mm). Errors bars, SEM. (C) Top, 
coronal section showing a representative RFP staining from an eNpHR-RFP-injected mouse. The track 
shows the location at which viral injection, followed by implantation of optical fiber, was made. Note 
the large diffusion of eNpHR-RFP in nearly the whole dorsal striatum. Cx: cortex, cc: corpus callosum, 
v: ventricle, St: striatum. Bottom, coronal schematic sections from the stereotaxic atlas of Paxinos and 
Watson showing the topography of RFP staining in eNpHR-RFP mice (from +1.42 to -0.58 mm with 
bregma as reference, n=14 mice). The intensity of the gradient of color (white to red) corresponds to 
the measured RFP positive area in the different brain structures studied for each injection performed. 
The highest intensity of red (100%) indicates that all animals had signal in the corresponding area, 
whereas the lowest color intensity (white, 0%) corresponds to non-stained areas. RFP labeling outside 
the striatum was very scarce and localized ventrally in the nucleus accumbens or caudally in the ventral 
pallidum and the bed nucleus of the stria terminalis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2: Functional expression of ChR2-mCherry and eNpHR-RFP in CINs both in vitro (A, B and C) 
and in vivo (D, E and F).  
(A) Action potential inhibition induced by 10 s yellow light illumination in a eNpHR-RFP-expressing 
neuron. (B) Action potentials in a ChR2-mCherry-expressing neuron evoked by 5-ms blue light pulses 
(10 Hz). (C) Average success probability for generating action potentials in neurons expressing ChR2-
mCherry at different stimulation frequencies (n=4-5, 5-ms pulse width). (D) Superimposed recordings 
of a CIN and a medium spiny neuron. CINs were distinguished from medium size spiny neurons by their 
typical tonic activity and spike duration. Dotted lines indicate spike duration. (E) Raw trace (top) of an 
isolated unit, identified as a CIN, inhibited by yellow light continuous stimulation. Raster plot (middle) 
displaying the response of the same unit to four repetitions of the light stimulation, with each action 
potential represented as a dot. Average and SEM of the firing rate over time (bottom) for the same 
unit. (F) Raw trace (top) of another putative CIN that is excited by 5ms-blue light pulses (10 Hz). Note 
at higher magnification that every light pulse drives a spike (bottom). Errors bars, SEM. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3, related to Figure 1: (A) Effects of CIN manipulation on the spontaneous locomotor activity 
in non-lesioned mice. Top, experimental design. Graphs show the locomotor activity before (OFF) and 
during (ON) bilateral striatal illumination in RFP, eNpHR-RFP, mCherry and ChR2-mCherry mice, in 3-
min period. No change in ambulation was observed in response to photoinhibition or photoactivation 
of CINs in either group (two-way ANOVA, ns), n=6-9 per group. (B, C) Muscarinic receptors blockade 
with scopolamine relieves parkinsonian-like motor deficits. B, in the cylinder test, 6-OHDA mice (n=14) 
showed a marked forelimb asymmetry compared to non-lesioned mice (*p<0.01, Fisher PLSD test after 
significant ANOVA F3,40=76.66). This asymmetry was significantly improved by intraperitoneal (i.p.) 
scopolamine injection (scopolamine 1 mg/kg vs. 0 mg/kg: # p<0.01, Student’s t test). Scopolamine did 
not affect asymmetry in non-lesioned mice (n=8). C, non-lesioned mice (n=8) placed in the cross-maze 
perform mainly straight-arm exploration with equivalent percentage of ipsi- or contralateral arms 
 
exploration (*p<0.01, Fisher PLSD test after significant ANOVA F5,35=402.9). 6-OHDA lesion induced a 
bias in arms exploration with a dramatic increase in ipsilateral turns and decrease in contralateral and 
straight exploration. Scopolamine significantly modified the performance of 6-OHDA mice (n=14) in 
the cross-maze (significant one-way ANOVA F5,65=48.58, p<0.01). It significantly decreased ipsilateral 
arm exploration (# p<0.01, Student’s t test) and increased straight exploration (# p<0.01, Student’s t 
test) while not affecting contralateral bias (ns, Student’s t test). Errors bars, SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4: Photoinhibition of CINs does not affect L-DOPA-induced dyskinesia. 
(A) Experimental design. Two weeks after intranigral injection of 6-OHDA, RFP and eNpHR-RFP mice 
received a chronic L-DOPA treatment for 21 days and dyskinesia were quantified at day 21. (B) Time 
profile of dyskinesia score (sum of the mean scores for axial and forelimb dyskinesia over 35 min; 
maximum score 8) after L-DOPA injection on day 21 of chronic treatment. Light did not produce a 
significant difference in dyskinesia score (two-way repeated measure ANOVA, ns, n = 7 per group). 
Errors bars, SEM. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5, related to Figures 4 and 5: (A) Representative photomicrographs of a transgenic eNpHR/D1 
mouse. Dorsal striatum sections showing eNpHR-EYFP expressing cells that are immunostained with 
antibodies against GFP (green) and D1-MSNs which are visualized by the direct fluorescence of 
tdTomato (red). Merge image shows no colocalization. (B) Photoinhibition of CINs potentiates 
corticostriatal transmission onto both populations of MSNs in 6-OHDA mice. EPSCs traces from a D1 
MSN recorded in a 6-OHDA mouse before, during and after light illumination. Light was sent 50 ms 
before cortical stimulation and continue 250 ms after. Graph illustrates the value of EPSCs change 
during light illumination compared to pre-light condition in all cells. Black circles represent the mean. 
Errors bars, SEM. 
 
 
 
 
 
 
  
 
 Frequency of discharge (Hz) Burst recurrence (burst/s) Burst duration (s) Number of spikes/burst 
 
Non-lesioned 
(n = 18) 
6-OHDA             
(n = 13) 
Non-lesioned 6-OHDA Non-lesioned 6-OHDA 
Non-
lesioned 
6-OHDA 
Pre 14.4 ± 1.7 12.3 ± 1.4 0.218 ± 0.057 0.258 ± 0.070 0.384 ± 0.033 0.517 ± 0.052* 9.5 ± 0.6 14.0 ± 1.1** 
Light 13.2 ± 1.8 11.1 ± 1.5 0.247 ± 0.053 0.315 ± 0.068 0.398 ± 0.036 0.374 ± 0.031# 9.4 ± 0.5 9.5 ± 0.5## 
Post 13.0 ± 1.7 11.9 ± 2.1 0.255 ± 0.046 0.290 ± 0.075 0.460 ± 0.030 0.404 ± 0.028 10.6 ± 0.5 11.9 ± 0.6 
 
Table S1, related to Figure 2: Effect of 6-OHDA lesion and impact of CIN photoinhibition on 
spontaneous activity of SNr neurons in transgenic eNpHR mice. 
* p<0.05, ** p<0.01, unpaired Student’s t test, 6-OHDA vs. non-lesioned mice. #p<0.05, ##p<0.01, one-
way ANOVA followed by Holm-Sidak post-hoc test, vs. pre-light condition. 
 
 
 
  Early excitation Inhibition Late excitation 
  L (ms) D (ms) Nb Sp L (ms) D (ms) L (ms) D (ms) Nb Sp 
N
o
n
-l
es
io
n
ed
 Pre-Light 11.0 ± 0.9 
(n = 13) 
7.5 ± 0.7 45.5 ± 8.3 22.8 ± 1.2 
(n = 18) 
25.4 ± 3.2 45.1 ± 3.4 
(n = 13) 
8.5 ± 1.0 44.0 ± 6.3 
Light 10.9 ± 0.9 8.1 ± 1.2 47.6 ± 7.7 21.8 ± 1.1 25.4 ± 3.9 43.9 ± 3.4 9.2 ± 1.2 44.9 ± 7.1 
Post-Light 11.5 ± 0.8 8.7 ± 0.8 54.0 ± 8.8 22.0 ± 1.2 25.3 ± 2.4 44.0 ± 2.3 9.6 ± 1.0 47.5 ± 8.6 
6
-O
H
D
A
  
Pre-Light 11.0 ± 2.5 
(n = 6) 
9.0 ± 2.9 60.3 ± 13.4 22.3 ± 1.5 
(n = 9) 
23.0 ± 4.3 58.0 ± 7.1 
(n = 10) 
33.8 ± 5.9 133.4 ± 32.1 
Light 10.0 ± 3.0 8.0 ± 2.5 55.0 ± 17.1 19.3 ± 1.7 36.3 ± 6.4** 62.2 ±10.2 35.8 ± 9.2 137.6 ± 26.7 
Post-Light 10.0 ± 2.6 9.3 ± 2.1 50.0 ± 23.3 20.0 ± 2.6 32.4 ± 4.8 61.2 ± 8.5 38.2 ± 4.8 119.2 ± 32.4 
 
Table S2, related to Figure 2: Characteristics of the responses evoked on the same SNr cells by 
electrical stimulation of the motor cortex in non-lesioned and 6-OHDA transgenic eNpHR mice, before, 
during and following CINs photoinhibition. 
The latency (L) and duration (D) of the different components of the cortically evoked response were 
measured on the basis of post-stimulus time histograms generated from 100 cortical stimulations. Nb 
Sp: number of spikes of the excitatory component. 
**p0.01, one-way repeated measure ANOVA followed by Holm-Sidak post-hoc test, vs. pre-light 
condition. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Mice. All mice strains used in this study were purchased from Jackson Laboratory. We used Choline 
acetyltransferase ChAT-IRES-Cre knock-in mice (ChATcre/cre mice, stock number: 006410), LoxP-stop-
eNpHR3.0-EYFP mice (Ai39 mice, stock number: 014539) and BAC Drd1a-tdTomato mice (TgD1-tdTomato 
mice, stock number: 016204). Ai39 mice were crossed with ChATcre/cre mice to induce eNpHR3.0 
expression in cholinergic neurons and were used for in vivo electrophysiology (RosaeNpHR/+::ChATcre/+ 
mice that were called transgenic eNpHR mice in this study). For in vitro electrophysiological 
experiments requiring distinguishing D1 and D2 MSNs, RosaeNpHR/+::ChATcre/+ mice were crossed with 
TgD1-tdTomato  mice to obtain both eNpHR expression in the cholinergic neurons and dtTomato expression 
in the direct(D1)-MSNs (RosaeNpHR/+::ChATcre/+::TgD1-tdTomato mice that were called transgenic eNpHR/D1 
mice in this study) (Figure S5).  
 
Stereotaxic surgery. Mice were anaesthetized with intraperitoneal (i.p.) injections of ketamine and 
xylazine (100 and 10 mg/kg, respectively) and mounted on a stereotaxic apparatus (Kopf Instruments). 
Injections were made with a 10-µl syringe, connected to the injector by a polyethylene tubing, and 
controlled by an injection pump at 0.3 µl/min.  
Viral expression of opsins in CINs. pAAV vectors containing opsins transgenes (ChR2: pAAV-Ef1a-DIO-
hChR2(H134R)-mCherry and eNpHR: pAAV-Ef1a-DIO-eNpHR3.0-EYFP) were provided by Dr. Deisseroth 
(Stanford University). For practical consideration, we switched EYFP by TagRFP by overlap extension 
PCR cloning method. The recombinant AAV vectors were serotyped with AAV5 coat proteins and 
packaged by the viral vector core at the University of North Carolina. To achieve Cre-dependent 
expression of opsins in CINs, we microinjected 1 µl of AAV at two dorso-ventral sites into the dorsal 
striatum of ChATcre/cre mice (+1.0 mm AP, ±1.5 mm ML, -2.7 and -2.1 mm DV). Opsin-expressing neurons 
were largely confined to the dorsal striatum (Figure S1B). Mice that were used in behavioral 
experiments were then implanted with a bilateral guide cannula (+1.0 mm AP, ± 1.5 mm ML, 26 gauge, 
positioned 2.5-mm below skull; PlasticsOne). All viral injections were made unilaterally except for in 
vitro recordings and haloperidol-induced catalepsy. 
6-OHDA lesions. Mice received one unilateral injection of 6-OHDA hydrochloride (1.5 µl at 2.7 µg/µl 
diluted in 0.9% sterile NaCl containing 0.1% ascorbic acid, Sigma-Aldrich) into the substantia nigra pars 
compacta: -3.0 mm AP, ±1.3 mm ML, -4.3 mm DV. 6-OHDA injection was immediately followed by 
unilateral intrastriatal viral injection and experiments were performed at least two weeks later. DA 
lesion extent was systematically assessed by anti-tyrosine hydroxylase immunochemistry. 
Optic fiber implantation. For L-DOPA-induced dyskinesia experiments that required long-term 
treatment, we used implantable optical fibers consisting of a zirconia ferrule with a 200-µm diameter 
and 3.3 mm-long cleaved bare optic fibers (0.22 N.A., Doric Lenses). Fibers were implanted ipsilaterally 
to the lesioned side at the following coordinates: +1.0 mm AP, ± 1.5 mm ML, -2.0 mm DV. 
 
In vitro electrophysiology. Coronal striatal slices (250 µm) from 7 to 10-week-old bilaterally AAV-
injected or transgenic mice were cut in ice-cold high-choline artificial cerebro-spinal fluid (ACSF) with 
a vibratome (Leica) as previously described (Beurrier et al., 2009). Recordings from 6-OHDA mice were 
performed 2 to 3 weeks after 6-OHDA injection and the extent of DA lesion was systematically assed a 
posteriori by anti-tyrosine hydroxylase immunochemistry in the striatum. Only mice exhibiting >70% 
of DA depletion compared to the non-injected hemisphere were kept for the analysis. Slices were then 
transferred to oxygenated ACSF and maintained at room temperature until recording. Neurons were 
visualized on an upright microscope (Nikon Eclipse FN1) equipped with DIC optic and filters set to 
visualize mCherry, TagRFP, tdTomato and EYFP using a x40 water-immersion objective. Combination 
of electrophysiological properties and expression of fluorophore was used to identify CINs and D1 
MSNs while unlabeled MSNs were considered as D2 MSNs. Recordings were interleaved in labeled D1 
MSNs and unlabeled putative D2 MSNs from the same mice. Patch-clamp recordings were performed 
in cell-attached and whole-cell configurations in current- or voltage-clamp mode in oxygenated ACSF 
warmed to 33°C. Patch-clamp electrodes (4-6 MΩ) were filled with an intracellular solution containing 
126 mM KMeSO4, 14 mM KCl, 3 mM MgCl2, 0.5 mM CaCl2, 5 mM EGTA, 10 mM HEPES, 2 mM NaATP 
and 0.5 mM NaGTP, pH adjusted to 7.25 with NaOH and osmolarity adjusted to 270-280 mOsm/L. To 
activate opsins, light was delivered under control of the acquisition software from a Spectra Light 
Engine (Lumencor, Optoprim) and was focused onto the back aperture of the microscope objective, 
producing a wide-field exposure around the recorded cell.  
MSN excitability was tested at least 5 min after seal rupture by sending a series of 500 ms depolarizing 
current steps with an increment of 10 pA. For trials in which CINs were photoinhibited, light was ON 
200 ms before and continue 200 ms after the 500 ms depolarizing current step, making the total 
illumination time equal to 900 ms. The time interval between each current step was 3 s. EPSCs were 
elicited by current pulses (0.1-ms width every 10 s) using a bipolar tungsten electrode placed 
preferentially at the motor cortex-dorsal striatum border to stimulate afferents from the motor cortex. 
For trials in which CINs were photoinhibited, light was ON 50 ms before cortical stimulation and 
continues 250 ms after. EPSCs amplitudes were calculated on at least 10 averaged traces by taking a 
mean of a 1-ms window around the peak and comparing this with the mean of a 3-ms window 
immediately before the stimulation artifact. Series resistances were monitored with a 5-mV negative 
step given with every afferent stimulus. Data were collected with a MultiClamp 700B amplifier 
(Molecular Devices), analyzed and plotted in clampfit (Molecular Devices, v 10.2) and Origin (v 7.5).  
 
Behavioral testing. Open-field. Spontaneous locomotor activity was evaluated in an open field placed 
in a dim lighted room. Before testing, mice were acclimated to the testing room for at least 1 h. RFP, 
eNpHR-RFP, mCherry and ChR2-mCherry mice were tested for 18 min in a square chamber (50 x 50 
cm) with a 30 cm-high white plastic wall. CINs were photoactivated (25-ms pulse width, 10 Hz) or 
photoinhibited (continuous illumination) during 3-min ON periods interspersed with 7-min OFF periods. 
Ambulation was defined as the total distance (in cm) covered by each mouse measured by 3-min bin 
for 18 min and recorded by a video track system (Viewpoint Life sciences Inc.).  
Haloperidol-induced catalepsy. Optical fibers were inserted into the bilateral cannula just before 
haloperidol injection. Mice received 0.25 mg/kg haloperidol i.p. After 20 min, mice forepaws were 
placed on an horizontal bar 4 cm above the floor and the latency to step down was measured (with a 
cut-off of 120 s) every 10 min during the 80-min test (Figure 1A). Head movements were also measured 
continuously for the whole test duration. Mice received either blue (25-ms pulse width, 10 Hz) or 
yellow (continuous illumination) light 20 min after haloperidol injection. Light was ON for 3-min during 
which catalepsy was measured and then turned OFF for 7 min until the next measurement started.  
Cylinder test. Mice were put into Plexiglas cylinders (20 cm height, 9 cm diameter) in order to evaluate 
motor asymmetry induced by 6-OHDA lesion. The number of contacts against the cylinder wall with 
the forepaws (weight-bearing contacts with fully extended digits) was monitored continuously for 
5 min by two investigators blind of experimental conditions. A double contact was defined as 
simultaneous or closely performed ipsilateral and contralateral forepaws touches. Mice failing to reach 
10 contacts were excluded from the analyses. Data are expressed as side bias calculated as % ipsilateral 
minus % contralateral contacts to the 6-OHDA lesioned side. All mice were tested only once to prevent 
habituation to the apparatus. Two groups of eNpHR-RFP or ChR2-mCherry 6-OHDA-lesioned mice were 
tested either in ON or OFF condition (yellow light: continuous illumination for 5 min, blue light: 25-ms 
pulse width, 10 Hz) and compared to the non-lesioned group. The same experiment was performed in 
two groups of RFP or mCherry 6-OHDA mice.  
Cross maze test. Mice were placed into a cross maze consisting of 4 identical arms (45 cm × 7 cm × 15 
cm) at 90° to each other and made with clear Plexiglas. The acquisition sessions started with the mouse 
placed in the middle, facing one arm. The number of ipsilateral and contralateral turns as well as the 
number of time the mouse went straight was monitored for 5 min. Pre-6-OHDA data were collected 
and then, 2 weeks after 6-OHDA lesions, mice were tested twice: one to collect post-6-OHDA data 
without light and the day after with the light ON (yellow light: continuous illumination for 5 min, blue 
light: 25-ms pulse width, 10 Hz).  
L-DOPA-induced dyskinesia. Fifteen to eighteen days after 6-OHDA injections, mice received a single 
daily injection of L-DOPA (20 mg/kg) and benserazide hydrochloride (10 mg/kg) for 21 days. The 
abnormal involuntary movements (AIMs) were assessed by two investigators blind of subject viral 
infections (eNpHR-RFP or RFP). Peak-dose dyskinesia scoring was performed for 1 min at different time 
points, 45 to 80 min after the last L-DOPA injection on day 21 (Figure S4). Axial and limb AIMs were 
scored using a previously established scale from 0 to 4 for each AIM subtype (Lundblad et al., 2004) 
and the sum of the 2 scores, defined as dyskinesia score, was determined for each animal (maximal 
score, 8). Yellow light was delivered during 13 min, starting 56 min after L-DOPA injections.  
For experiments involving scopolamine injection (scopolamine hydrobromide, Sigma-Aldrich), 
scopolamine was dissolved with NaCl and administered by i.p. injection at a dose of 1 mg/kg in 
ChATcre/cre mice. 
 
Optogenetic photostimulation and photoinhibition in awake mice. Optical fiber (200 µm- diameter, 
0.22 N.A., Doric Lenses) was inserted without anesthesia through the implanted cannula (tip 
protruding 0.3 mm). For bilateral illumination, optical fibers were connected to the laser through a 
rotary joint (FRJ_1x2i_FC-2FC, Doric Lenses) that sent half of the light coming from the laser into each 
of the two optical fibers inserted in the mouse brain and enabled the mouse to move freely during 
behavioral assessments. Light was provided by a yellow- (589 nm, 75.2 mW) and blue- (473 nm, 118.5 
mW) laser (Combined Dual Wavelength DPSS Laser System, Laserglow). Optical-fiber light power was 
measured using a light sensor and intensity calculated using the model based on direct measurements 
in mammalian brain tissue for predicting irradiance values developed in K. Deisseroth’s lab and 
available at http://www.stanford.edu/group/dlab/cgi-bin/graph/chart.php. Light intensity at 0.2 mm 
from fiber tip was calculated to be 11.3 and 20.0 mW/mm2 for blue and yellow light, respectively 
(corresponding to 200 and 140 mW/mm2 at the fiber tip). 
 
In vivo recordings in anaesthetized mice. Non-lesioned and 6-OHDA lesioned (at least two weeks post-
lesion) transgenic eNpHR mice were anesthetized with a mixture of ketamine and xylazine (100 and 10 
mg/kg i.p., respectively, supplemented as needed by i.p. injection during the course of the experiment) 
and fixed in a stereotaxic head frame (Horsley-Clarke apparatus; Unimécanique). Body temperature 
was monitored by a rectal thermometer and maintained at 36.5°C with a homeothermic blanket 
(Harvard Apparatus). Single-unit activity of SNr cells was recorded extracellularly using glass 
micropipettes (25-35 MΩ) filled with a 0.5 M sodium chloride solution containing 1.5 % neurobiotin 
(Vectors Laboratories Inc.). Single neuron action potentials were recorded using the active bridge 
mode of an Axoclamp-2B amplifier (Molecular Devices), amplified, and filtered with an AC/DC amplifier 
(DAM 50; World Precision Instruments). Nigral neurons were identified as non-dopaminergic by their 
classically defined electrophysiological characteristics: narrow spikes (width ≤ 2 ms) and ability to 
present relatively high frequency discharges (> 10 Hz) without decrease in spike amplitude (Deniau et 
al., 1978). The optical fiber (core 200 µm, N.A. 0.22, Dorics Lenses) was positioned in the striatum (+1.0 
mm AP, ±1.5 mm ML, -2.0 mm DV). The cortical and SNr areas to stimulate and record, respectively, 
were precisely defined by anterograde and retrograde tracing methods consisting in an iontophoretic 
deposit, at these striatal coordinates, of wheat germ agglutinin horseradish peroxydase (Vector 
Laboratories). This striatal territory receives inputs from the motor cortical area stimulated (+2.1 mm 
AP, ±0.5 mm ML, -0.7 mm DV) and sends projections to the recording site in the SNr (-3.3 mm AP, ±1.5 
mm ML, -4.0/-4.8 mm DV). The patterns of cortically-evoked responses in the same SNr neuron were 
analyzed before, during and after CIN photoinhibition in the striatum. Yellow light was delivered for 5 
min (589 nm, power at the tip of optical fiber: 140 mW/mm2). Only SNr cells presenting an inhibitory 
component in response to cortical stimulation were recorded as they were the only ones to receive 
direct inputs from the striatal area activated by cortical stimulation meaning they belonged to the basal 
ganglia channel in register with the cortical area stimulated. This inhibitory component was preceded 
and/or followed by excitations due to the activation of the two trans-subthalamic pathways. 
Population post-stimulus time histograms (PSTHs) were generated by aligning the evoked responses 
on the onset of the inhibitory component. Results are given as means ± SEM of the individual responses 
per condition. 
Spontaneous activity of SNr neurons was analyzed before, during and after CIN photoinhibition in the 
striatum by sampling a period of 60 s in each condition. Yellow light was delivered for 5 min (589 nm, 
power at the tip of optical fiber: 140 mW/mm2). Epochs of elevated discharge rate were classified as 
bursts using a Poisson Surprise analysis (Legendy and Salcman, 1985). This was done using a script 
written for the Spike2 software. Briefly, this analysis evaluates how improbable any given burst, that 
contains n spikes in a time interval T, occurred by chance and computed as follows:  S = -log p, where 
p is the probability that, in a random (Poisson) spike train having the same average spikes rate r as the 
spike train studied, a given time interval of length T contains n or more spikes. p is given by Poisson's 
formula, as follows:    
 
where S refers to the Poisson Surprise of the burst (the degree to which the burst surprises a person 
who expects the spike train to be a Poisson process). In this study, only spike trains with S ≥ 2 were 
considered to be bursts. At the end of electrophysiological experiments, the tip of the stimulating 
electrodes was marked by an electrical deposit of iron (5 μA anodal, 20 s) and the tip of the recording 
electrodes was marked by iontophoretic ejection of Chicago Sky Blue (Sigma, 4% in NaCl 0,6 M; 8 µA 
cathodal, 20 min). Brains were removed and fixed in a 10% formalin solution after a ferri-ferrocyanide 
reaction. The localization of the blue points and iron deposits were observed on serial frozen sections 
(70 µm) counterstained with safranin O (Sigma). All the recorded cells kept in the analysis were 
localized in the SNr. 
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Histology, immunohistochemistry and microscopy. Animals were deeply anesthetized with a mixture 
of ketamine/xylazine and then transcardially perfused with an ice-cold solution of paraformaldehyde 
4% in PBS. After dissection, brains were post-fixed overnight in the same fixative at 4 °C, cryoprotected 
in 30% sucrose dissolved in 1X PBS for an additional 36 h at 4 °C, and frozen. Coronal cryostat sections 
(40 µm) covering the antero-posterior extent of the striatum or the substantia nigra pars compacta 
were used for labeling. Brain sections were permeabilized in PBS with 0.4% Triton X-100 (PBST) for 30 
min at room temperature. Sections were then incubated in a blocking solution composed of PBST with 
3% bovine serum albumin and 10% normal goat serum for 1h at room temperature. Immunostaining 
was done on free-floating sections, which were then mounted onto SuperFrost Plus glass slides (VWR) 
and coverslipped with FluorSave mounting media (Merck Chemicals). Quantification of colocalization 
was performed from approximately bregma +1.42 to +0.02 mm (around 14 sections per mouse) using 
Mercator System (Explora Nova) combined with a DMR Leica microscope coupled to a DXC-990P color 
video camera (Sony). Images were collected using Axio Imager Z1 with the Apotome system (Zeiss) 
with a Plan-Apochromat 20×/0.8 or a Plan-Neofluar x40/1.3 objective (Zeiss) for the high magnification 
or with a Plan-Apochromat 10×/0.45 objective (Zeiss) to acquire whole-brain images. 
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